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Abstract: This work describes a holistic archaeometric approach to ancient Macedonian specimens.
In the region of the ancient city Lete, the deceased members of a rich and important family were
interred in a cluster of seven tombs (4th century BC). Among the numerous grave goods, there was
also a set of metal containers preserving their original content. The physico-chemical analysis of the
containers and their contents was performed in order to understand the purpose of their use. For the
containers, Energy Dispersive micro-X-Ray Fluorescence (EDμXRF) spectroscopy was implemented
taking advantage of its non-invasive character. The case (B35) and the small pyxis (B37) were made of
a binary Cu-Sn alloy accompanied by a slight amount of impurities (Fe, Pb, As) and the two miniature
bowls were made of almost pure Cu. For the study of the contents, a combination of EDμXRF,
X-Ray Diffraction (XRD), and Gas Chromatography—Mass Spectrometry (GC-MS) was carried out.
Especially for the extraction of the volatile compounds, the Solid Phase Micro-Extraction (SPME)
technique was used in the headspace mode. Because of the detection of Br, High Pressure Liquid
Chromatography coupled to a Diode-Array-Detector (HPLC-DAD) was implemented, confirming
the existence of the ancient dye shellfish purple (porphyra in Greek). The analytical results of the
combined implementation of spectrometric and chromatographic analytical techniques of the metal
containers and their contents expand our knowledge about the pharmaceutical practices in Macedonia
during the 4th century BC.
Keywords: Derveni; Ancient Macedonia; micro-XRF; XRD; HPLC-DAD; HS-SPME/GC-MS; ancient
medicines; ancient pharmaceuticals; shellfish purple; porphyra; high-tin bronzes; bronzes
1. Introduction
The Derveni tombs were accidentally revealed in 1962, 9.5 km NW of Thessaloniki, Macedonia,
Greece. The six cist graves and one Macedonian tomb that were excavated then had not been looted
and contained rich offerings, mainly dated to the 4th century BC. The deceased were members of a
rich and important Thessalian family that probably lived in the nearby ancient city Lete. In grave A,
the so-called Derveni papyrus was found; fragments of a papyrus roll with the most important Orphic
religious text of the 4th century BC, preserving excerpts of an earlier poem. The biggest and richest
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grave was grave B. It contained the cremated remains of a man and his female consort, which had
been placed in an elaborate bronze vessel, today known as the famous Derveni krater. That male
individual was an important member of the elite, probably a royal companion who died when he was
approximately 35–50 years old. In addition to the bronze krater, the burial contained a gold wreath
and other gold jewelry, twenty silver vessels, many bronze vessels, stone alabastra, glass vessels and
pottery vases, the iron weapons of the dead, a folding board gaming set with glass gaming counters,
pieces of a leather cuirass, bronze greaves, and a gold coin of King Philip II [1,2].
Among the numerous grave goods, from grave B, was a lidded box (B35), preserving its original
content (Figure 1). It is a semi-cylindrical case divided into three compartments. Each compartment is
filled with a mass of “clay”. The case has a hinged lid that protects the contents. According to the first
estimations [1], B35 is a case for storing cosmetics and its contents are materials for makeup. Ongoing
research on the history of medicine in Macedonia and the comparison with other metal cases which
have been unearthed in Macedonian burials [3,4], after B35, had led to suspicions that the Derveni case
was a medical case. Other metal finds from the same grave that were more or less associated with the
case B35 are: two bowls (B43a, B43b) and a pyxis (B37), all preserving their original content. In the two
bowls, there are preserved pieces of a thin dark-coloured cake and in the pyxis there is a red powder.
 
 
(a)  (b)  
  
(c)  (d)  
Figure 1. Metal containers and their contents. (a) Lidded case B35 and its content (cakes B35-I, B35-II,
B35-III). (b) Case B35 without the lid. (c) Bowls B43a and B43b. (d) Lidded pyxis B37 (with and
without lid).
The aims of the present physico-chemical study are: (a) to determine the composition of the alloy
used for the construction of the metal containers, as well as the differentiation according to each part
of the artefact (e.g., body, lid, handle, nails); and (b) to identify the inorganic and organic components
of the contents using chemical and mineralogical analysis. The analytical results will contribute to the
effort to determine the nature of these artefacts and consequently their purpose of use, as well as to
illuminate the identity of their owner.
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2. Materials and Methods
The metal containers under study are: one lidded case (B35), two miniature bowls (B43a, B43b),
and a small pyxis (B37), all found in Derveni grave B. The metal case B35 consists of different parts:
body, lid, handle, the lid’s hinges, the rim of the case proper, and the nails the latter is fastened with.
The bowls B43a and B43b have been made from a single metal sheet and pyxis B37 consists of its body
and a lid. Case B35 is preserved in very good condition. It has been chemically cleaned in the past
and does not carry any corrosion products. Its color, after the cleaning, is golden. On the other hand
the two bowls (B43a, B43b) are reddish, denoting a differentiation of the alloy compared to that of
B35. They are also preserved in a very good state and apparently do not present corrosion layers.
Finally, pyxis B37 presents, at the body, a thick reddish corrosion layer in combination with extensive
restoration works. Its lid maintains a better condition with areas where the metal does not present
extensive corrosion layers.
For the analysis of the metal containers, the choice of a non-invasive and non-destructive analytical
technique is obligatory. Sampling is largely prohibited, according to the Greek Archaeological Law,
due to the uniqueness, integrity, and small size of the artefacts. So the choice of a non-invasive
technique like Energy Dispersive micro X-ray Fluorescence (EDμXRF) spectroscopy—which is a
widespread technique for the analysis of ancient metals [5,6]—was a requisite instead of a technique
that provides bulk analysis, such as Inductively Coupled Plasma Spectroscopy (ICP) or Atomic
Absorption Spectroscopy (AAS). On the other hand, EDμXRF provides a chemical profile of the surface,
which may differ from the bulk composition and perhaps is not representative of the whole [7,8].
When bronze artefacts are exposed to the atmosphere or are buried in the ground, their surface acquires
a more or less thick patina under which the metal core may remain substantially unchanged [9].
Before the implementation of the EDμXRF analysis, optical macro- and microscopic examination of
each artefact was applied in order to select the spots for analysis. Areas free of corrosion products or
materials from conservation treatments were selected. Especially at the pyxis B37, mechanical removal
of the corrosion products took place in order to measure from the bulk of the metal.
The contents of case B35 bear similar hues. Starting from left to right, they were numbered: B35-I,
B35-II, and B35-III. Especially at the middle compartment of B35 and on the top of cake B35-II, a fourth
cake can be seen which has a different hue than the others. Instead of an earthy hue, it is reddish and
was hence numbered B35-IIa. Macroscopically, cakes B35-I, B35-II, and B35-III resemble dried out clays.
Respectively, the contents of bowls B43a and B43b were numbered B43a-I and B43b-I. These cakes
are harder than those in case B35 and their hue is brownish red with a dark top. To characterize the
components of the four cakes that are preserved in the lidded case B35, as well as the two from the
bronze bowls (B43a, B43b) and the red powder from the pyxis (B37), a physico-chemical analysis was
undertaken in combination with a mineralogical examination. After the preliminary morphological
examination by stereomicroscopy, EDμXRF spectroscopy was carried out for the analysis of the
inorganic constituents. In order to determine their mineralogical composition, XRD diffractometry
was implemented. For the study of the organic constituents, the samples were extracted with the
Head Space—Solid Phase Micro-Extraction (HS-SPME) technique and the absorbed volatiles were
analyzed by Gas Chromatography—Mass Spectrometry (GC-MS). Because of the significance of the
material under study, an effort has been made to implement the above analytical techniques, as much
as possible, in a non-destructive way. Analysis using High Pressure Liquid Chromatography coupled
to a Diode-Array-Detector (HPLC-DAD) was carried out in only one sample from cake B35-IIa in order
to ascertain the constituent which is responsible for its color. The cause of this implementation was the
interesting results of EDμXRF in combination with its reddish hue.
2.1. Energy Dispersive Micro-X-ray Fluorescence spectrometry (EDμXRF)
The instrument ARTAX 400 (Bruker AXS Microanalysis GmbH, Berlin, Germany) was used for
the implementation of the micro-X-ray Fluorescence spectroscopy technique (μXRF). This Energy
Dispersive spectrometer has been specially designed for the demands of archaeometry [10].
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The measuring head, which is placed on a x,y,z—motor driven positioning stage, is comprised of: (a) an
air cooled Mo X-ray fine focus tube, (b) a peltier cooled silicon drift detector (SDD), and (c) a Charge
Coupled Device (CCD) camera for the visual inspection of the sample. The X-ray beam is restricted by
a collimator and on the surface of the sample has a diameter between 200 μm and 1500 μm, depending
on the type of collimator used. All excitation and detection paths can be rinsed with Helium (He) gas
which is directed, by use of two gas jets, towards the sample surface in order to reduce the absorption
of the beam through the air and thus improve the excitation conditions for elements with a lower
atomic number. Acquired spectra were processed with software SPECTRA 7.4. This program enables
the acquisition of measurement data including the control of all Artax 400 components. Parallel to
the measurement, it is possible to carry out qualitative elemental analysis, data reduction (integral
calculation of the different spectral lines through deconvolution), and calculation of the artefact
elemental concentration.
For the analysis of the metal containers, EDμXRF measurements (ARTAX 400, Bruker AXS
Microanalysis GmbH, Berlin, Germany) were taken in order to determine their elemental composition.
For the metal case B35, measurements were taken from every different part (body, lid, hinge, rim,
nails). Each final reported result is the mean value of three measurements. The measurement time
for each spot analysis was 100s. The voltage of the exciting X-ray beam was 50 kV and the current
was 700 μA. The collimator with a 1500 μm diameter was used in order to get a representative result
and to avoid alterations due to micro structural inhomogeneity [11,12]. Especially for the analysis of
the pyxis B37, which presents corrosion layers, and in order to avoid the removal of corrosion in an
extended area (since it is considered as a destructive action), the collimator with a diameter of 650 μm
was used. The certified data from Certified Reference Material (CRM) 32XSN1 (MBH—Analytical Ltd.,
Barnet, UK) was used as a calibration file. The quantified results were balanced to 100%. In order to
check the accuracy of the implemented method, measurements were taken with the same parameters
as those employed for the artefacts, from Certified Reference Materials (CRMs). BCR-691 (European
Commission—Joint Research Centre, Institute for Reference Materials and Measurements, Brussels,
Belgium), a set of five (5) copper alloys, was used (Table 1).
Table 1. Results of the analysis of Certified Reference Materials (CRM’s) and detection limits (wt %).
BCR-691 Sn Zn Pb As
Quaternary bronze (A)
Certified value ± unsertainty 7.16 ± 0.21 6.02 ± 0.22 7.90 ± 0.7 0.19 ± 0.01
Measured value ± std 7.00 ± 0.3 6.20 ± 0.45 7.50 ± 0.50 0.20 ± 0.00
Brass (B)
Certified value ± unsertainty 2.06 ± 0.07 14.80 ± 0.50 0.39 ± 0.04 0.10 ± 0.01
Measured value ± std 2.00 ± 0.10 14.50 ± 0.21 0.30 ± 0.06 0.10 ± 0.00
Arsenic copper (C)
Certified value ± unsertainty 0.202 ± 0.029 0.05 ± 0.005 0.175 ± 0.014 4.6 ± 0.27
Measured value ± std 0.17 ± 0.06 0.03 ± 0.01 0.18 ± 0.04 4.5 ± 0.50
Lead bronze (D)
Certified value ± unsertainty 10.1 ± 0.80 0.148 ± 0.024 9.2 ± 1.7 0.285 ± 0.022
Measured value ± std 9.60 ± 0.50 0.17 ± 0.02 9.05 ± 0.416 0.26 ± 0.05
Tin bronze (E)
Certified value ± unsertainty 7 ± 0.60 0.157 ± 0.025 0.204 ± 0.018 0.194 ± 0.02
Measured value ± std 7.33 ± 0.50 0.17 ± 0.01 0.2 ± 0.00 0.2 ± 0.00
Estimated detection
limits (%)
0.02 0.01 0.03 0.01
For the elemental analysis of the contents of the metal containers, with the EDμXRF technique,
the voltage of the exciting X-ray beam was 35 kV and the current was 900 μA. It was also implemented
in an He gas atmosphere. The 1500 μm diameter collimator was used to counterbalance the
inhomogeneity of the materials under study. Each final reported result is the mean value of seven
measurements since the contents present greater inhomogeneity than the metal containers. For the
quantification of the analytical results, the CRM soil sample SO-3 (Canada Centre for Mineral & Energy
Technology, Ottawa, ON, Canada) was used in combination with software SPECTRA 7.4 (Bruker AXS
Microanalysis GmbH, Berlin, Germany).
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2.2. X-ray Diffraction (XRD)
The content of the metal containers were archaeological material and therefore were studied in
their bulk form without any grinding, homogenization, or pretreatment. In order to identify their
mineralogical composition, X-ray diffraction analysis (XRD) was applied directly on the surface of
the samples.
A Phillips PW1820/00 diffractometer equipped with a PW1710/00 microprocessor (PHILIPS,
Almelo, The Netherlands) was used and the samples were scanned over the 3◦–63◦ 2θ interval at a
scanning speed of 1.2◦/min. Semi-quantitative analysis estimates of the abundance of the mineral
phases were derived from the XRD data, using the intensity of a certain reflection [13], the density,
and the mass absorption coefficient for Cu-Kα radiation for the minerals present. The identification
of the minerals present was made using the DDView+/SiIeve+ ICDD’s viewing/search indexing
software provided with the PDF-4+ (PDF-4+, 2009, Powder diffraction fileTM, International Centre for
Diffraction Data, Newtown Square, PA, USA) relational database. Corrections were made using the
external standard mixtures of minerals (i.e., standard mixtures of the identified minerals in the studied
samples such as quartz and cristobalite, feldspars, micas and chlorite, amphibole, calcite and sulfate
minerals, as well as iron oxides). The detection limit of the method was ±1% w/w [14]. The degree
of crystallinity and the calculation of the amorphous phase amount were calculated according to the
method described by Kantiranis et al. (2004) [14].
2.3. Head Space—Solid Phase Micro-Extraction/Gas Chromatography—Mass Spectrometry
(HS—SPME/GC—MS)
The pre-treatment and extraction of the samples was done by the HS-SPME technique using
a polydimethylsiloxane (PDMS) coated fiber (100 μm film) in the head space above the heated
samples. GC-MS (Agilent 6873 K gas chromatograph—Agilent 5973 quadrupole mass detector,
Agilent Technologies, Santa Clara, CA, USA) analysis of the absorbed volatiles from the samples
was carried out and finally the identification of the compounds was succeeded by using the NIST
library. The GC-MS operating conditions are listed in Table 2.
Table 2. GC-MS operating conditions.
Operating Conditions Value
GC model Agilent 6873 K gas chromatograph (Electron Ionization mode)
Column DB-5MS (capillary) 30 m × 0.25 mm × 0.10 μm
Injector port temperature 200 ◦C (SPME fiber was remained there for 6 min)
Carrier gas, Flow-rate Helium, 2.0 mL/min (constant pressure at 29.8 psi)
Oven temperature program 60 ◦C (3 min) to 270 ◦C, 10 ◦C/min ramp time
Transfer line temperature 250 ◦C
MS model Agilent 5973 quadrupole mass detector (Scan mode)
Total time of chromatographic analysis 40 min
2.4. High Pressure Liquid Chromatography—Diode Array Detector (HPLC-DAD)
High Pressure Liquid Chromatography was coupled to a Diode-Array-Detector (Ultimate 3000,
Dionex, Sunnyvale, CA, USA,) and consisted of a LPG-3000 quaternary HPLC pump with a vacuum
degasser, a WPS-3000SL auto sampler, a column compartment TCC-3000SD, and a UV-Vis Diode Array
Detector (DAD-3000) (Dionex, Sunnyvale, CA, USA) Analyses were carried out by injecting 20 μL into
an Alltima (Grace-Alltech, Deerfield, IL, USA) HP C18 (250 mm × 3 mm, i.d. 5 μm) column at a stable
temperature of 35 ◦C.
Two solvent reservoirs, containing (A) water + 0.1% (v/v) Tri-Fluoro-Acetic Acid (TFA) and (B)
acetonitrile + 0.1% (v/v) TFA, were used under a gradient elution program which was developed and
evaluated for the analysis of shellfish purple components offering extremely low limits of detection [15].
The sample was immersed in a hot (80 ◦C) dimethyl sulfoxide (DMSO) bath and kept there
for 15 min. After centrifugation, the upper liquid phase was immediately submitted to HPLC.
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By employing this method, polar and apolar compounds are detected. The method was previously




According to the results of Table 3, the main parts (body, lid, and rim) of the metal case B35
were made of copper-tin (Cu-Sn) alloy. Lead (Pb), iron (Fe), and calcium (Ca) were detected, at all
parts, at quantities much lower than 1 wt %. Arsenic (As) is also detected, except at the four nails
which present significant differentiation, at their chemical composition, compared to the main parts
of B35. They consist of almost pure Cu which is detected at levels higher than 99.0 wt %. Nickel (Ni)
and titanium (Ti) are only detected at the nails of B35, at very low quantities (rounded average for
the four nails are: 0.17 ± 0.03 and 0.01 ± 0.00 wt % for Ni and Ti, respectively), while Sn is present
at levels below 1 wt %. Another part of B35 that presents a significant differentiation is the hinge
of the lid where the quantity of Sn (6.56 ± 0.30 wt %) is very low compared to the body of the case
(12.11 ± 0.20 wt %).
Bowls B43a and B43b present the same qualitative and quantitative analysis. Cu is detected at
levels around 99 wt %. The two bowls present also the same chemical elements Sn, Pb, Fe, As, Ni,
and Ca at similar quantities (lower than 0.5 wt %). At pyxis B37, measurements were only taken from
its lid after the removal of superficial corrosion products. The body presents thick corrosion layers
which will not provide us with a safe quantitative result. The lid of pyxis B37 mainly consists of Cu
(86.96 ± 0.40 wt %) and Sn (12.16 ± 0.20 wt %) at quantities similar to the main parts of the metal case
B35, e.g., the body (Cu: 87.61 ± 0.60 wt % and Sn: 12.16 ± 0.20 wt %). Similar to B35, Pb and Fe are the
minor elements, at quantities lower than 1 wt %. However, Ni is only detected at a very low quantity
(0.15 ± 0.50 wt %).
3.2. Contents of the Metal Containers
According to the EDμXRF analysis (Table 4), cakes B35-I, B35-II, and B35-III, which present a
similar appearance, texture, and colour, also present similar analytical results. Major constituents
(concentration higher than 1 wt %) are: SiO2, Al2O3, Fe2O3(total), MgO, CaO, CuO, and K2O; and minor
constituents (concentration between 0.1 wt % and 1.0 wt %) are: V2O3, and MnO. Finally, at the level
of traces (concentration lower than 0.1 wt %), the following were detected: Cr2O3, NiO, ZnO, Rb2O,
SrO, and PbO.
Cake B35-IIa, which presents a reddish hue, presents some differentiations compared to the other
cakes. Al2O3, which is a main constituent in the other cakes, is a minor one at B35-IIa (0.28 ± 0.30 wt %).
Furthermore, the total percentage of the inorganic constituents is lower in than the other cakes and
ranges from 16.56 wt % to 42.27 wt %. Finally, B35-IIa is the only cake where the chemical element
bromine (Br) was detected (Figure 2). This result, in combination with the differentiation of the colour
of the cake (reddish hue), created suspicions for the possible existence of a dye. In the cakes (B43a-I,
B43b-I) of the two bowls, there is a similar distribution between major and minor constituents and those
that detected as traces. Compared to cakes of the metal case B35, the total percentage of the inorganic
oxides (30.98 wt % for cake B43a-Iand 15.03 wt % for cakeB43b-I) is significantly lower. The powder in
pyxis B37 presents great differentiations, in terms of the analytical results, compared to the contents of
the others containers. There are only two major constituents: Fe2O3(t) (11.44 ± 1.10 wt %) and CuO
(9.71 ± 1.10 wt %). The minor constituent detected is CaO, and ZnO and K2O are only detected
in traces.
6
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Figure 2. EDμXRF spectrum of cake B-35-IIa—detection of Br (peak Ka1 at 11.88 keV and Kb1 at 13.29 keV).
The detection of Br in combination with the colour differentiation of the sample B35-IIa led to the
investigation of the possible existence of a dye that contains Br. The implementation of the HPLC-DAD
technique resulted in the detection of the compound 6,6′-dibromoindigotin (DBI) (Figure 3), which was









Figure 3. 6,6′-dibromoindigotin (DBI).
According to the results of the mineralogical analysis (Table 5) of the cakes in case B35, similar
amounts of quartz (SiO2) (39–44 wt %) were detected at high quantities. Other constituents in
abundance are: plagioclase (8–29 wt %), mica (6–14 wt %) that belongs to the group of silicate
minerals, and chlorite (4–8 wt %). Minerals like K-feldspar and calcite are only detected in cakes
B35-II and B35-III. Amorphous matter estimated at high level ranges from 16% to 31%, except in cake
B35-I, where it is only 5 wt %. In cakes B43a-I and B43b-I, the amorphous matter estimated at even
higher levels ranges from 65 wt % to 78 wt %. Except for the siliceous minerals (quartz, plagioclase,
and mica), cristobalite (6–12 wt %), gypsum (5 wt %), and graphite (1 wt %) were also detected.
Graphite was possible to identify (Figure 4) and measure using the 89-8487 ICDD card (main peak
3.3540Å, in comparison with the 3.3434 Å main peak of quartz, 46-1045 ICDD card). Especially 2 wt %
bassanite was detected in cake B43b-I, a calcium sulfate mineral. Finally, powder B37-I presented a
very different mineralogical composition than the others. The dominant constituents are the ferrous
oxides (hematite and magnetite: 71 wt %), a copper sulphate mineral antlerite (15 wt %), gypsum
(8 wt %), bassanite (5 wt %), and a low quantity of a rare borate mineral: inderite (1 wt %).
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Figure 4. XRD pattern of cake B43b-I.
Table 5 presents the organic constituents of the contents of the metal containers according to
the results of the HS-SPME/GC-MS analysis. In cake B35-I, only three (3) organic compounds were
detected, none were detected at B35-II, and only three (3) (most of them fatty acids) were detected at
B35-III. Contrary to the above, in cake B35-IIa, which presents a reddish hue, twenty-two (22) organic
constituents (fatty acids, fatty acid esters, hydrocarbons, quinolines, phthalate esters, and amines) were
detected (Figure 5). At contents B43a-I and B43b-I, the same three organic constituents were detected
and at the red powder B37-I, seven (7) (thioamides, lactam, hydrocarbons, halide, and phthalate
ester) were detected. Except for B43a-I and B43b-I, the other contents do not share any of the organic
compounds. Fatty acids are the class of organic compounds which is common in the B35 and B43
contents. On the other hand, classes like thioamides and lactam are only detected at powder B37.
Figure 5. GC-MS chromatogram of volatile constituents of the sample B35-IIa (retention times
correspond to analytes as described in Table 6).
9




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Separations 2018, 5, 32
4. Discussion
4.1. Metal Containers
Metal case B35, which was found in Derveni grave B, presents differentiation in terms of the
chemical composition of its various parts (Table 2). These parts have been made from hammered metal
sheets (except the lid’s handle which was cast). In general when Sn exceeds the limit of 1% in a Cu
alloy, it is characterized as a deliberate addition [17]. The main parts of B35 (body, lid, the lid’s handle,
and the rim) were made of tin bronze (Cu-Sn) alloy accompanied by a low amount of impurities
(Pb, Fe, As, Ca). This type of alloy was employed in Macedonia during the Classical period for the
manufacture of vessels and utensils [7,18,19]. There is a classification of bronzes from low to high
Sn depending on the amount of Sn that was added to the alloy. According to the related literature,
there is no single definition of the concentration of Sn that would define an ancient bronze artefact as a
“high-tin” [8,12,20]. The most accepted compromise, to characterize an ancient bronze as “high-tin”,
is an Sn concentration between 14 wt % and 16 wt %. [21,22]. Given that the lid’s handle and the rim
contain enough Sn (14.42–15.62 wt %) to characterize them as “high-tin” bronzes, the body and lid are
close to this definition since they contain around 12 wt % Sn. On the contrary, the hinge contains only
6.59 ± 0.30 wt % Sn. The addition of Sn to Cu increases the strength and hardness of the alloy [23–25].
It also increases the resistance of the bronze artefact to corrosive parameters [21]. On the other hand,
a Sn content higher than 15 wt % strongly increases the embrittlement of the alloy, raising problems
(e.g., cracking) during hammering [18,25]. The role of the quantity of Sn is also significant to the
appearance of bronze artefacts. A high Sn content gives them a “golden” hue which probably imitates
vessels of precious metals [8,21,26] and denotes the high social status of the owner of B35; already
suggested for grave goods in Derveni grave B [1]. Only the four nails are different and those contain
Sn as an impurity and not as an additive [17]. Its very low level (0.06–0.76 wt %) makes the alloy easy
to work with [27], but the authors also express their reservation as to whether the nails and hinge
are ancient, or are modern additions. The chemical composition of bowls B43a and B43b, which are
also hammered, is also different. Their main constituent is Cu (at level of 99 wt %) accompanied by a
low amount of impurities (Sn, Pb, Fe, Ni, Ca). Sn is detected at very low quantities (0.04 ± 0.01 wt %)
and is characterized as an impurity and not as an additive [17]. Finally, the lid of pyxisB37 presents
a relatively high amount of Sn (12.16 ± 0.20 wt %), similar to the lid of case B35 (12.07 ± 0.01 wt %).
The criteria of the ancient smith and their customers were more the social status and prestige imparted
by the appearance of the objects [28] (ensuring the golden appearance of the artefacts with the addition
of a relatively high amount of Sn) and not so much the workability. The smith of the 4th century
BC probably developed skills to work with such brittle alloys without causing any cracks. The fact
that pyxis B37 presents extensive corrosion compared to the good preservation of case B35 must be
attributed to the taphonomic environment (e.g, the coexistence with other metal artefacts [27]) and not
so with the chemical composition.
Fe is detected in all metal artefacts of the present study. In all cases, it is characterized as an impurity
due to its very low concentration (0.04–0.20 wt %) [23,29]. Fe readily enters Cu during smelting and
differences in Fe content arise through differences in the smelting process. The implementation of a
simple and short smelting process results in an average Fe content of around 0.05 wt % instead of a
process that involves slagging where the average Fe content rises at 0.5 wt % [30,31]. In this study,
it is estimated that the first procedure was implemented. Moreover, for cold hammering procedures,
Fe must not exceed 0.5 wt % because the formability of the artefact decreases due to precipitation
phenomena [32]. Finally, the detection of very low Fe concentrations is an indicator that native and
unrefined Cu was used [23,30].
Pb is considered as an impurity for all results of Table 2 since its concentration is lower than
2 wt % [33]. This is an expected result for hammered objects but not for cast ones (e.g., B35 lid’s handle
which contains only 0.15 ± 0.03 wt % Pb). This result is unexpected since Pb was a common additive
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in ancient bronzes. It improved fluidity and castability as it causes a reduction of the melting point.
Most Hellenistic bronze cast artefacts contain more than 2 wt % Pb [34].
Arsenic was detected at all parts of B35 case (except the four nails) and bowls B43a and B43b at
very low levels (0.01–0.04 wt %). This very small quantity may indicate that the initial ore deposit was
not rich in As [33]. According to a previous study [7], Greek bronzes of the 4th century BC contain,
in general, less than 1 wt % As, which is confirmed by the present investigation.
4.2. Contents of the Metal Containers
Elements like Si, Al, Fe Mg, Ca, and K which were detected as the main constituents, according
to the EDμXRF analysis (Table 4), are in abundance in the earth’s crust [21,27] and are consequently
common soil elements. The only chemical element that is not common and is detected in all contents
is Cu. A possible interpretation for this is contamination from the metal containers due to the
long-term coexistence at the burial environment [35]. The other result, not common in soil, is the
detection of Br in cake B35-IIa. Br was only detected in this cake, which also presents a reddish hue.
The consequent implementation of the HPLC-DAD technique led to the detection of the compound
6,6′-dibromoindigotin (DBI), which is used as an index for the identification of shellfish purple
(or porphyra in Greek or mollusc purple). Purple was the colour of royalty and a designator of
social status.
According to the EDμXRF results of (Table 4), the powder of pyxis B37 presents a very different
chemical composition. Elements which are the main constituents in the other contents (Si, Al, Mg, Ca,
K) have not been detected in B37-I. Fe and Cu oxides comprises almost 20 wt % of the powder. The rest
of it could be organic material, carbon oxides, or chemical elements of a very low atomic number (lower
than 12) for which the excitation conditions of the EDμXRF technique are poor [36]. The high content
of powder B37-I in ferrous constituents was also confirmed by the XRD results (Table 5), which have
been normalized at 100 wt % contrary to the results of EDμXRF (Table 4). According to them, B37-I is
mostly comprised of hematite (Fe2O3), magnetite (Fe3O4), and antlerite (Cu3(SO4)(OH)4). Hematite is
a red mineral pigment well known in antiquity [37]. Antlerite is a possible corrosion product of the
reaction of the bronze antiquities, which are located in urban areas, with sulfur dioxide (a common
pollutant). Especially in sheltered areas, the low weathering permits the accumulation of copper ions
and enhancement in the acidity of water films [38].
A possible grouping according to the XRD results is: group A of the four B35 cakes where
silicate minerals dominate, group B of the two B43 cakes which are mostly comprised of amorphous
material, and finally group C of the red ferrous mineral powder which comprises entirely crystalline
phases (Table 5). Gypsum (CaSO4·2H2O) is a common constituent in groups B and C. It is known,
in antiquity, for adhesive and quick binding properties, especially regarding constructions [27].
Especially and only in the B37-I bassanite [CaSO4·0.5(H2O)], a semi-hydrous form of sulfate salt
is detected. Bassanite probably resulted from the dehydration of gypsum under dried conditions.
The authors, however, express their reservation that the presence of gypsum and bassanite in B37-I
may be explained by contamination with reservation materials applied. In cake B35-I, the mineral
hydrozincite Zn5(CO3)2(OH)6, which was used in antiquity for ophtalmic purposes, is detected [39].
The mineral cristobalite is only detected in the contents of B43a and B43b bowls. It is a member of
the quartz group minerals and has the same chemical formula as quartz, SiO2, but a distinct crystal
structure. The above grouping of the contents under study implies a targeted selection of raw materials
in order to have the desired effects during use.
In the sample B35-IIa, pentanoic acid has been detected (Table 6). Pentanoic acid or valeric
acid is a compound with an unpleasant rancid odour and naturally occurs in the roots of the plant
“valeriana officinalis”. It is used in pharmaceuticals, as well as in cosmetics and perfumes, in its
pure form or as an ester [40]. “Valeriana officinalis” was traditionally used in ancient Greece as a
treatment against stress and insomnia [41]. At the same sample, another organic substance detected is
nonadecane. Nonadecane is used as a fragrance agent and it is one of the components of the essential
13
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oils of some of the species that belong to the genus “Artemisia” [42]. More specifically, “Artemisia
absinthium” is a species of Artemisia native to Eurasia and analysis has shown that, among several
other chemical substances, its essential oil also contains nonadecane [43]. In ancient Greece, “Artemisia
absinthium” was used for its medicinal properties against gastrointestinal disorders, as an astringent,
helminthicide, diuretic, and emmenagogue [41]. In this case, nonadecane could have been used for
its sole properties or as a masking agent to cover the unpleasant odour deriving from pentanoic acid.
Nevertheless, access to other species of Artemisia or even completely different genuses, not native to
the Mediterranean or Eurasia, cannot be excluded. As traces of fatty acid esters can be observed in all
the compartments of the lidded case (B35), a possible explanation could be a preparation in the form
of an ointment or even a formulation to be consumed orally, which would target the gastrointestinal
system, simultaneously combining the sedative properties of “Valeriana officinalis” and the therapeutic
activity of Artemisia absinthium, as gastrointestinal disorders are commonly associated with stress.
Hexadecanoic acid was detected in the B-35-I cake. This chemical substance is also known by
the name palmitic acid and is used widely as a cleansing agent and in the production of soaps [44].
Palmitic acid can be found naturally in meat, dairy products, palm oil, and palm kernel oil, as well as
in other plant oils, in smaller amounts [45]. More specifically, palmitic acid is one of the constituents of
the essential oil of the plant “carum carvi”, widely known as “caraway”, which was used in Europe as
a traditional medicine for stomach disorders and flatulence [41]. The content of sample B-35-I could
potentially constitute a soap or a cleansing agent, some kind of medicinal ointment, or a decoction for
oral consumption to treat stomach disorders.
It is well known that fatty acids and their derivatives were used in antiquity as constituents of
pharmaceutical products [41,46]. According to the results of the HS-SPME/GC-MS analysis (Table 6),
many of the twenty-two organic compounds that were detected in cake B35-IIa belong to the above
classes. In the same cake, 6,6′-dibromoindigotin (DBI) was detected, which in combination with the
reddish colour, denotes the existence of the royal dye shellfish purple. In the other cakes, very few
organic compounds were detected. A possible interpretation is that cake B35-IIa was the basis that
contained a large number of drastic substances and the reddish—purple colour a useful indicator for
distinguishing it easily from other preparations. Alternatively, cake B35-IIa was perhaps contaminated
by purple-dyed items that had been deposited in the burial. Dioscuridies Pedanius, in his work
“De Materia Medica” [46], refers to the storage of fats in tin containers for pharmaceutical purposes.
The metal case B35 and pyxis B37 were made of a high tin bronze alloy, but on the other hand, bowls
B43a and B43b were made of almost pure Cu.
5. Conclusions
The combination of spectrometric (EDμXRF, XRD) and chromatographic (HPLC-DAD,
HS SPME/GC-MS) analytical techniques was used as a holistic archaeometric approach in order
to determine the construction technology of a group of metal containers and the chemical synthesis of
their contents. The analytical methodology gave priority to a non-destructive implementation, as far as
possible, due to the uniqueness and significance of the analyzed material. For the elemental analysis of
the metal containers, EDμXRF spectrometry was implemented, in a non-invasive way, which resulted
in the determination of their raw materials. Moreover, differentiations in their constituent parts were
found. Generally, two kinds of alloy were used: a high tin bronze alloy for the construction of the main
parts of metal case B35 and pyxis B37 and pure Cu accompanied by a low amount of impurities for the
manufacture of bowls B43a and B43b. Furthermore, their chemical composition reveals the ancient
archaeometallurgical procedures of the 4th century BC.
The implementation of a non-invasive technique like EDμXRF could be used as a guide for the
selective implementation of a destructive one, e.g., the detection of Br in cake B35-IIa, which led to
the implementation of HPLC-DAD and the detection of the royal dye shellfish purple. Although
the archaeological approach led to the conclusion that this set was used for medical purposes [4],
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the archaeometric approach provides us with further information on medical knowledge in Macedonia
during the 4th century BC
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Abstract: Antibiotics are a common practice in veterinary medicine, mainly for therapeutic purposes.
Sectors of application include livestock farming, aquacultures, and bee-keeping, where bacterial
infections are frequent and can be economically damaging. However, antibiotics are usually
administered in sub-therapeutic doses as prophylactic and growth promoting agents. Due to
their excessive use, antibiotic residues can be present in foods of animal origin, which include
meat, fish, milk, eggs, and honey, posing health risks to consumers. For this reason, authorities
have set maximum residue limits (MRLs) of certain antibiotics in food matrices, while analytical
methods for their determination have been developed. This work focuses on antibiotic extraction
and determination, part of which was presented at the “1st Conference in Chemistry for Graduate,
Postgraduate Students and PhD Candidates at the Aristotle University of Thessaloniki”. Taking a
step further, this paper is a review of the most recent sample preparation protocols applied
for the extraction of sulfonamide antibiotics from food samples and their determination with
high-performance liquid chromatography (HPLC), covering a five-year period.
Keywords: food; sample preparation techniques; sulfonamides; high-performance liquid
chromatography; HPLC; ultra-high-performance liquid chromatography; UHPLC
1. Introduction
The scope of this state-of-the-art review is to cover the literature regarding the sample
preparation protocols developed for the extraction of sulfonamides (SAs) from food samples followed
by high-performance liquid chromatography (HPLC) determination, covering the last five years.
The review is divided in two main sections. In this first main section, a theoretical background
on veterinary drugs and antibiotic use, sulfonamides and their applications, the reported sample
preparation techniques, as well as the chemical composition of the reported food matrices and official
methods for the determination of antibiotics/sulfonamides in foodstuff samples are provided for
the reader to have a prompt introduction to basic terminology. More details can be found in the
cited review articles and book sections. In the second main section, the reported sample preparation
protocols are provided in full detail for each food matrix.
1.1. Veterinary Drugs—Antibiotics
The European Union Council Directive 96/23/EC “on measures to monitor certain substances
and residues thereof in live animals and animal products” divides all pharmacological substances
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used for veterinary purposes and their corresponding residues into two main groups, A and B.
Group A includes substances with anabolic effect, such as antithyroid agents, steroids, and β-agonists,
as well as unauthorized substances, such as chloramphenicol, chlorpromazine, metronidazole,
and nitrofurans. Group B includes veterinary drugs, such as antibiotics, anthelmintics, anticoccidials
and non-steroidal anti-inflammatory drugs, and environmental contaminants, such as organochlorine
and organophosphorus compounds [1].
Antibiotics are used in veterinary medicine in order to improve the health and increase the
productivity of the food-producing animals and at the same time reduce the morbidity and mortality
rates among the livestock. Animals are administered with antibiotics not only for therapeutic purposes
but also as prophylactic and metaphylactic measures [2]. Prophylaxis is a preventative measure,
where animals are administered with sub-therapeutic doses and in some cases full doses of antibiotics
through feed or water and is a common practice in massive livestock production. Metaphylaxis
is a measure taken when a number of animals exhibits some of the disease symptoms, and all the
animals are administered in order to prevent the disease from spreading. However, both practices
are not always effective due to the fact that some antibiotic groups are active during bacterial cell
proliferation [3]. The most common routes of administration are through water and feed medication,
followed by injection [2]. Antibiotics can also be used as feed additives. Their intake favors the
natural intestinal flora of the animals by inhibiting the harmful microorganisms, and as a result,
nutrient absorption and assimilation are increased, thus providing a growth promoting effect [3].
Aminoglycosides, β-lactams (penicillins and cephalosporins), macrolides, phenicols, quinolones, SAs,
and tetracyclines are among the most common antibiotic substances in veterinary medicine [4].
The presence of veterinary drug residues in animal-originated products relies on the
physicochemical properties of each compound that affect the absorption, distribution, metabolism,
and excretion of the drug from the animal body. For this reason, a withdrawal period, between the last
drug administration and the slaughter or milk, egg, and honey collection, is established in order to
ensure the existence of animal-originated products with low drug residues [4]. However, the extensive
use of antibiotics besides therapeutic purposes has led to the presence of antibiotic residues in animal
originated food products and the development of bacterial drug resistance [3]. The main reasons for
antibiotic residues is the illegal use and uncontrolled administration of veterinary drugs to healthy
animals, as well as not taking into consideration the withdrawal period, the lack of professional advice,
extra label use, frequent drug administration, and increased dosing, as well as contaminated housing,
water, and animal feed [4–6]. Antibiotic residues can cause adverse effects to consumers, such as
acute allergic or toxic reactions, chronic toxic effects from prolonged exposure to antibiotic residues,
and natural intestinal flora disruption [5].
Liver, kidney, and fat are animal tissues with high antibiotic residue concentration, while muscle
tissue has relatively lower residues [5]. The European Union Commission Regulation No 37/2010 sets
the legislative basis for the “pharmacologically active substances and their classification regarding
maximum residue limits in foodstuffs of animal origin”, by classifying the substances into the categories
of allowed and prohibited. For the allowed substances, a maximum residue limit (MRL) is provided for
each target tissue expressed in micrograms per kilogram (μg/kg) of fresh target tissue. Target tissues
include muscle, fat, liver, and kidney, as well as milk, eggs, and, in a few cases, honey. The MRLs
usually refer to a specific compound, a metabolite, or a compound mixture [7].
1.2. Sulfonamides
SAs constitute a wide-spectrum synthetic antibiotic category effective against a wide range of
bacterial species, such as Bacillus spp., Brucella spp., Streptococcus spp., staphylococci gram-positive
aerobes, and enterobacteriaceae gram-negative aerobes, as well as protozoa, parasites, and fungi.
SAs are derivatives of sulfanilamide and the various SA analogues, that result from the various R
radicals of the −SO2NHR group (Figure 1). Each SA analogue has different physicochemical and
pharmacokinetic properties and as a result antibiotic effect. SAs are relatively insoluble with solubility
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increasing in alkaline pH, which is an important factor for the type of administration and disease
treatment they are intended for [8].
Figure 1. Diagrams of the chemical structure of sulfonamide, sulfanilamide, 4-aminobenzoic acid,
and the chemical structure of the most common SA analogues in veterinary medicine.
The SA antibacterial effect relies on their ability to inhibit the conversion of folic acid
to tetrahydrofolic acid by competitively antagonizing 4-aminobenzoic acid (Figure 1) for the
dihydropteroate synthetase enzyme. Tetrahydrofolic acid is essential for the nucleic acid synthesis,
thus SAs inhibit the bacterial DNA and RNA synthesis and subsequently the protein synthesis.
Additionally, SAs reduce the bacterial cell permeability for glutamic acid that is essential for the folic
acid synthesis. SAs are effective against bacterial species that synthesize the required 4-aminobenzoic
acid, but ineffective in the presence of increased amounts of 4-aminobenzoic acid and against species
that receive the required 4-aminobenzoic acid from other sources or have antibiotic resistance [6].
SA formulations usually consist of a SA analogue and a diaminopyrimidine, such as aditoprim,
baquiloprim, ormetoprim, or trimethoprim, that have a synergistic interaction. The liver and
kidney are animal tissues with the highest concentrations of SAs and their metabolites [4].
Sulfamethoxazole, sulfacetamide, and sulfasalazine are SA analogues commonly used in human
medicine, while sulfadiazine (SDZ), sulfamethazine (SMZ), sulfadimethoxine (SDMX), sulfamerazine,
and sulfathiazole are commonly used in veterinary medicine [6]. The European Union Commission
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Regulation No 37/2010 sets the MRL for all SA analogues to 100 μg/kg for muscle, fat, liver, and kidney
from all food-producing species and bovine, ovine, and caprine milk, while their use is prohibited for
animals that produce eggs for human consumption. In the case of more than one SA analogue, the
sum of the SA residues should not exceed the provided MRL value (Table 1) [7]. Honeybees are also
considered food-producing species and antibiotics are used in beekeeping in order to treat two of the
most severe diseases for bees, the American/European foulbrood, and nosemosis. More specifically,
the SA analogue sulfothiazole is used against the American foulbrood caused by Paenibacillus larvae in
order to prevent the spread of the disease, suppress the symptoms, and inhibit the spore germination.
SAs can also be used prophylactically against nosemosis. However, a beehive lacks in metabolic
pathways for the elimination of antibiotic residues and a withdrawal period does not apply in the case
of bees. For this reason, the European Union has not established MRLs for antibiotic residues in honey
and only veterinary drugs with zero residues are authorized for beekeeping [9].
Table 1. MRLs for sulfonamide antibiotics, provided by the EU, Codex Alimentarius and FDA.
Sulfonamide Animal Species MRL Target Tissue
Commission Regulation (EU) No 37/2010 [7]
Sulfonamides











Cattle 25 μg/L Milk





CFR—Code of Federal Regulations—U.S. Food & Drug Administration (FDA) [11]
Sulfabromomethazine sodium
Cattle 100 μg/kg Uncooked edible tissue
Not specified 10 μg/L Milk
Sodium sulfachloropyrazine
monohydrate Chicken 0 Uncooked edible tissue









100 μg/kg Uncooked edible tissue
Not specified 10 μg/L Milk
Sulfaethoxypyridazine
Cattle 100 μg/kg Uncooked edible tissue
Swine 0 Uncooked edible tissue
Not specified 0 Milk












100 μg/kg Uncooked edible tissue
The most crucial problem arising from the uncontrolled use of SAs is the development and
spreading of drug resistance, rather than the presence of SA residues in animal originated products
itself. SA drug resistance derives from mutations in the dihydropteroate synthase gene that results in
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enzymes with structural alterations with decreased affinity towards the SAs. Drug resistance genes
can be transferred between bacterial strains or genera during a horizontal gene transfer in plasmids,
transposons, or integrons. For this reason, SA resistant strains are higher than tetracyclines and other
antibiotics, while bacterial species with more than one gene for SA resistance have been observed.
Furthermore, drug resistance in an antibiotic group can favor the development of cross-resistance [6].
1.3. Sample Preparation
Food samples are complex heterogenous matrices, where all analytes are distributed in a random
manner. Food analysis involves sampling, homogenization, and sample preparation that increase
the analytical accuracy and precision. Focusing on sample preparation it usually involves storage,
particle size reduction, homogenization, weighting, dilution, filtration, extraction, clean-up, and
derivatization. Proper sample preparation protocols result in matrix interference elimination and
analyte preconcentration, thus affecting the selectivity, sensitivity, detection capability, and the
overall performance of an analytical technique. The most time-consuming step in analytical method
development is the optimization of the sample preparation protocol that includes analyte extraction
and clean-up. Some of the most common sample preparation techniques used in food analysis are
liquid-liquid extraction (LLE), solid-liquid extraction (SLE), solid-phase extraction (SPE), solid-phase
microextraction (SPME), stir bar sorptive extraction (SBSE), supercritical fluid extraction (SFE),
accelerated solvent extraction (ASE), ultrasonic, and Soxhlet extraction [12].
1.3.1. LLE
LLE is one of the most used sample preparation techniques, along with SPE, and probably the
oldest. In LLE the analytes are extracted from an aqueous sample into a water immiscible solvent,
according to relative solubility. Despite the wide use of LLE, there are many disadvantages, such as
increased time and solvent requirements, analyte lose, sample contamination, and low sensitivity,
that reduce LLE applications in modern analytical chemistry. Liquid-phase microextraction (LPME)
is an LLE-based microextraction technique that has been developed in order to overcome LLE
disadvantages. Extraction takes place between the aqueous sample phase (donor phase) and a
water immiscible solvent extraction phase (acceptor phase). LPME can be divided into single-drop
microextraction (SMDE), hollow fiber liquid-phase microextraction (HF-LPME), and dispersive
liquid-liquid microextraction (DLLME). DLLME is a ternary extraction system that involves the
aqueous sample, an extraction solvent, and a disperser solvent. Microliters of the organic extraction
solvent and the dispersive solvent are injected into the sample solution and extraction solvent
droplets are formed with the help of the dispersive solvent, resulting in a cloudy solution. After the
extraction equilibrium between the sample and the extraction solvent is achieved, the cloudy solution
is centrifuged and the lower organic phase is collected for analysis. The extraction solvent should be
water immiscible, such as chloroform, carbon tetrachloride, and dichloromethane, while the dispersive
solvent should be miscible in both aqueous solution and organic solvent, such as ethanol, methanol,
acetonitrile, and acetone. Following the principles of green analytical chemistry, conventional
extraction solvent can be replaced by ionic liquids that are liquid organic salts, combinations of
organic cations with inorganic anions with unique physicochemical properties. Ionic liquids are
characterized by low volatility and high density, thus forming more stable droplets and better phase
separation than the conventional organic solvents [13].
1.3.2. SLE
The principals of SLE are similar to LLE, except that the analytes are extracted from solid
samples. The solid sample is mixed with extraction solvent, the two phases interact, and the soluble
sample components diffuse into the extraction phase. Various organic solvents can be used in SLE,
however, SLE is usually laborious and has analogous disadvantages as LLE, such as increased solvent
requirements, partial extraction, solvent impurities, and emulsion formation. In order to increase the
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extraction efficiency of the organic solvent, heating and pressure or ultrasounds can be applied during
the extraction. In pressurized liquid extraction (PLE), also known as ASE, the solid sample and the
extraction solvent are transferred into an extraction cell and the extraction takes place under high
temperature (40–200 ◦C) and pressure (500–3000 psi) for 5–15 min. After the extraction is complete,
the sample extract is collected and purged. The increased temperature and pressure applied in PLE
result in reduced extraction time, enhanced analyte’s solubility and mass transfer, better solvent
penetration, and overall improved extraction yields. However, PLE requires expensive equipment and
high temperature solvent reduces the extraction selectivity and applicability of PLE for the extraction
of less thermal stable compounds. Ultrasound-assisted extraction (UAE) is a less extreme extraction
approach in which extraction is assisted by the application of ultrasounds. Compared with other
sample preparation techniques, UAE is relatively faster with reduced solvent requirements, and at
the same time enables the extraction of analytes in room temperature. However, this technique lacks
selectivity and enrichment capability when extraction of trace amounts is required and is usually
combined with other clean-up techniques for improved extraction efficiency [14].
1.3.3. Salting-Out Extraction
The salting-out effect has been exploited in sample preparation techniques, such as Quick Easy
Cheap Effective Rugged Safe (QuEChERS) and salting-out liquid-liquid extraction (SALLE), in order
to improve analyte’s extraction from aqueous samples. The salting-out effect is based on the decrease
of solubility of water soluble organic analytes when salt concentration in the aqueous sample solution
is increased. This effect favors the partition of the analytes into a water-miscible organic solvent and
separation between the two phases. Various water-miscible solvents can be used, but acetonitrile
is the most convenient water-miscible organic solvent for the application of the salting-out effect
due to being chemically inert with organic analytes and the most common mobile phase component
in liquid chromatography, and at the same time, acetonitrile has the ability to precipitate matrix
proteins. Salting-out agents are usually inorganic and organic salts that provide cations (Mg2+,
Sr2+, Ca2+, Ba2+, K+, Na+, NH4+, Li+) and anions (SO42−, CH3COO−, Cl−, NO3−, Br−, I−, CNS−),
such as MgSO4, NaCl, CH3COONH4, CH3COONa, and (NH4)2SO4, which promote the transfer of the
hydrophilic compounds to the organic phase. These salts should be soluble in the aqueous sample
but have negligible solubility in the organic phase [15]. In either QuEChERS and SALLE procedures,
a water-miscible solvent and a salting-out agent are sequentially added to the sample and the mixture is
shaken and centrifuged. The formed organic phase is then collected and can be either injected directly
for analysis or further treated for water removal and analyte isolation [14]. Aqueous two-phase system
(ATPS) extraction is another alternative based on the partitioning of the analytes between two phases
and is used for the extraction of analytes from aqueous samples. The most common biphasic system
in food analysis is polymer/salt, while ionic liquid/salt systems were also reported. Polyethylene
glycol is usually the polymer of choice combined with phosphate, sulfate, or citrate salts. Parameters
that affect the extraction include the molecular weight and concentration of the polymeric phase,
the solution pH, and temperature. ATPS does not require the use of organic solvents in contrast
with other sample preparation techniques, while sample deproteinization or defatting is not always
required [16].
1.3.4. SPE
SPE is a widely used sample preparation technique that provides high enrichment factors and
recoveries with reduced sample volume requirements and automation capability. SPE can be used
for the daily laboratory routine and in many cases SPE has replaced LLE. In SPE the components
of the sample solution interfere with a solid phase (sorbent material) and separation between the
target analytes and the matrix interferences can be achieved. The sorbent is usually packed into SPE
cartridges between two frits. SPE cartridges are commercially available for specific applications or
can be manually prepared with the selected sorbents. In a typical SPE procedure, the SPE cartridges
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are conditioned/activated with a solvent or a solvent mixture, the sample solution is loaded into the
cartridge, the loaded cartridge is washed to remove the retained interreferences, and the retained
analytes are eluted with an appropriate solvent (Figure 2a). However, SPE applications are restricted by
the type of the sorbent and the characteristics of the sample components, while the tightly packed SPE
cartridges increase the extraction time and cause backpressure [13]. These problems can be eliminated
with dispersive solid-phase extraction (DSPE) where the sorbent is dispersed in the sample solution
and not packed into a cartridge. After the dispersion, the solution is shaken, and when the extraction
is complete, the sorbent is collected by centrifugation or filtration and the analytes are eluted by
repeating the previous step with the use of an appropriate solvent (Figure 2b) [17]. C18 and OASIS®
HLB are two of the most widely applied commercially available materials for SPE. C18 is a nonpolar
sorbent that consists of octadecylsilane bonded to silica particles and is suitable for the reversed-phase
binding of hydrophobic analytes. OASIS® HLB is a water-wettable hydrophilic-lipophilic-balanced
polymeric reversed-phase sorbent that consists of N-vinylpyrrolidone and divinylbenzene and can
be used for the binding of acidic, basic, or neutral analytes [14]. Novel SPE sorbents include
carbon nanotubes (CNTs) [13], molecularly imprinted polymers (MIPs) [18], and magnetic materials.
Magnetic solid-phase extraction (MSPE) is a SPE-based technique that employs magnetic sorbent
materials. The magnetic materials comprise of a magnetic metal oxide nanoparticle core, usually
Fe3O4, coated with inorganic or organic materials, such as silica, alumina, chitosan, or polypyrrole,
while the coating can be modified with functional groups for improved sorption capability. A MSPE
application is similar to DSPE, with the difference that the sorbent can be collected by means of a
magnet (Figure 2b) [19]. While solid-phase techniques can be used for aqueous samples or sample
solutions, matrix solid-phase dispersion (MSPD) can be applied directly for the extraction of analytes
from solid, semi-solid, and viscous samples. Typically, the sample is mechanically blended with solid
support in order to achieve matrix disruption and the development of interactions between the analytes
and the sorbent material. The mixture is then transferred and packed into a SPE cartridge and the
analytes are eluted with an appropriate sorbent. Apart from the applicability on solid samples, MSDP
provides a simple and selective approach for sample extraction and clean-up in a single step [14].
Other solid-phase extraction variations include SPME and SBSE. In both techniques, the sorbent
material is coated on a substrate, and extraction/analyte desorption follow the same principles.
SPME employs silica or stainless-steel fibers coated with the sorbent material that can be used for the
extraction of analytes from gaseous, liquid, and solid samples. A typical SPME procedure involves
the partitioning of the analytes between the sorbent and the sample matrix and analyte desorption
directly into the analytical instrument. SPME can be coupled with HPLC by means of a six-port injector
combined with a desorption chamber, and desorption can be performed with an organic solvent or the
mobile phase in static or dynamic mode. SMPE fibers can be coated with various sorbent materials,
thus SMPE applicability can be expanded for the extraction of a wide range of analytes and sample
matrices [14]. SBSE employs magnetic stir bars coated with polydimethylsiloxane that is a polar
polymeric material and develops hydrophilic interactions with the analytes, such as hydrogen bonds
and van der Waals forces. In a typical SBSE procedure, a coated stir bar is introduced into the sample
solution and the analytes are absorbed onto the coating by continuous stirring. After the extraction,
the bar is collected, washed with deionized water, and dried, while analytes can be desorpted, either
thermally by thermal or liquid desorption [13]. Both SPME and SBSE are less time-consuming and
have reduced sample and solvent requirements in comparison with SPE.
1.3.5. FPSE
Fabric phase sorptive extraction (FPSE) is a recently introduced novel microextraction technique
that employs reusable cellulose or polyester fabric substrates homogenously coated with sol-gel hybrid
sorbents. In a typical FPSE procedure, the coated fabric, along with a magnetic stir bar, are introduced
into a vial that contains the sample or sample solution, and analyte extraction is conducted under
stirring. The coated fabric is collected and placed for 4–10 min into a second vial that contains the
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eluting solvent (Figure 2c). The eluate can be centrifuged prior to analysis. The coated fabric is
washed with an appropriate organic solvent and rinsed with deionized water between extractions.
Reported FPSE coatings include polydimethylsiloxane, poly(ethyleneglycol), C18, and graphene.
The FPSE protocol is simple and fast, with reduced solvent requirements, while the coated fabric can
be introduced directly to the liquid samples and is compatible with a wide range of organic solvents.
FPSE substrates are characterized by increased sorbent loading and improved adsorption capacity in
comparison with SPME, providing high analyte preconcentration [20].
 
Figure 2. Schematic representation of the basic steps in (a) SPE, (b) DSPE and MSPE, and (c) FPSE.
1.4. Food Composition
Meat contains 72–75% water, 19% proteins, 2.5–5% lipids, 1% vitamins and carbohydrates, and 1%
ash. Lipids can vary between 1% and 15%. The main edible animal tissue is the muscle, while
other edible parts include organs, such as liver and kidneys, fat, and blood. Edible animal livestock
species include bovine and porcine species and poultry. Animal lipids are mostly deposited under
the skin (subcutaneous fat), between the muscles (intermuscular fat), and around organs, such as
kidneys and heart, but varies between animal species [21]. The chemical composition of fish varies
among species, with 50–60% of fish weight being muscle. Fish muscle contains 52–82% water, 16–21%
proteins (or 10–25% for farmed species), 0.5–2.3% lipids, 1.2–1.5% ash, and 0.5% carbohydrate content.
In comparison with red meat, fish lipid content is lower and ranges between 0.2% and 30%, while
lipids are deposited in the liver, muscle, perivisceral, and subcutaneous tissues. Fatty fish species
deposit fat all over the muscle tissue that is colored grey, yellow, or pink, such as salmon, and more
than 50% of the skin consists of lipids (in other species it ranged between 0.2% and 3.9%) [22]. Milk
is a heterogenous mixture that consists of water, emulsified fat, caseins and whey proteins, lactose,
minerals, and vitamins. The gross cow milk composition is 86.3% water, 4.9% fat, 3.4% proteins, 4.1%
lactose, and 0.7% ash. Buffalo, sheep, and goat milk can also be consumed by humans. Fat is the most
important milk component, both organoleptically and commercially, and ranges from below 3% to
more than 6% [23]. Eggs consist of white and yolk for 60% and around 30–33% of the total egg weight,
respectively. The egg white or albumen is a protein solution that contains over 40 different proteins,
with ovalbumin constituting the 54% of the total white proteins. The egg yolk contains lipoproteins,
with low-density lipoproteins constituting the 65% of the total yolk proteins. Egg fat is mainly present
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in egg yolk as triacylglycerol and phospholipids and comprises the 9–10% of the total egg weight.
Other egg components include minerals and vitamins that are also located in the egg yolk [24].
1.5. Official Methods of Analysis
Official methods for the determination of antibiotics/sulfonamides in food samples are available
by regulating agencies. The website of the FDA provides a “Laboratory Methods—Drug & Chemical
Residues Methods” section [25] that includes analytical methods for the determination of multiple
phenicol residues in honey samples with electrospray liquid chromatography—mass spectrometry
(LC-MS) and chloramphenicol residues in crustacean species (shrimp, crab, crawfish) samples with
liquid chromatography—tandem mass spectrometry (LC-MS/MS) [26], as well as the determination of
fluoroquinolone residues in milk samples with LC-MS/MS [27]. Two multi-class and multi-residue
LC-MS/MS methods for the determination of drug residues in milk and aquaculture samples (fish,
shrimp) are provided in the “Field Science and Laboratories—Laboratory Information Bulletins”
section of the FDA website [28]. A high-performance liquid chromatography—ultraviolet detection
(HPLC-UV) method for the determination of sulfamethazine in milk samples is also provided by
the FDA [29]. The Association of Official Analytical Chemists (AOAC) provides the “AOAC Official
Method 993.32” for the determination of eight sulfonamide residues in raw bovine milk samples with
liquid chromatography—ultraviolet detection (LC-UV) [30].
2. Extraction of Sulfonamides from Food Samples
Meat, milk, eggs, and honey are animal-originated products with increased demand. In this
section the detailed sample preparation protocols are provided for each reported paper.
2.1. Animal Tissue Samples
2.1.1. SLE
The same team developed two SLE protocols for multi-class antibiotic extraction, including
15 SAs, from bovine tissue [31] and fish tissue samples [32] followed by ultra-high-performance liquid
chromatography—mass spectrometry (UHPLC-MS/MS). In the first protocol, spiked bovine tissue
(2 g) was mixed with acetonitrile (ACN) (10 mL) and ethylenediaminetetraacetic acid (EDTA) (0.1 M,
1 mL) and the mixture was shaken for 20 min and centrifuged at 3100 g for 15 min. The supernatant
was collected, mixed with n-hexane (3 mL), vortexed for 30 s, centrifuged at 3100× g for 15 min,
and the n-hexane layer was discarded. The extract was evaporated under nitrogen stream at 40 ◦C to
0.5 mL final volume, dissolved in mobile phase (400 μL), and passed through a 0.45 μm filter, prior to
analysis. The authors emphasized the simplicity, as well as the reduced cost and time requirements of
the developed sample preparation protocol. The addition of EDTA, the sample defatting with n-hexane,
and the evaporation to 0.5 mL were employed in order to increase the recoveries of all analytes [31].
The same protocol was applied for the fish tissue samples, except for the n-hexane treatment step.
Spiked fish tissue (2 g) was mixed with ACN (10 mL) and EDTA (0.1 M, 1 mL), and the mixture
was shaken for 20 min and centrifuged at 3100× g for 15 min. The supernatant was collected and
evaporated under nitrogen stream at 40 ◦C and the residue was dissolved in mobile phase (400 μL) [32].
In both cases, a SPE sample clean-up step was omitted due to increased selectivity over specific
antibiotics that prohibits multi-class extraction, while the sample preparation protocol cost and time
requirement were decreased and the number of samples analyzed in a daily routine was increased.
Another SLE protocol was reported for the extraction of SDZ, SMZ, SIX, SDMX, and sulfaquinoxaline
(SQX) from shrimp tissue samples. Spiked tissue (0.5 g) was mixed with methanol (MeOH)-ACN
(50:50, v/v; 1 mL) and the mixture was vortexed, sonicated for 15 min, and centrifuged at 3500 rpm for
10 min. The extraction step was repeated twice with MeOH-ACN (50:50, v/v; 1 mL) and twice with
0.1% CH3COOH-MeOH (60:40, v/v; 0.5 mL) and the supernatants were collected between extractions.
All collected supernatants were combined, evaporated to dryness under nitrogen stream, and the
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residue was dissolved in MeOH (500 μL) and passed through a 0.20 μm syringe filter. Analysis
was carried out by high-performance liquid chromatography—diode array detection (HPLC-DAD).
SPE and MSPD were also tested but higher recoveries were achieved with the developed sample
preparation protocol [33].
Two ASE protocols were reported for the extraction of 15 SAs and metabolites from baby food
samples [34], and multi-class antibiotic extraction, including 9 SAs, from fish tissue samples [35].
In the first protocol, spiked baby food sample (5 g) was transferred into an ASE extraction cell
and mixed with 1% CH3COOH in MeOH-ACN (4:1, v/v). Extraction was carried out at 70 ◦C
and 1500 psi with 5 min preheating time and 5 min static time, while flush volume was 60% and
purge time 60 s. Extraction was repeated for 3 cycles. The extracts (3 × 18 mL) were diluted with
extraction solvent (3 × 20 mL), placed in the freezer at −18 ◦C overnight and centrifuged at 4 ◦C and
4000 rpm for 5 min. The supernatant was collected and passed through a 0.45 μm filter and analyzed
with ultra-high-performance liquid chromatography—orbitrap high-resolution mass spectrometry
(UHPLC-Orbitrap-MS). The developed sample preparation protocol provided higher recoveries in
comparison with an official AOAC QuEChERS extraction protocol [34]. In the second report, the fish
tissue samples were purified with C18 resin inside the ASE extraction cell. The sample extracts were
evaporated to dryness, dissolved in mobile phase, and centrifuged at −4 ◦C and 10,000 rpm prior to
high-performance liquid chromatography—mass spectrometry (HPLC-MS/MS) analysis. However,
information could be collected only from the abstract and the further details are not available because
the rest of the paper is written in Chinese [35].
Two extraction protocols, PLE and USE, were reported for the extraction of 16 SAs and
metabolites from chicken, sheep, fish, and horse tissue samples. In both cases, analysis was carried
out by high-performance liquid chromatography—quadrupole linear ion trap—mass spectrometry
(HPLC-QqLIT-MS/MS). For the PLE protocol, spiked tissue (5 g) was defatted with hexane, mixed with
diatomaceous earth, and transferred inside a PLE cell. The extraction solvent was 0.2% CH3COOH in
ACN, the preheating period was 8 min, and extraction was achieved at 90 ◦C and 1500 psi for 7 min.
The total flush volume was 80%, 60 s of purging under nitrogen stream was applied and the extraction
step was repeated three times. The collected extracts were placed in the freezer at −18 ◦C for 1 h
and centrifuged at 3500 rpm for 10 min in order to remove the tissue proteins. The supernatant was
evaporated to dryness under nitrogen stream at 40 ◦C and the residue was dissolved in H2O-ACN
(85:15, v/v; 1 mL). For the UAE protocol, spiked tissue (5 g) was mixed with ACN (10 mL) and the
mixture was vortexed for 10 s and placed inside an ultrasonic bath for 60 min. Then, the mixture was
placed in the freezer at −18 ◦C for 1 h and centrifuged at 3500 rpm for 10 min, in order to remove the
tissue proteins. The supernatant was collected and evaporated to dryness under nitrogen stream at
40 ◦C. The residue was dissolved in H2O-ACN (85:15, v/v; 2 mL), hexane (2 mL) was added, and the
mixture was vortexed for 5 s and centrifuged at 3500 rpm for 10 min. The lower phase was used for
analysis. Although both developed protocols could efficiently extract the SAs from the tissue samples,
UAE is simpler and less solvent and time-consuming [36].
2.1.2. Salting-Out Extraction
Three QuEChERS extraction protocols were reported in the literature. In the first report,
a QuEChERS extraction protocol was developed for the extraction of 22 SAs and metabolites from
bovine, chicken, pork, and sheep tissue samples. Spiked tissue (5 g) was mixed with H2O (5 mL),
vortexed for 1 min, and 1% CH3COOH in ACN (10 mL) was added to the mixture. Sodium hydrogen
citrate sesquihydrate (0.5 g), sodium citrate (1 g), MgSO4 (4 g), and NaCl (1 g) were added in
sequence and the mixture was shaken and vortexed for 1 min between each addition. The mixture
was centrifuged at 3500 rpm for 5 min, the supernatant (6 mL) was collected, mixed with primary
secondary amine (PSA) (150 mg) and anhydrous MgSO4 (900 mg), and the mixture was shaken,
vortexed, and centrifuged as described. The supernatant (4 mL) was collected and evaporated to
dryness under nitrogen stream at 35 ◦C. The residue was dissolved in 0.01% formic acid in 5% MeOH
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aqueous solution (500 μL), passed through a 0.22 μm nylon filter, and centrifuged at 13,500 rpm
for 10 min prior to high-performance liquid chromatography—high-resolution mass spectrometry
(HPLC-HRMS) analysis [37]. In the second report, a modified QuEChERS extraction protocol was
developed for the extraction of eight SAs from chicken muscle and egg sample. The extraction protocol
employed a commercially available sorbent material Z-Sep+, consisting of C18 and zirconia both
bonded to silica particles, for the chicken samples and PSA for the egg samples. Spiked tissue (5 g)
was mixed with H2O (5 mL) and 1% CH3COOH in ACN (10 mL) and the mixture was shaken for
10 min. MgSO4 (4 g) and CH3COONa (1 g) were added and the mixture was shaken for 1 min,
vortexed for 2 min, and centrifuged at 5000 rpm for 5 min. The supernatant (3 mL) was collected
and mixed with C18-zirconia sorbent (300 mg) and the mixture was shaken for 30 s and vortexed for
1 min. The supernatant (2 mL) was collected, evaporated under nitrogen stream, and the residue was
dissolved in MeOH-H2O (50:50, v/v; 1 mL), vortexed for 1 min and filtered prior to high-performance
liquid chromatography—fluorescence detection (HPLC-FLD) analysis. A similar protocol was used
for the egg sample (5 g), where it was mixed only with 1% CH3COOH in ACN (10 mL) and PSA was
used instead of the C18-zirconia sorbent [38]. Lastly, a fully automated on-line QuEChERS extraction
protocol was reported for the extraction of 27 SAs and metabolites from salmon tissue samples. Spiked
tissue (1 g) was mixed with 1% CH3COOH in ACN-H2O (84:16, v/v; 5 mL) and the mixture was
vortexed at 3200 rpm for 1 min. MgSO4 (1 g) and CH3COONa (0.1 g) were added and sample extract
(2 mL) was aspirated three times, followed by 30 s equilibrium time and centrifuged at 2264× g for
5 min. The supernatant (1 mL) was collected and mixed with Z-Sep+ (45 mg), PSA (32 mg), and Na2SO4
(0.25 g) and the mixture was vortexed for 1 min and centrifuged at 2264× g for 5 min. The supernatant
(200 μL) was collected and mixed with MeOH (300 μL) and ammonium formate solution (0.008 M,
500 μL) prior to ultra-high-performance liquid chromatography—electrospray ionization—quadrupole
Orbitrap high-resolution mass spectrometry (UHPLC-ESI-Q-Orbitrap-MS) analysis [39].
Two SALLE protocols were also reported. In the first protocol SALLE was reported in combination
with magnetic separation for the extraction of eight SAs from fish tissue samples. Spiked tissue (2 g)
was mixed with 0.1% formic acid in ACN (5 mL) and the mixture was vortexed for 1 min. NaCl (0.5 g),
MgSO4 (2 g) and Fe3O4 (100 mg) were added and the mixture was vortexed for 1 min. The magnetic
particles were collected by means of a magnet and the supernatant (1 mL) was collected and evaporated
to dryness under nitrogen stream at 45 ◦C. The residue was dissolved in 0.1% formic acid aqueous
solution (1 mL), mixed with n-hexane (1 mL), and the mixture was centrifuged at 8000 rpm for 3
min. The aqueous phase was collected and passed through a 0.22 μm syringe filter and analyzed
with HPLC-MS/MS. The authors emphasized the good recoveries and the reduced time requirements
of the developed sample preparation protocol [40]. In the second report, the samples were treated
with ethyl acetate and concentrated under vacuum. The analytes were extracted with HCl solution
(2 M), the extract was defatted with n-hexane, filtered, and mixed with MeOH-ACN-CH3COONa
(5:5:20, v/v/v). Analysis was carried out by HPLC-FLC. However, information could be collected only
from the abstract and the further details are not available because the rest of the paper is written in
Chinese [41].
2.1.3. SPE
Two SPE protocols were reported for multi-class antibiotic extraction, including 16 SAs,
from bovine liver samples [42] and the extraction of SAs from chicken and pork tissue samples [43].
The first extraction protocol employed Oasis HLB cartridges (3 mL, 200 mg) (Waters, Milford, MA,
USA). Spiked liver tissue (2 g) was mixed with ACN (10 mL) and EDTA (0.1 M) and the mixture was
shaken for 10 min, sonicated for 20 min, and centrifuged at 4000× g for 10 min. The supernatant
was collected and evaporated under nitrogen stream to 1 mL final volume. H2O (5 mL) was added
and the mixture was vortexed for 15 s and loaded into a SPE cartridge preconditioned with ACN
(10 mL) and H2O (10 mL). The loaded cartridge was washed with H2O (5 mL) and dried under
reduced pressure for 5 min. The analytes were eluted with ACN (10 mL) and the eluate was
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evaporated under nitrogen stream to 0.5 mL final volume. The reduced eluate was dissolved in
mobile phase (400 μL), n-hexane (2 mL) was added, and the mixture was vortexed for 30 s and
centrifuged at 4000× g for 10 min. The mixture was passed through a 0.45 μm filter and analyzed
with UHPLC-MS/MS. The developed sample preparation protocol included a SPE clean-up step in
order to reduce the liver tissue interferences and utilized SPE cartridges with wide range selectivity
in order to achieve multi-class antibiotic extraction [42]. The second extraction protocol employed
multi-walled carbon nanotubes (MWCNTs) as the sorbent material. The samples were treated with
ACN and the sample extract was dissolved in Na2HPO4 buffer (pH 5.5–6.0) and loaded into the SPE
cartridges. The cartridges were washed with acetone-hexane (5:95, v/v) and the analytes were eluted
with acetone-dichloromethane (1:1, v/v). Analysis was carried out by HPLC-UV. However, information
could be collected only from the abstract and the further details are not available because the rest of
the paper is written in Chinese [43].
Two variations of SPE, a MSPE and a DSPE protocol, were reported for the extraction of SDZ,
sulfathiazole, sulfamerazine, SMZ, and SMP from chicken, pork, and shrimp tissue samples [44] and
for multi-class antibiotic extraction, including 21 SAs, from animal tissue samples [45], respectively.
The MSPE protocol employed a magnetic Fe3O4@JUC-48 nanocomposite as the sorbent material.
Spiked tissue (2 g) was mixed with ACN (20 mL) and the mixture was vortexed for 5 min, sonicated
for 30 min, and kept overnight. The mixture was centrifuged at 10,000 rpm and the supernatant was
collected and stored at 4 ◦C. Sample extract (8 mL) was mixed with Fe3O4@JUC-48 (25 mg) and the
mixture was vortexed for 8 min. The magnetic sorbent was collected by means of an external magnet
and the supernatant was discarded. The analytes were eluted with MeOH-CH3COOH (95:5, v/v; 0.8
mL) and sonication for 10 min. The sorbent was separated by means of an external magnet and the
eluate was collected, passed through a 0.22 μm nylon filter, and analyzed with HPLC-DAD. Sorbent
reusability was studied by applying the sorbent material in several extraction cycles. Between the
extractions, the sorbent was washed with MeOH-CH3COOH (95:5, v/v; 3 × 1 mL) and MeOH (3 × 1
mL) and dried at 60 ◦C. The sorbent could be reused for seven extraction cycles without significant
adsorption capacity reduction. The authors emphasized the increased sensitivity and the higher
recovery values achieved, as well as the reduced extraction time and sorbent requirements of the
developed sample preparation protocol [44]. In the DSPE protocol, the samples were treated with
Na2EDTA (0.1 M) and 1% CH3COOH in ACN, followed by a DSPE clean-up step. Analysis was carried
out by HPLC-MS/MS. However, information could be collected only from the abstract and the further
details are not available because the rest of the paper is written in Chinese [45].
Other reported approaches included a combined MSPD-homogeneous ionic liquid
microextraction (HILME) protocol for the extraction of seven SAs from bovine, chicken,
and pork tissue samples [46], an on-line SPME protocol for the extraction of five antimicrobials,
including sulfametoxydiazine, sulfamethoxazole, and SQX from chicken and pork tissue and egg
samples [47] and a SBSE protocol for the extraction of ten SAs from chicken and pork tissue samples [48].
For the MSPD-HILME protocol, the ionic liquid employed acted both as elution solvent in MSPD and
extraction solvent in HILME. Spiked tissue (0.2 g), silica gel (1 g), and 1-butyl-3-methylimidazolium
tetrafluoroborate ([C4MIM][BF4]) (200 μL) were mixed with a pestle and mortar and the mixture was
transferred and placed inside a glass column between absorbent cotton layers. Pure H2O was passed
through the packed mixture and the eluate (3 mL) was mixed with NaCl (0.45 g) and ammonium
hexafluorophosphate (2.4 M, 1 mL). The cloudy mixture was centrifuged at 5 ◦C and 10,000 rpm for 5
min, the supernatant was discarded and the remaining ionic liquid phase was diluted with ACN (300
μL), passed through a 0.22 μm polytetrafluoroethylene membrane filter and analyzed with HPLC-DAD.
The authors emphasized the simplicity and the higher extraction recoveries achieved, as well as the
reduced reagent requirements of the developed sample preparation protocol [46]. In the on-line SPME
protocol, spiked tissue or egg (5 g) was mixed with Na2SO4 (5 g) and ACN (10 mL) and the mixture
was sonicated for 10 min and centrifuged at 8000 rpm for 5 min. This step was repeated twice and
the three sample extracts were combined and evaporated to dryness. The residue was dissolved in
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ACN-toluene-n-hexane (1:4:45, v/v/v; 25 mL) and used for the on-line SPME. The extraction protocol
employed molecularly imprinted monolithic capillary columns with SQX as the template molecule.
Activated capillaries were treated with propyltrimethoxysilane and filled with the polymerization
mixture that consisted of methacrylic acid (functional monomer), ethylene glycol dimethacrylate
(cross-linker), N,N-dimethylformamide, isooctane, and paraxylene (polymerization and porogenic
solvents), while polymerization occurred at 60 ◦C for 70 h. A prepared monolithic capillary column
preplaced the sample loop in an on-line HPLC-UV system and extraction consisted of three steps.
In the first step, the sample extract passed through the capillary at a flow rate of 0.15 mL/min so
that the analytes came in contact with the imprinted polymeric phase and extracted. In the second
step, nitrogen was passed through the capillary so that the residual sample solution was completely
removed. Finally, the analytes were eluted from the capillary with 400 μL of mobile phase at a flow
rate of 0.15 mL/min. The authors emphasized the increased selectivity and sensitivity, as well as
the simplicity and the environmental friendliness of the developed sample preparation protocol [47].
Finally, the SBSE protocol employed poly(vinylphthalimide-co-N,N-methylenebisacrylamide) monolith
coated stir bars. Spiked tissue (0.5 g) was mixed with ACN (5 mL), the mixture was sonicated for 15 min
and centrifuged at 3000 rpm for 5 min and the supernatant was collected and passed through a 0.45 μm
filter. This step was repeated and both supernatants were diluted with Milli-Q H2O (100 mL). For SBSE,
sample solution pH was adjusted (pH 4.0) and NaCl (5%, w/v) was added, while extraction time was
120 min and liquid desorption time was 60 min. Analysis was carried out by HPLC-MS/MS [48].
All reported literature for the extraction of SAs from animal tissue samples is summarized in
Table 2, including recoveries, limit of detection (LOD), limit of quantification (LOQ), or/and decision
limit (CCα), decision capability (CCβ) values.
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2.2. Milk Samples
2.2.1. LLE
An LLE protocol was reported for the extraction of nine SAs from milk samples. Spiked milk (100
μL) was mixed with acidified dichloromethane (800 μL) and the mixture was sonicated for 10 min and
centrifuged at 93,000× g for 10 min. The organic phase was collected and the step was repeated. The
combined organic phases were evaporated to dryness under nitrogen stream at 40 ◦C and the residue
was dissolved in acidified MeOH (100 μL) and filtered prior to HPLC-MS/MS analysis. The authors
emphasized the reduced sample and reagent requirements of the developed sample preparation
protocol, while a SPE clean-up step was omitted in order to simplify and reduce the cost of the
protocol [49]. DLLME and modified QuEChERS extraction, were reported for the extraction of nine
SAs from milk samples. In both cases off-line derivatization was conducted with fluorescamine (50 μL)
and sonication for 15 min prior to HPLC-FLD analysis. For the DLLME protocol, spiked milk (30 mL)
was mixed with 20% trichloroacetic acid aqueous solution (15 mL) and the mixture was vortexed for
10 s and centrifuged at 6000 rpm for 5 min. The supernatant was passed through a 0.2 μm filter and
pH was adjusted to pH 4.0–4.5. Treated supernatant (5 mL) was mixed with chloroform (1000 μL,
extraction solvent) and ACN (1900 μL, dispersive solvent) and the mixture was shaken until a cloudy
solution was formed and centrifuged at 6000 rpm for 5 min. The chloroform phase was collected with
a syringe, evaporated under nitrogen stream and the residue was dissolved in Tris buffer (pH 7.0,
1.5 mL) and passed through a 0.2 μm nylon filter. For the QuEChERS protocol, spiked milk (2 mL)
was mixed with H2O (8 mL), vortexed for 10 s, 5% CH3COOH in ACN (10 mL) was added, and the
mixture was shaken for 30 s. The QuEChERS (C18, MgSO4 and PSA) were added and the mixture
was shaken for 1 min and centrifuged at 4000 rpm for 5 min. The supernatant (1.5 mL) was collected,
evaporated under nitrogen stream and the residue was dissolved in Tris buffer (pH 7.0, 1.5 mL) and
passed through a 0.2 μm nylon filter. Both developed sample preparation protocols were simple,
fast, and environmentally friendly, providing good recoveries. When compared, DLLME gave lower
LOD values and higher recoveries, while QuEChERS extraction was more reproducible with higher
throughput [50].
2.2.2. Salting-Out Extraction
SALLE, combined with SPE [51] and a miniaturized SALLE protocol [52], were reported for
multi-veterinary drug extraction, including 26 SAs, from milk samples and sulfonamide from tea
beverage, water, milk, honey, plasma, blood, and urine samples, respectively. The first protocol
employed Oasis HLB Plus cartridges (225 mg) (Waters, Milford, MA, USA). For the SALLE step, spiked
milk (5 g) was mixed with oxalic acid-EDTA buffer (pH 3.0, 5 mL) and ACN (10 mL) and the mixture
was shaken for 30 s and centrifuged at 3000 rpm for 5 min. The supernatant was collected, (NH4)2SO4
(1 g) was added and the mixture was shaken for 2 min, left for 2 min and centrifuged at 3000 rpm
for 3 min. Three layers resulted after centrifuging, and the upper ACN and the lower aqueous layer
were used for the SPE clean-up step, while the middle layer was the milk fat. The SPE cartridges
were preconditioned with MeOH (10 mL), H2O (10 mL), and oxalic acid-EDTA buffer (pH 3.0, 2 mL),
loaded with the aqueous layer, washed with buffer (2 mL) and the analytes were eluted with the ACN
layer (10 mL) and MeOH (5 mL). The eluate (3 ML) was evaporated to 0.1–0.2 mL final volume under
nitrogen stream at 50 ◦C for 20 min and the residue was dissolved in CH3COONH4 solution (0.1 M,
1 mL), vortexed for 30 s, and passed through a 0.45 μm filter device prior to UHPLC-ESI-Q-Orbitrap-MS
analysis [51]. The second protocol employed two 1 mL syringes coupled via their tips that contained the
sample solution and extraction solution, respectively. For the preparation of milk samples, spiked milk
(1 mL) was mixed with ACN-MeOH-H2O (40:20:20, v/v/v; 1 mL), the mixture was centrifuged at
3000 rpm for 10 min. For the preparation of honey samples, spiked honey was diluted with H2O at a
concentration of 0.1 g/mL and the mixture was homogenized and centrifuged at 4000 rpm for 20 min.
Milk or honey supernatant (0.5 mL) was retracted with the sample syringe A, NaCl (250 mg/mL) was
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added, and the mixture was vortexed for 20 s and adjusted to pH 7.0 with NaOH solution (0.1 M). ACN
(250 mL) was retracted with the extraction solution syringe B and both syringes were coupled and held
vertically. The extraction was conducted by injecting the extraction solvent from syringe B into syringe
A, forming a cloudy solution and the content was pumped back to syringe B. This step was repeated
five times and the mixture was left in syringe B vertically for 2 min. After phase formation, the upper
phase was collected and injected for HPLC-UV analysis. The authors emphasized the reduced organic
solvent and sample requirements, as well as the simplicity and the improved extraction efficiency of
the developed sample preparation protocol [52].
Two ATPS extraction protocols were reported in the literature for the extraction of SAs from milk.
A modified ATPS protocol was reported for the extraction of SDZ and SMZ from milk, egg, and water
samples. The extraction protocol employed polyoxyethylene lauryl ether and Na2C4H4O6 in order to
form the polymer-organic salt extraction system. For the preparation of milk and egg samples, spiked
milk (50 mL) or homogenized spiked egg (50 mL) was mixed with 10% trichloroacetic acid solution
(20 mL) and H2O to 100 mL final volume and the mixture was shaken and centrifuged at 4000 rpm
for 30 min. The supernatant was collected and passed through a 0.45 μm filter in order to remove
the proteins. The filtrate was added to a mixture of polyoxyethylene lauryl ether (0.027 g/mL) and
Na2C4H4O6 (0.180 g/mL) and filled with H2O to 10 mL final volume. The mixture was placed in
a heated water bath under continuous stirring for 20 min and after the phase formation, the upper
phase was collected and analyzed with HPLC-UV [53]. An ionic liquid ATPS extraction protocol was
reported for the extraction of six SAs from milk samples. Spiked milk (5 mL) diluted with pure H2O
(2.5 mL) was mixed with 10% HClO4 aqueous solution (500 μL) and the mixture was shaken for 2 min
and centrifuged at 10,000 rpm for 10 min. The supernatant was collected and passed through a 0.45 μm
filter. Butyl-3-methylimidazolium tetrafluoroborate ([C4MIM][BF4]) (300 μL) and C6H5Na3O7·2H2O
(3 g) were added and the mixture was shaken and centrifuged at 10,000 rpm for 10 min. The upper
IL phase was collected, diluted with ACN at 1:1 ratio, sonicated, and passed through a 0.22 μm
filter. Analysis was carried out by HPLC-UV. The authors emphasized the reduced organic solvent
consumption of the developed sample preparation protocol in comparison with classic LLE, as well as
the combination of sample preconcentration and clean-up in one step [54].
2.2.3. SPE
Two SPE protocols were reported for multi-veterinary drug extraction, including 18 SAs [55],
and the extraction of six SAs [56] from milk samples. The first extraction protocol employed Oasis
MCX cartridges (3 mL, 60 mg) (Waters, Milford, MA, USA). Spiked milk (2 g) was mixed with 1%
CH3COOH in ACN (5 mL) and the mixture was vortexed for 30 s and centrifuged at 5000 rpm
for 12 min. The supernatant was evaporated to dryness under nitrogen stream at 40 ◦C and the
residue was dissolved in HCl solution (0.1 M, 3 mL) and loaded to a SPE cartridge, conditioned
with MeOH (3 mL) and HCl solution (0.1 M, 3 mL). The loaded cartridge was washed with
HCl solution (0.1 M, 3 mL) and MeOH (3 mL) and the analytes were eluted with 10% ammonia
in ACN (4 mL). The eluate was evaporated to dryness under nitrogen stream at 40 ◦C and the
residue was dissolved in 0.1% CH3COOH in CH3COONH4-MeOH (90:10, v/v; 1 mL) and passed
through a 0.22 μm filter prior to ultra-high-performance liquid chromatography—electrospray
ionization—mass spectrometry (UHPLC-ESI-MS/MS) analysis [55]. The second extraction protocol
employed multi-template MIPs prepared by sol-gel synthesis. Spiked milk (1 g), deproteinized with
ACN, was loaded into MISPE cartridges packed with the prepared MIPs (30 mg) and left for 15 min
to equilibrate. The loaded cartridge was washed with MeOH (2 mL) and the analytes were eluted
with 1% CH3COOH-MeOH-ACN (50:10:40, v/v/v; 2 mL) at a flow rate of 1 mL/min and the eluate
was evaporated to dryness under nitrogen stream. Analysis was carried out by HPLC-DAD. MISPE
cartridge conditioning was omitted as an unnecessary step, thus reducing the time of the developed
sample preparation protocol [56].
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Three MSPE protocols were reported for the extraction of nine SAs [57], SMP, SMZ,
sulfamethoxazole and sulfachloropyridazine [58], and five SAs [59] from milk samples. The first
protocol employed silica-based magnetic sorbent material. Magnetic sorbent (0.1 g), conditioned
with MeOH (5 mL) and sonication for 5 min and washed with deionized H2O (2 × 10 mL), was
added to spiked milk (10 mL). The mixture was sonicated for 15 min, the magnetic sorbent was
collected by means of a magnet and the supernatant was discarded. The sorbent was washed with
acetate buffer (pH 4.0, 3 × 5 mL) and the analytes were with 10−3 M NaOH in MeOH (5 mL) for 5
min. The eluate was collected, evaporated to dryness under nitrogen stream and the residue was
dissolved in 1% formic acid aqueous solution (500 μL) and passed through a 0.2 μm nylon filter prior
to HPLC-DAD analysis. The authors emphasized the simplicity, higher recovery values, and the
lower organic solvent requirements of the developed sample preparation protocol in comparison
with classic SPE [57]. The second protocol employed a magnetic hyper cross-linked polystyrene
composite as the sorbent material. Spiked milk (25 mL) was agitated for 15 min and the magnetic
sorbent was added (20 mg). The sample pH was adjusted to pH 5.0, extraction/stirring time was 10
min and analytes were eluted with ACN (2 × 1 mL) and sonication for 5 min. Analysis was carried
out by high-performance liquid chromatography—amperometric detection (HPLC-AD). The proposed
magnetic composite combined large surface area, high adsorption, and magnetic separation, while
a small amount could be used for the extraction from large volumes of untreated milk. The authors
emphasized the good recovery’s simplicity of the sample preparation protocol, as well as the reduced
time and solvent requirements in comparison with classic sample preparation techniques [58]. The last
MSPE protocol employed a magnetic graphene-based composite (CoFe2O4-graphene) as the sorbent
material. Spiked milk (1.5 mL) was mixed with 15% HClO4 aqueous solution (0.2 mL) and the mixture
was vortexed for 30 s and centrifuged at 14,000 rpm for 5 min. The supernatant was collected, diluted
with deionized H2O (100 mL), and the pH was adjusted to pH 4.0 and mixed with the magnetic
sorbent (15 mg). The magnetic sorbent was previously conditioned with MeOH (5 mL), H2O (5 mL)
and sonication for 5 min. The mixture was shaken for 20 min and vortexed for 2 min. The magnetic
particles were collected by means of a magnet and the supernatant was discarded. The analytes were
eluted with 5% CH3COOH in MeOH (0.5 mL) and the eluate was passed thought a 0.22 μm filter
prior to HPLC-UV analysis. The authors emphasized the simplicity, low LOD values, and improved
recoveries of the developed sample preparation protocol in comparison with other reported methods.
The magnetic sorbent displayed increased extraction efficiency for the analytes, while it could be
reused after washing with ACN and ultrapure H2O [59].
2.2.4. Other Extraction Techniques
Interesting approaches reported for the extraction of SAs from milk samples include FPSE,
graphene-modified melamine sponge (GMeS) microextraction and miniaturized syringe assisted
extraction (mini-SAE). The FPSE protocol was reported for the extraction of SMZ, SIX, and SDMX from
milk samples. The extraction protocol employed highly polar sol-gel poly(ethylene glycol) coated
cotton cellulose fabric segments as the sorbent material. FPSE media incubated in MeOH-ACN (50:50,
v/v; 2 mL) for 5 min and rinsed with H2O (2 mL), was introduced into spiked whole milk (1 g) for
30 min. The fabric-milk system was stirred by means of a magnetic stirrer for 30 min and the extraction
media was transferred and incubated in MeOH (250 μL) for 8 min and ACN (250 μL) for 5 min.
The extract was filtered prior to HPLC-UV analysis. The coated fabric was washed with ACN-MeOH
(50:50, v/v; 2 mL) for 5 min, left to dry for 5–10 min, and kept in an air-tight container between
extractions and could be reused for up to 30 times. The developed sample preparation protocol
eliminated deproteinization and evaporation/reconstitution, thus reducing the extraction time and
the errors resulting from these steps. The proposed fabric sorbent could be applied directly into the
untreated milk sample offering a simpler extraction protocol and higher recoveries. Furthermore,
the fabric sorbent displayed high chemical and solvent stability that allows the use of the suitable
extraction solvent for sample analysis with multiple chromatographic techniques [60]. The GMeS
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microextraction protocol was reported for the extraction of eight SAs from milk, egg, and water.
The extraction protocol employed novel graphene-modified melamine sponges as the sorbent material.
For the preparation of milk samples, spiked milk (15 mL) was defatted with centrifuging at 4000 rpm
and 4 ◦C for 10 min and deproteinized with 15% trichloroacetic acid solution (1 mL for every 10 mL
defatted sample solution), vortexing for 1 min, and centrifuging at 4000 rpm for 5 min. The supernatant
was collected and mixed with NaCl (6% w/v) and centrifuged. The supernatant was used for the
GMeS extraction. For the preparation of egg samples, homogenized spiked egg (1 g) was mixed
with double distilled H2O (8.7 mL), 15% trichloroacetic acid solution (0.3 mL), and NaCl (6% w/v)
and stirred for 1 min prior to extraction. GMeS cubes conditioned with MeOH and distilled H2O
were placed inside the sample solution (10 mL) and stirred at 600 rpm for 30 min. The cube was
collected, placed into a syringe cartridge, rinsed with H2O, and squeezed in order to remove the
absorbed sample. The analytes were eluted with 5% ammonia in ACN (2 × 1 mL), the eluate was
evaporated to dryness under nitrogen stream and the residue was dissolved in H2O-ACN (70:30, v/v;
100 μL) and sonicated for 1 min prior to HPLC-DAD analysis. The authors emphasized the simple
and rapid preparation and easier handling, as well as the improved recoveries and environmental
friendliness of developed GMeS material in comparison with other sorbents found in the literature [61].
The mini-SAE protocol was reported for the extraction of SDZ and sulfamonomethoxine from milk
samples. The extraction protocol employed a poly (hydroxyethyl methacrylate) polymer as the sorbent
material. Spiked milk (50 g) was mixed with 16% lead acetate aqueous solution (3 mL) and the mixture
was stirred for 5 min and centrifuged at 4000 rpm for 4 min. The supernatant was collected, 16%
lead acetate aqueous solution (2 mL) was added, and the mixture was centrifuged at 4000 rpm for
4 min. The supernatant (1 mL) was loaded into the mini-SAE device packed with the polymer sorbent
(50 mg) and conditioned with MeOH (2 mL) and H2O (2 mL). The device was washed with H2O (1 mL)
and the analytes were eluted with 5% CH3COOH in MeOH (3 mL). The eluate was evaporated to
dryness under nitrogen stream and the residue was dissolved in phosphate buffer (pH 4.0, 1 mL) and
derivatized with fluorescamine prior to HPLC-FLD analysis [62].
2.3. Milk Product Samples
Three protocols were also reported for the extraction of SAs from milk products (baby formula,
cheese, and butter). Firstly, a SLE protocol was reported for multi-veterinary drug extraction, including
24 SAs, from baby formula samples. Spiked formula (1 g) was mixed with EDTA aqueous solution
(0.05 M, 10 mL), the mixture was vortexed, 0.1% formic acid in ACN (10 mL) was added, and the
mixture was vortexed, shaken for 15 min and centrifuged at 2000 rcf for 10 min. The supernatant
(2 mL) was collected, evaporated to dryness under nitrogen stream at 40 ◦C, and the residue was
dissolved in H2O-ACN (75:25, v/v; 1 mL). Analysis was carried out by UHPLC-MS/MS. A clean-up
step was omitted due to low recoveries for β-lactams, tetracyclines and dyes, and variable recoveries
for the other analytes [63]. A QuEChERS extraction protocol was reported for multi-veterinary drug
extraction, including sulfachloropyridazine, sulfadimidine, SDMX, and SQX, from cheese samples.
Spiked cheese (10 g) was mixed with 1% CH3COOH in ACN (10 mL) and Na2EDTA solution (0.1 M,
10 mL) and the mixture was vortexed for 1 min. MgSO4 (4 g) and CH3COONa (1 g) were added and
the mixture was stirred for 1 min and centrifuged at 4500 g for 5 min. The supernatant (2 mL) was
collected and passed through a 0.2 μm nylon filter and the filtrate (1 mL) was diluted with 0.01%
formic acid solution-MeOH (50:50, v/v; 1 mL) prior to analysis with UHPLC-MS/MS. The developed
sample preparation protocol enabled the extraction of multiple veterinary drugs, in comparison with
other similar protocols, that were used for the extraction of a single antibiotic or antibiotic group [64].
An ionic liquid—magnetic bar—liquid-phase microextraction (IL-MB-LPME) was reported for the
extraction of eight SAs from butter samples. The extraction protocol employed magnetic hollow fibers
as the extraction configuration and 1-octyl-3-methylimidazolium hexafluorophosphate ([C8MIM][PF6])
immobilized on the hollow fiber micropores as the extraction solvent. Spiked butter (30 g) was added
into a vessel containing eight magnetic fibers and Na2SO4 aqueous solution (3 M, 6 mL) and the
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vessel was sealed and placed into a water bath at 45 ◦C and magnetic stirring at 500 rpm for 25 min.
The magnetic fibers were collected by means of a magnet, washed with hexane (1 mL), and the analytes
were eluted with MeOH (200 μL) and sonication for 3 min. The eluate was collected, mixed with
Na2SO4 (100 mg) and the supernatant was passed through a 0.22 μm filter. Analysis was carried out
by HPLC-UV. The Na2SO4 aqueous solution acted both as the extraction solvent for the extraction
of the SAs from the butter and as the sample solution for the IL magnetic hollow fibers, thus the
developed sample preparation protocol combined analyte extraction, clean-up, and preconcentration
in one step [65].
2.4. Egg Samples
Two SPE protocols were reported for the extraction of SAs from egg samples. The first SPE
protocol was reported for the extraction of 13 SAs from egg samples. The extraction protocol employed
Strata-X SCX cartridges (Phenomenex, Macclesfield, UK). Homogenized spiked egg (10 g) was adjusted
to pH 5.0–6.0 with 10% CH3COOH solution (900 μL) for 15 min. Chloroform-acetone (50:50, v/v;
30 mL) was added and the mixture was shaken for 10 min and sonicated for 20 min. NaCl (3 g) and
Na2SO4 (3 g) were added and the mixture was centrifuged at 2209 g and 10 ◦C for 10 min and placed
at −70 ◦C for 30 min. The organic phase was collected (25 mL), mixed with CH3COOH (2.5 mL),
and loaded into the SPE cartridge conditioned with n-hexane (2 × 3 mL) and acetone-5% CH3COOH
in chloroform (50:50, v/v; 2 × 3 mL). The loaded cartridge was washed with H2O (5 mL) and MeOH
(5 mL) and the analytes were eluted with MeOH-ammonia solution (97.5:2.5, v/v; 13 mL). The eluate
was evaporated to dryness under nitrogen stream at 45 ◦C and the residue was dissolved in mobile
phase (0.5 mL), mixed with n-hexane (0.5 mL), and centrifuged at 2209× g and 20 ◦C for 10 min.
The lower phase was collected, centrifuged for another 10 min, and the supernatant was analyzed
with HPLC-DAD [66]. The second SPE protocol was reported for the extraction of SDZ from egg
samples. The extraction protocol employed SDZ imprinted microspheres (100 mg) packed into a
glass syringe conditioned with MeOH (5 mL) and Milli-Q H2O (5 mL). Spiked egg yolk (2 g) and
white (2 g) were respectively mixed with MeOH (10 mL) and the mixture was sonicated for 10 min.
The supernatants were collected and the step was repeated for both egg yolk and white. All collected
supernatants were combined, concentrated to 10 mL final volume, and loaded to the MISPE cartridge.
The loaded cartridge was washed with MeOH-H2O (30:70, v/v; 1 mL) and the analyte was eluted
with MeOH (1 mL). The eluate was analyzed directly with HPLC-DAD. The authors emphasized
the clean-up efficiency and analyte preconcentration achieved by the developed extraction protocol,
while sample defatting was not necessary [67]. Additionally, QuEChERS extraction [38], on-line
SPME [47], ATPS [53], and GMeS microextraction [61] were reported for the extraction of SAs from
egg samples and sample preparation protocols are given in detail in Sections 2.1 and 2.2.
2.5. Honey Samples
An on-line SPE protocol was reported for the extraction of 15 SAs from honey samples.
The extraction was achieved in a Zorbax Extended C-18 (12 mm × 4.6 mm; 5 μm) column (Agilent,
Santa Clata, CA, USA). Spiked honey (1 g) was hydrolyzed with HCl solution (3 M, 800 μL) for 90 min
and neutralized with citrate buffer (pH 3.5, 200 μL) and NaOH solution (10 M, 240 μL). The SAs were
derivatized with 0.2% fluorescamine (200 μL) and the sample solution was passed through a 0.22 μm
filter and injected to the on-line SPE-HPLC-FLD system. The authors emphasized the reduced organic
solvent and sample requirements, as well as the simplicity, environmental friendliness, and increased
selectivity and sensitivity of the automated SPE protocol [68]. Additionally, a miniaturized SALLE [52]
protocol was reported for the extraction of sulfonamide from honey samples and details are provided
in Section 2.2.
All reported literature for the extraction of SAs from milk and milk product, egg, and honey
samples is summarized in Table 3.
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3. Conclusions
The most recent literature regarding the extraction of SAs from food samples was successfully
reported. In the case of animal tissue samples, SLE [31–33], ASE [34–36], QuEChERS extraction [37,38],
SALLE [40,41], and SPE [42] were the most reported methodologies for the extraction of SAs, along with
other antibiotic or veterinary drugs, followed by reports of USE [36], DSPE [45], and SBSE [48].
Reports of on-line techniques include a fully automated on-line QuEChERS extraction protocol [39]
and an on-line SPME protocol that utilized molecularly imprinted monolithic capillary columns [47].
Reported novel solid-phase sorbent materials include MWCNTs utilized in a SPE protocol [43],
and Fe3O4@JUC-48 nanocomposite utilized in a MSPE protocol [44]. An ionic liquid application
was also reported in a MSPD-HILME protocol [46]. SPE [55], MSPE [57], and ATPS extraction [53,54]
were the most reported approaches for the extraction of SAs from milk samples. Other approaches
include LLE [49], DLLME [50], as well as a modified QuEChERS extraction protocol that employed
C18, MgSO4 and PSA [50], SALLE combined with SPE [51], and a miniaturized SALLE protocol [52].
Interesting approaches include FPSE [60], GMeS microextraction [61], and mini-SAE [62]. Reported
novel materials include a magnetic hyper cross-linked polystyrene composite [58] and a magnetic
graphene-based composite [59] utilized in MSPE protocols and multi-template MIPs prepared by
sol-gel synthesis utilized in a SPE protocol [56]. Furthermore, SLE [63], QuEChERS extraction [64],
and IL-MB-LPME [65] were reported for the extraction of SAs from milk products. In the case
of egg samples, SPE [66,67] was the main reported technique, while QuEChERS extraction [38],
on-line SPME [47], ATPS [53], and GMeS microextraction [61] protocols included eggs, along with
other food matrices. Finally, for honey samples only an on-line SPE [68] and a miniaturized SALLE [52]
protocol were reported in the recent literature.
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Abstract: Bisphenol-A, a synthetic organic compound with estrogen mimicking properties, may enter
bloodstream through either dermal contact or ingestion. Probiotic bacterial uptake of bisphenol
can play a major protective role against its adverse health effects. In this paper, a method for
the quantification of BPA in bacterial cells of L. lactis and of BPA and its potential metabolites
4-hydroxybenzoic Acid, 4-hydroxyacetophenone and hydroquinone in the culture medium is described.
Extraction of BPA from the cells was performed using methanol–H2O/TFA (0.08%) (5:1 v/v) followed
by SPE. Culture medium was centrifuged and filtered through a 0.45 μm syringe filter. Analysis was
conducted in a Nucleosil column, using a gradient of A (95:5 v/v H2O: ACN) and B (5:95 v/v H2O:
ACN, containing TFA, pH 2), with a flow rate of 0.5 mL/min. Calibration curves (0.5–600 μg/mL)
were constructed using 4-n-Octylphenol as internal standard (1 > R2 > 0.994). Limit of Detection
(LOD) and Limit of Quantification (LOQ) values ranged between 0.23 to 4.99 μg/mL and 0.69 to
15.1 μg/mL respectively. A 24 h administration experiment revealed a decline in BPA concentration
in the culture media up to 90.27% while the BPA photodegradation levels were low. Our results
demonstrate that uptake and possible metabolism of BPA in L. lactis cells facilitates its removal.
Keywords: HPLC-DAD; bisphenol A; 4-Hydroxybenzoic Acid; 4-Hydroxyacetophenone hydroquinone;
Lactococcus lactis
1. Introduction
Bisphenol-A is the organic synthetic compound 4, 4′-Isopropylidenediphenol, which is widely
used in thermal paper industry and as a component of synthetic plastic (vinyl-chloride) due to its
mechanical and extreme-temperature resistance [1]. BPA, was found to exhibit estrogenic properties,
arising from its structural resemblance to the human 17β-estradiol [2], thus it is also referred to as
xenoestrogen or endocrine disruptor. The main routes of human exposure to BPA are the consumption
of food in BPA containing packages [3] and through dermal contact with BPA rich materials [4].
Following exposure, BPA is mainly metabolized in humans to BPA-glucuronide through the hepatic
glucuronide transferase and excreted from the body [5,6]. However, a percentage of BPA, referred
to as “free” or “active” BPA, remains in the blood circulation for up to a week and can interfere
with endogenous biological processes [4]. Due to its estrogenic and genotoxic effects and its wide
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occurrence, BPA presents a risk to humans and animals and hence it is the object of great environmental
concern [7–9].
Although part of bisphenol is degraded via photo-oxidation [10–12], monitoring of its levels
is deemed necessary in various environmental sources [13]. To this end, biodegradation has been
proposed as an advanced technique for BPA elimination [13–15], since a variety of microorganisms have
been identified to decompose BPA [15,16]. Probiotics are bacteria beneficial to the host, which have
been recognized as safe for human consumption and are used in the production of food products [17,18].
Recently they have been reported to be ideal against heavy metal toxicity since they bind and
sequester metals [19]. Moreover, the probiotic bacteria Bifidobacterium breve and Lactobacillus casei
when administered to rats showed a prophylactic effect against the detrimental effects of BPA, by
reducing its intestinal absorption and facilitating its excretion, [18]. Likewise, the ability of Bacillus
strains [20–22], certain Lactococcus strains [23] and Shingomonas paucimobilis [24] to degrade bisphenol
has been documented. Recently a simplified method for the extraction of bisphenol from bacterial
culture suspensions has been reported [25]. Moreover, the compounds 4-hydroxy acetophenone
(HAP), 4-hydroxy benzoic acid (HBA) and Hydroquinone (HQ) have been proposed as major bacterial
metabolites of BPA bacterial degradation pathways [14,26,27]. However, all these studies employed
the determination of bisphenol in the cell free culture supernatant and not in the bacterial cells even
though they examine the kinetics of bisphenol.
Analytical methods for the determination of bisphenol in various food samples [3], as well as in
biological fluids and environmental samples [28], have been extensively reviewed. The determination
of BPA has also been investigated in more complex matrices such as rat tissues [29], human breast
milk [30] resin-based dental restorative materials [31] and saliva [32]. However, to the best of our
knowledge, no method has been reported for the determination of bisphenol in bacterial cells.
In the present study, the development and validation of an analytical method for the quantification
of BPA in bacterial cells is reported for the first time using the widespread probiotic bacterium
Lactococcus lactis (ATC 11454). The method is also validated in bacterial culture supernatants for the
simultaneous determination of the bacterial metabolites reported to be produced during the bacterial
major metabolic pathway [14], namely 4-hydroxy-acetophenone (HAP), 4-hydroxy benzoic acid (HBA)
and Hydroquinone (HQ). The application of this method demonstrates the uptake of bisphenol by
Lactococcus lactis cells and allows its quantification.
2. Materials and Methods
2.1. Chemicals and Reagents
Acetonitrile was purchased from VWR Chemicals (Paris, France). Methanol and Absolute ethanol
were purchased from Fisher Scientific (Loughborough, UK). Trifluoroacetic acid (TFA), KH2PO4 and
FeCl3 were purchased from AppliChem GmbH (Darmstadt, Germany), while NaCl, CaCl2, (NH4)2SO4
and MgSO4 were purchased from Merck KGaA (Darmstadt, Germany). All the chemicals used were
HPLC Grade, unless specified otherwise.
Bisphenol-A (BPA) and the internal standard 4-n-Octylphenol (OP) were purchased from Alfa
Aesar (Karlsruhe, Germany). 4-Hydroxyacetophenone (HAP), 4-Hydroxybenzoic Acid (HBA) and
Hydroquinone (HQ) were purchased from Acros Organics (Ceel, Belgium).
The bacterial strain from which the liquid culture supernatant and the pellet originated and used
for the spike-recovery studies, was Lactococcus lactis (ATCC 11454). The liquid culture medium that
was used for the growth of L. lactis was Brain Heart Infusion broth (BHI broth) and was purchased
from AppliChem GmbH (Darmstadt, Germany). An artificial bacterial culture medium was prepared,
namely Basal Salts Medium (BSM), composed of KH2PO4 and (NH4)2SO4 1 g/L each, MgSO4 0.1 g/L,
NaCl and CaCl2 0.05 g/L each and FeCl3 0.01 g/L. BPA was used as a sole carbon source in BSM
in varying concentrations for the feeding experiments. For the retrieval of the bacterial culture
supernatant and pellet 100 μL of an L. lactis glycerol stock solution were inoculated in a 250 mL
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flash with BHI broth. Following a 24-h incubation at 28 ◦C under constant stirring, the culture was
centrifuged at 5000 rpm and the precipitate was transferred to a 250 mL flask containing BSM. At the
end of the experiment, the culture was centrifuged, the precipitate was placed on a filtering paper and
its weight was recorded following removal of excess water. The recorded weight is referred as ‘wet
cell weight’. The culture supernatant and the wet cell weight were used for the spike-recovery assays.
Solid Phase Extraction columns, frits and C18 sorbent material, 35–75 U were purchased from
Grace Davison Discovery Sciences (Bannockburn, IL, USA). Membrane filters with 0.45 μm diameter
pores were purchased from Merck KGaA (Darmstadt, Germany).
2.2. Standard Preparation
2.2.1. Stock Solution Preparation
Stock solutions 500 μg/mL of BPA, HAP, HBA and HQ were prepared by dissolving 25 mg of the
analyte in 50 mL methanol. The stock solution of BPA (50 mg/mL) was prepared by dissolving 2.5 g of
BPA in 50 mL ethanol. The internal standard stock solution of 500 μg/mL was prepared by dissolving
25 mg of OP in 50 mL methanol.
2.2.2. Working Standard Solution Preparation
Seven-point and six-point working standard solutions were prepared for analytes at concentrations of
0.5, 10, 50, 100, 200, 400, and 600 μg/mL for BPA, at 0.5, 2, 4, 6, 8 and 10 μg/mL for HAP and HQ and
at 1, 2, 4, 6, 8 and 10 μg/mL for HBA and the internal standard 4-n-octylphenol (75 μg/mL).
2.3. Sample Preparation
For the bacterial pellet method development, 0.1 g of wet cell weight L. lactis was added in a
test tube with 8 mL methanol, 2 mL of double distilled water containing 0.08% (v/v) TFA and 150 μL
internal standard from the 500 μg/mL stock. The concentration of the internal standard in the final
1 mL volume was 75 μg/mL. The test tube was transferred to an ice-filled container and was placed
under a homogenizer for 5 min. The homogenate was separated in ten Eppendorf centrifuge tubes
and was centrifuged for 10 min in 8000 rpm. The supernatant was collected and mixed with an
equal volume of ddH2O containing 0.08% TFA. BPA extraction was performed using Solid Phase
Extraction (SPE). An SPE cartridge was prepared using 0.5 g of C18 sorbent in an SPE column. The SPE
cartridge was conditioned with 10 mL methanol, 5 mL ddH2O and 5 mL ddH2O containing 0.08% TFA.
The sample was loaded on the cartridge and a manual flow of 1 mL/min was employed. The cartridge
was, then, washed with 5 mL ddH2O and elution was performed using 4 mL methanol. The eluate was
collected and placed under a rotary evaporator in a 37 ◦C water bath, to dryness. Finally the sample
was reconstituted with 1 mL acetonitrile and stored in an aluminum foil-covered Eppendorf tube at
−20 ◦C. All experiments were conducted in dark or covered tubes to avoid photodegradation of BPA.
For the bacterial supernatant, an 8.5 mL sample of the culture was added in a test tube along with
1.5 mL internal standard from the stock solution. The sample was placed in 10 Eppendorf centrifuge
tubes (1 mL per tube), and was centrifuged for 10 min in 8000 rpm. The supernatant was collected and
filtered through a 0.45 μm diameter pore filter. The filtrate was stored in an aluminum foil-covered
Eppendorf tube at −20 ◦C.
2.4. BPA Administration (Feeding) Assay
For the feeding assays 6 falcon tubes of 50 mL volume were filled with BHI broth and were
inoculated with 100 μL of a L. lactis glycerol stock solution. The cultures were incubated for 24 h at
28 ◦C under constant stirring. The cultures were, then, centrifuged and the medium was discarded.
A total of 50 mL of fresh BSM was added to each culture along with varying quantities from the
BPA stock solution (50 mg/mL) so that the final BPA concentration in each culture would be 50, 100,
150, 200, 400 και 500 μg/mL respectively. The cultures were incubated for another 24 h at 28 ◦C
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under constant stirring. The remaining BPA in the cultures was quantified using the method and the
calibration curves that were described.
2.5. Photodegradation Assay
To investigate potential photodegradation of BPA, a falcon tube of 50 mL containing BSM and
BPA at a concentration of 50 μg/mL was prepared and was incubated under the same conditions as
the feeding assays. BPA was quantified at the beginning and the end of the 24 h incubation period.
The presence of photodegradation products was examined in the resulting chromatograms.
2.6. HPLC-DAD Conditions and Methods
The instrument used consisted of an LC20AD pump and an SPD-20A photodiode array detector
(DAD) purchased from Shimadzu (Kyoto, Japan). Separation of BPA was achieved on a Nucleosil 100
C18 column (250 × 4.6 mm, 5 μm) purchased by Macherey-Nagel GmbH & Co. (Duren, Germany)
with a binary mobile phase system at room temperature. The injection was performed using a 100 μL
Hamilton syringe, with an injection volume of 80 μL. Mobile Phase A consisted of a 0.1% TFA in ddH2O
solution and Acetonitrile at a ratio of 95:5, v/v. Mobile Phase B consisted of a 0.08% TFA in ddH2O
solution and Acetonitrile at a ratio of 5:95, v/v. The gradient started at 100% Mobile Phase A which
was brought down to 80% over 1 min, 70% over 4 min, 55% at 15 min, 40% at 17 min, 20% at 20 min
and finally to 10% over 2 min and then was kept at this level until the end on the analysis. The flow
rate was constant at 0.5 mL/min. BPA was detected at 220 nm with a band width of 2.0 nm. HAP,
HBA and HQ were detected at 280 nm with a band width of 2.0 nm. Identification was conducted by
matching the peak retention times (Rt) with those of the pure standards. Internal standard calibration
was used by plotting the peak area ratio of the analyte to the peak area of the internal standard against
the concentration of the analyte.
3. Results and Discussion
3.1. Optimization of Sample Preparation
The homogenization of the sample was performed to lyse the cells and release the adsorbed
BPA for the feeding assay. Initially, ethyl acetate was used instead of methanol and a manual
homogenization was attempted with a glass homogenizer, but cell lysis was deemed inadequate. Hence
methanol was selected as the extraction solvent. The addition of an equal volume ddH2O containing
0.08% (v/v) TFA after centrifugation aimed to increase the solubility of BPA due to further dilution.
An elaborate and efficient vortex assisted liquid-liquid microextraction with octanol was used
for the trace analysis of bisphenol in water and wastewater samples [33]. However, an attempt to
use liquid-liquid extraction with ethyl acetate in the samples of the present study resulted to the
formation of an emulsion zone between the two phases, a fact that led to greatly varying percentages
of BPA recovery due to the loss of the analyte during the procedure. Thus, solid phase extraction was
implemented, since SPE is a common step in the extraction procedures of bisphenol from complex
matrices, such as rat tissues [29] or human serum [5] and its benefits in the biomonitoring of bisphenol
have been demonstrated [28,33]. In the present study a flow rate of 1 mL/min was selected throughout
the SPE procedure, as effective and timely favorable, while higher flow rates did not provide full
retention of BPA by the C18 material, especially at high BPA concentrations employed and resulted in
lower recovery values. A 37 ◦C water bath was selected to facilitate the evaporation of methanol after
SPE. The slightly higher evaporation temperatures of 45 ◦C that have been reported for the analysis of
bisphenol and 4-nonylphenol [29] resulted in heat-induced decomposition of the internal standard
when used in the present study. Our results for BPA extraction are in accordance with a recently
published report on a methanol extraction of bisphenols from bacterial cultures and solid matrices [25]
in which, however, SPE was not employed and lower concentrations of BPA were used [25], resulting
in recoveries up to 95%. The SPE step used in the present study greatly improved recovery which
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amounted to 99.38–100.18% in culture supernatants and to 90.8–102.46% in bacterial cells, in the wide
range of concentrations employed (Table 1).






















y = 0.0295x + 0.0077
1
0.5 0.48 ± 0.05 −3.6 8.7 10.4 96 ± 13
10 9.94 ± 0.08 −0.6 0.1 0.8 99.4 ± 0.7
50 50.2 ± 0.7 0.4 0.8 1.4 100 ± 1
100 100 ± 2 0.05 0.8 1.7 100 ± 1
200 200 ± 2 −0.2 0.7 1.2 100 ± 1
400 401 ± 3 0.2 0.2 0.8 100.2 ± 0.6
600 600 ± 3 −0.01 0.3 0.6 100.0 ± 0.5
BPA in L. lactis
precipitate
y = 0.0232x + 0.0092
0.9999
0.5 0.41 ± 0.03 −18.5 3.2 7.4 82 ± 5
10 9.1 ± 0.4 −9.2 2.3 4.7 91 ± 4
50 48± 1 −3.7 2.7 2.7 96 ± 2
100 98 ± 3 −2.0 2.0 2.9 98 ± 2
200 205 ± 3 2.5 0.4 1.4 103 ± 1
400 400.6 ± 0.9 0.2 0.2 0.2 100 ± 0.2
600 597 ± 5 −0.6 0.1 0.8 99.4 ± 0.7
HAP in BSM
y = 0.202x + 0.0134
0.9994
0.5 0.52 ± 0.02 3.4 2.8 3.8 103 ± 3
2 2.06 ± 0.05 2.9 0.2 2.4 103 ± 2
4 3.84 ± 0.04 −4.1 0.7 1.0 95.9 ± 0.8
6 6.1 ± 0.1 1.1 1.0 2.3 101 ± 2
8 8.0 ± 0.2 0.6 2.1 2.2 101 ± 2
10 10.0 ± 0.1 −0.3 0.3 1.0 99.7 ± 0.8
HBA in BSM
y = 0.0407x + 0.0073
0.994
1 0.91 ± 0.03 −9.5 2.7 3.3 90 ± 2
2 1.86 ± 0.04 −6.9 0.3 2.2 93 ± 3
4 4.1 ± 0.2 2.3 3.2 4.2 102 ± 2
6 6.2 ± 0.1 3.0 2.1 2.3 103 ± 2
8 8.3 ± 0.3 4..2 3.0 3.1 104 ± 3
10 9.62 ± 0.04 −3.8 0.3 0.4 96.2 ± 0.3
HQ in BSM
y = 0.0351x − 0.0082
0.999
0.5 0.48 ± 0.01 −3.8 1.4 2.1 96 ± 2
2 2.2 ± 0.1 7.5 3.4 6.5 108 ± 5
4 3.91 ± 0.03 −2.2 0.03 0.8 97.8 ± 0.6
6 5.91 ± 0.09 −1.5 1.6 1.5 98 ± 1
8 7.9 ± 0.2 −1.4 0.5 2.0 99 ± 2
10 10.1 ± 0.2 1.3 1.4 2.2 101 ± 2
In an effort to perform the analysis of BPA in the BHI medium, which is recommended for growth
of L. lactis, the nutrients in the broth resulted in the presence of peaks in the chromatogram that
appeared to interfere with the tested bacterial metabolites peaks. The artificial bacterial medium
(BSM) was prepared to tackle the problems that arose in the analysis using the reference BHI medium.
Moreover, in this manner BPA was the sole carbon source for the bacterium, a fact that contributes in
its biotransformation.
3.2. Method Validation
The results of the linear regression analysis performed using the “Linear Regression” package
of Microsoft Excel 2013 software are presented in Table 1, while detection limits and Retention time
variance are presented in Table 2. The coefficient of determination values (R2) for the standard curves
in BSM supernatant and L. lactis cells were 1 and 0.999 respectively, while for HAP, HBA and HQ
in BSM supernatant the values exceeded 0.9994, 0.994 and 0.999 respectively, indicating excellent
linearity. The Relative Bias was calculated by computing the percentage of the difference of the mean
calculated concentration to the nominal concentration divided by the nominal concentration of the
analyte. All results are within the accepted range of ±10%. Intra-day precision was calculated by
performing a total of three injections of the nominal concentration on the same day, while inter-day
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precision was calculated by performing six injections of the nominal concentration over three days.
Both were computed as % R.S.D. = (S.D./mean) × 100. None of the values exceeded 6.0% for all
analytes, with the exception of the values obtained for the lowest nominal value of 0.5 μg/mL of BPA
in bacterial cells and in the medium, which might be due to the fact that this nominal value is below
LOD (Table 2). Since an elaborate extraction protocol was required for the bacterial cells, the use of an
internal standard was deemed necessary, to compensate for sample losses during sample preparation.
The internal standard 4-n-octylphenol was selected, due to the fact that it is well resolved and it has
a structure similar to bisphenol. Moreover, it is not expected to be present in samples, since only
4-t-octyphenol has been reported to be found at very low concentrations in environmental samples
and human milk [34,35]. Our results, as presented in Table 1, indicate that the method is highly precise
and repeatable. Recovery rates were well within range of 10% error, reaching close to 100% recovery,
thus further supporting the precision of this method. The recovery results presented in Table 1 are in
good correlation with those reported for rat serum (95%) and higher than those reported for rat testis
(78.6%) and liver (84.0%) [29].
Table 2. Analyses LOD, LOQ and Rt values for all analytes.
Std. Curve
Retention Time (Min)
Mean ± SD (RSD %) LOD (μg/mL) LOQ (μg/mL)
BPA in L. lactis 26.68 ± 0.13 (0.41) 4.99 15.01
BPA in BSM 26.71 ± 0.09 (0.38) 0.64 1.93
HAP in BSM 15.66 ± 0.05 (0.29) 0.24 0.73
HBA in BSM 12.77 ± 0.12 (0.23) 0.73 2.21
HQ in BSM 10.80 ± 0.08 (0.90) 0.32 0.98
The nominal concentrations of 0.5 μg/mL BPA in BSM and cell precipitate were below the
calculated LOD values (Table 2) and were thus excluded from the estimation of recovery results
described above. The values for the Limit of Detection (LOD) and Limit of Quantification (LOQ) were
calculated from the calibration curves. The LOD was calculated to 3.3 times the ratio of the Standard
Error (intercept) to the Coefficients x, while the LOQ was 10 times this ratio. The retention time means,
standard deviations and RSDs were calculated using the data from one chromatogram of each of the
nominal concentrations used. The value of an LOD of 4.99 μg/mL estimated in the present study for
BPA in bacterial cells at the range of 10–600 μg/mL, is higher than the value of 2.8 ng/mL reported for
rat tissues, but over a narrower range of concentrations of 0.15–150 μg BPA/mL [29]. A lower value
of LOD was found for BPA in the less complex sample of BSM, amounting to 0.64 μg/mL (Table 2),
although the same range of concentrations was employed (Table 1), possibly due to lower matrix
complexity. Similar low LOD values were estimated for all possible metabolites tested, as shown in
Table 2. Although these compounds have been proposed as possible bisphenol bacterial metabolites,
they were identified using MS and NMR analysis of the HPLC isolated fractions [27]. In fact, in the
studies on the determination of bisphenol degradation using HPLC-DAD [20,23], no validation was
included. The method presented in this work allows the simultaneous quantification of bisphenol A
and three of its major bacterial metabolites.
3.3. Feeding Results
A typical chromatogram of HQ, HBA and HAP and BPA is presented in Figure 1. Analyte peaks
of HQ, HBA, HAP, BPA and internal standard OP are shown with a retention time (Rt) of 10.671,
12.728, 15.579, 26.241 and 40.771 min respectively. The peak that appears at 25.6 (Figure 1) might be
attributed to a BPA photodegradation product, since it was also identified during the photodegradation
experiment and is presented in Figure 2. Photodegradation of BPA via photooxidation has been
confirmed [10,12], and the products of this process presented higher toxicity than the parent
compound [11]. Since the feeding experiments were conducted under normal light, it was deemed
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appropriate to test if any BPA loss was due to photodegradation. In these experiments the initial BPA
concentration was calculated at 48.65 μg/mL and the concentration following the 24 h incubation
amounted to 44.18 μg/mL. Hence, the BPA loss due to photodegradation was 9.19%. These values are
in accordance with those reported for bisphenol A degradation by UV irradiation in the absence of
hydrogen peroxide [36].
Figure 1. A chromatogram containing all analytes at a concentration of 10 μg/mL and internal standard
at 75 μg/mL in fresh BSM without L. lactis inoculation. The first two peaks with Rt of 5.7 min and
7.5 min are background noise from acetonitrile solvent and TFA.
 
Figure 2. Chromatogram displaying BPA and its identified photodegradation product with a Rt of
26.515 min and 25.610 min respectively. The compounds were detected at a wavelength of 300 nm.
Typical chromatograms of the feeding assays are presented in Figure 3 (bacterial cells) and
Figure 4 (bacterial culture medium). The relative blank chromatograms resulting from bacterial cells
and from their culture medium any additions are shown in the Supplemental section. The peaks
appearing at 10.2 min in both chromatograms does not represent one of the metabolites described
in this paper, as confirmed by comparing the absorbance spectra of the peak to those of the pure
metabolites analyzed.
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Figure 3. Chromatogram of cell precipitate originating from the administration of 150 μg/mL BPA in
the bacterial cells. The peaks at 26.528 min and 40.822 min correspond to BPA and the internal standard.
Figure 4. Chromatogram of culture supernatant originating from the administration of 150 μg/mL
BPA in the bacterial cells. The peaks at 26.672 min and 41.604 min correspond to BPA and the
internal standard.
Two major pathways have been proposed for the metabolism of bisphenol A by bacteria, the first
leading to mineralization, with HBA and HAP as intermediates and the second to hydroxylation [6,16].
However, it has been pointed out that the metabolic pathways might be strain specific [14], since
certain metabolites produced by one strain are not detected when another bacterial strain is used.
In a similar manner, the analytes HQ, HBA and HAP were not detected in the chromatograms of
the feeding assays. Absence of bacterial metabolites has also been reported for Bacillus pumilus [20]
and certain Lactococcus strains [23]. In all these reports, including the present work, the presence of
metabolites was examined at 24 h of culture. However, when various Bacilli and Sphingomonas strains
were tested for bisphenol degrading capacity, metabolites were detected for three of them and only
from 8–12 h, in a declining manner [37]. These results indicate that the time period of 24 h used in the
present paper might be too long, since the metabolites under investigation might have formed and then
further transformed. On the other hand, the bacterial metabolites examined in the present paper were
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reported to be produced by Bacillus sp., yet only after 3 days of incubation in the presence of 20 mM
BPA [21]. Moreover, the photodegradation of BPA metabolites has been reported for hydroxybenzoic
acid as well as for hydroquinone [38,39]. It is evident that more experiments are needed in the course
of bacterial incubation, since metabolism is an ongoing process and each strain presents particular
metabolic characteristics.
A depletion of up to 58% in total BPA (μg) was observed in our experiments, in all bacterial
cultures as shown in Table 3. Complete degradation of BPA has been reported following a 48 h
incubation period [37] or after 9 days of incubation [21]. In our experiments BPA was reduced by
90.27%, 64.16%, 58.60%, 67.74%, 79.83% and 85.05% in the cultures corresponding to initial BPA
concentration of 50, 100, 150, 200, 400 and 500 μg/mL. Our results suggest that the initial BPA
concentration added has a profound effect on its degradation. Many bacterial strains that can degrade
BPA have been reported, and this degrading ability varies among the species [14]. It should also be
noted that different initial concentrations of BPA are used in the reports employing bacteria, ranging
from 0.1 to 60 mg/L [22,37,40] and for varying incubation periods. Bacteria can clearly employ a
variety of metabolic pathways to exploit pollutants as energy sources, under the prerequisite that the
pollutants are bioavailable and at levels that could trigger such mechanisms [16].
Table 3. Comparative data of BPA administered (μg) and found in feeding assays.
BPA
Administered in
50 mL Culture (μg)
BPA Found in
Precipitate







2500 (50 μg/mL) 46.77 196.46 243.23 90.27
5000 (100 μg/mL) 110.48 1681.74 1792.22 64.16
7500 (150 μg/mL) 255.75 2849.48 3105.23 58.60
10,000 (200 μg/mL) 262.20 2964.01 3226.22 67.74
20,000 (400 μg/mL) 437.24 3595.83 4033.07 79.83
25,000 (500 μg/mL) 421.16 3316.41 3737.57 85.05
4. Conclusions
The developed analytical method provides a reliable, robust and sensitive approach for the
simultaneous detection and quantification of bisphenol A and its potential metabolites in the complex
matrix sample of bacterial cells. Good chromatography separation was achieved on a Nucleosil 100
C18 column with a longer run time, which however allows the detection and separation of metabolites.
LC-DAD combined with solid phase extraction and the use of 4-n-octylphenol as the internal standard,
is capable of operating with a detection limit of 4.99 μg/mL for bisphenol and lower limits for
metabolites in bacterial cells. The method was also successfully applied in the analysis of bacterial
culture medium with a detection limit of 0.64 μg/mL for bisphenol. The feeding experiments revealed
that L. lactis is capable to uptake of bisphenol and contribute to its elimination from the culture medium.
Further experiments are needed for the detection and quantification of metabolites as a function of
culture time and administrated bisphenol concentration.
Supplementary Materials: The following are available online at http://www.mdpi.com/2297-8739/5/1/12/s1,
Figure S1: Blank chromatograms of L. lactis cells (A) and cell free bacterial medium (B).
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Abstract: Silk fibroin nanoparticles were prepared in the present study based on phase separation
between silk fibroin and polyvinyl alcohol. The drug encapsulation efficiency of the prepared
nanoparticles was examined at a range of concentrations from 10 ppm to 500 ppm for pramipexole,
curcumin, and propranolol hydrochloride. Silk fibroin nanoparticles encapsulated with propranolol
presented the highest drug release profile. In order to improve the drug encapsulation efficiency and
drug release performance, a modification of silk fibroin nanoparticles with bovine serum albumin
and magnetic nanoparticles was tried. The modification was found to improve the drug encapsulation
and release of the modified nanoparticles. Bovine-serum-modified nanoparticles presented the
best improvement.
Keywords: silk fibroin; drug delivery; magnetic silk fibroin; bovine serum albumin
1. Introduction
Drug delivery aims to bring the compound with pharmaceutical activity to the exact point of
need in the organism with the right concentrations in order to increase the efficiency of action [1].
The improvement of cellular uptake, the reduction of the side effects, the control of drug release,
the enhancement of drug bioavailability, and the reduction of the drug degradation rate are the
purposes of drug delivery systems [2]. Recently, nanoparticles are considered to be suitable for
drug delivery due to their ability to act as modifiable platforms, their tunable size, and their high
surface-to-volume ratio [2]. In addition, they can be used to deliver hydrophilic and hydrophobic drug
molecules as well [3].
Silk fibroin, from the silk worm Bombyx mori, consists of hydrophobic and hydrophilic regions [2].
The hydrophobic domains, i.e., protein crystals and beta sheets, are dominated by repeats of alanine,
glycine-alanine, and glycine-alanine-serine. Recently, silk fibroin, due to its excellent properties, such as
biocompatibility, biodegradability, and low immunogenicity, has been extensively tested for a drug
delivery application since silk materials exhibit high encapsulation efficiency and controllable drug
release kinetics [4–6].
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Bovine serum albumin (BSA) is a water-soluble protein with a well-defined structure. Positively or
negatively charged drug molecules can be non-covalently bound to the charged amino acids of albumin.
Silk fibroin contains hydrophobic amino acids that could create strong electrostatic interactions through
the amino acids’ carboxyl groups and the amino groups of bovine serum albumin. These interactions
prevent leakage of hydrophobic drugs from bovine serum albumin; thereby, it is expected to improve
drug encapsulation, delivery to affected body areas, and drug release rate [7]. Albumin was found to
enable the localization of drug carriers in specific tissues (i.e., liver and heart tissues), regulating in
this way biodistribution and drug release [8]. Besides this, it was shown that readily available and
inexpensive serum albumin can overcome many drugs’ shortcomings, such as insolubility, instability
in biological environments, poor uptake into cells and tissues, sub-optimal selectivity for targets,
and unwanted side effects [9].
Additionally, magnetic carriers and external magnetic fields that focalize on tumors have emerged
as a hopeful strategy to enhance drug accumulation at tumor sites. Magnetic targeting has the
advantage of not requiring complex chemical modification of targeting ligands on the surface of
nanocarriers when compared with conventional tumor targeting. Exploiting a magnetic field as
a driving force represents a noninvasive therapeutic approach [10,11].
In the present study, we report aqueous-based preparation methods for silk fibroin nanoparticles,
based on phase separation between silk fibroin and polyvinyl alcohol (PVA), with a simple,
inexpensive, and appropriate method for pharmaceutical and biomedical applications of drug delivery.
Curcumin, pramipexole, and propranolol hydrochloride were chosen as model drugs in this study for
their different molecular weights (MWs), surface chemistries, and disease targets. Curcumin, a natural
compound with diphenolic groups, is extracted from the rhizome of turmeric. It has been used in
clinical trials for cancer therapy [12,13]. Propranolol is a non-selective beta adrenergic blocking agent
and has been used in the treatment of hypertension, angina pectoris, and many other cardiovascular
disorders [14]. Pramipexole is a potent dopamine D2 agonist with a preference for D3 receptors and is
approved worldwide for the treatment of Parkinson’s disease symptoms [15].
Moreover, nanoparticles of silk fibroin were modified with bovine serum albumin for the
enrichment of silk fibroin with the above-mentioned properties of albumin [7–9]. Silk fibroin-bovine
serum albumin nanoparticles were prepared since bovine serum albumin has been found to be
biocompatible, biodegradable, non-toxic, and non-immunogenic and has interesting results in drug
encapsulation and release [16]. Finally, magnetic silk fibroin nanoparticles were also prepared and
examined to identify the contribution of magnetic nanoparticles to the encapsulation efficiency and
in vitro drug release of the model drugs.
2. Materials and Methods
2.1. Materials
Polyvinyl alcohol high molecular weight solid, (PVA 98-99 hydrolized) and curcumin
(95% total curcuminoid content) from Tumeric rhizome were purchased from A Johnson Company
(New Brunswick, NJ, USA). Ethanol, Lithium Bromide 99%, and Bovine Serum Albumin (BSA)
(lyophilized powder, 66.000 kDa), were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Propranolol hydrochloride and Pramipexole were purchased from Fagron Hellas (Trikala, Greece).
FeCl3•6H2O, FeCl2•4H2O, and NH4OH of analytical grade were purchased from Sigma-Aldrich.
2.2. Methods
2.2.1. Preparation of Silk Fibroin Solution
Silk fibroin aqueous solution was prepared according to described protocols [17]. Briefly, 5 g
cocoons of Bombyx mori were boiled in 2 L of an aqueous solution of sodium carbonate (0.02 M)
for 30 min and the degummed silk fibroin was thoroughly rinsed with deionized water, air dried
58
Separations 2018, 5, 25
overnight, and then dissolved in a 9.3 M LiBr solution at 60 ◦C. The solution was dialyzed against
deionized water using Slide-a-Lyzer dialysis cassettes (MWCO 3.500, Pierce, Thermo-Fischer Scientific,
Waltham, MA, USA) for 2 days for salt removal. In order to clean the solution from impurities, silk
aggregates, and debris of cocoons, the silk fibroin solution was centrifuged twice at 9000 rpm for 30 min.
The prepared silk fibroin solution was stored at 4 ◦C for further use.
2.2.2. Preparation of Silk Fibroin (SF) Nanoparticles
Silk fibroin particles were prepared according to the following method [18]: 5 mL of silk
fibroin solution was mixed with 2 mL ethanol with a sample pipette and then vortexed for 10 s.
Subsequently, 50 mL of 5% PVA solution were added to the fibroin/ethanol mixture and vortexed
for 10 s. The fibroin/ethanol/PVA solution mixture was refrigerated for 24 h and centrifuged. In order
to remove PVA and ethanol from the nanoparticles, the mixture was washed with deionized water
three times and centrifuged after each wash [18].
2.2.3. Preparation of Silk Fibroin-Bovine Serum Albumin (SF-BSA) Nanoparticles
For the preparation of the Silk Fibroin-Bovine Serum Albumin nanoparticles (SF-BSA-NPs), 2.5 mL
of the silk fibroin solution were mixed with 2.5 mL of 2% BSA solution and then the mixture was
stirred for 15–20 min. The SF-BSA-NPs were prepared following the method used to prepare the silk
fibroin nanoparticles.
2.2.4. Synthesis of Fe3O4 Nanoparticles
For the preparation of the magnetic silk fibroin nanoparticles (SFm-NPs), the magnetic material
used was magnetite nanoparticles (Fe3O4) prepared in the laboratory. The Fe3O4 nanoparticles were
prepared according to the modified Massart method [19] via the co-precipitation of FeCl3•6H2O and
FeCl2•4H2O [18]; briefly, 11.2 mmol FeCl3•6H2O and 5.6 mmol FeCl2•4H2O were dissolved in 150 mL
of deionized water, heated to 60 ◦C under agitation in an inert atmosphere, and then aqueous ammonia
solution was added dropwise until the solution’s pH became 10. The precipitate that was formed was
magnetically collected, washed with deionized water and ethanol, and freeze-dried.
2.2.5. Preparation of Silk Fibroin-Fe3O4 (SFm) Nanoparticles
For the preparation of the magnetic silk fibroin nanoparticles (SFm-NPs), 0.1 g Fe3O4 was added
to 5 mL of silk fibroin solution followed by the preparation of nanoparticles as above described.
2.2.6. Preparation of Drug-Encapsulated Silk Fibroin Nanoparticles
Curcumin (MW = 368.39 g/mol), propranolol hydrochloride (MW = 259.34 g/mol),
and pramipexole (MW = 211.32 g/mol) were the model drugs tested for the encapsulation in the silk
fibroin nanoparticles; the chemical formulas of the drugs are presented in Table 1.
Amounts of the pramipexole and propranolol were dissolved in deionized water and mixed with
5 mL of the silk fibroin solution; curcumin was dissolved in ethanol and then mixed with 5 mL of the
silk fibroin solution. Different amounts of the drugs were estimated for the preparation of solutions
with concentrations of 10, 35, 50, 100, 200, and 500 ppm for each drug. Finally, the drug-encapsulated
silk fibroin nanoparticles were prepared as previously described.
The encapsulation efficiency in the silk fibroin nanoparticles was determined by measuring
the UV-vis absorbance (HITACHI U-2000) of the supernatant after the centrifugation that follows
the formation of silk fibroin nanoparticles at 430, 265, and 235 nm for curcumin, pramipexole,
and propranolol, respectively. Standard calibration curves of model drugs were used for drug
quantification (r2 ≥ 0.999). All experiments were performed in triplicate and the mean value is
presented. The difference between the total amount of drug used in the experiment and the amount
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that remained in the supernatants was expressed as encapsulation efficiency (EE) in silk fibroin
nanoparticles [20] and determined by the following equation:
Encapsulation Efficiency =
amount of drug that remained in the particles
total amount of drug used
× 100 (1)





MW = molecular weight.
2.2.7. Silk Fibroin Nanoparticles Characterization
For the identification of the crystalline phase of silk fibroin nanoparticles, X-ray powder diffraction
(XRD) patterns were recorded on a Philips PW 1820 diffractometer (Amsterdam, The Netherlands)
with Cu Kα radiation from 20◦ to 60◦. The morphology of silk fibroin nanoparticles as well as that of
drug-encapsulated silk fibroin nanoparticles was imaged using a JEOL JMS-840A scanning electron
microscope (JEOL, Tokyo, Japan). The control samples of silk fibroin nanoparticles suspensions
in water, the samples of SF-BSA-NPs and SFm-NPs, and their respective drug-encapsulated
nanoparticles suspensions in water were lyophilized and the powder obtained was subjected to Fourier
Transform Infrared measurement using a Perkin-Elmer FTIR spectrophotometer (model Spectrum
1000, Rodgau, Germany). Nanoparticle size, size distribution, and surface charges of the nanoparticles,
and those of their respective drug-encapsulated nanoparticles, were determined by Dynamic Light
Scattering (DLS) with a NanoBrook ZetaPALS Brookhaven Instruments (Holtsville, NY, USA) equipped
with a diode laser (wavelength, λ = 532 nm). Hysteresis loops for the SF-magnetite nanoparticles were
recorded with an Oxford 1.2 H/CF/HT vibrating sample magnetometer (VSM).
2.2.8. In Vitro Drug Release
The amount of drug released in vitro from the drug-encapsulated silk fibroin nanoparticles,
at specific time intervals, was calculated as follows: 4 mL of the drug-encapsulated nanoparticles
were added to 20 mL of phosphate buffer saline (PBS) at pH 7.4 and shaken at a rate of 120 rpm
at 37 ◦C. At specified time intervals, 2 mL were sampled and centrifuged at 9000 rpm for 10 min.
The concentration of the drug in the supernatant was measured by UV-vis spectrometry at 430, 265,
and 235 nm for curcumin, pramipexole, and propranolol, respectively. The percentage release was
determined as the ratio of the measured amount of the drug released at different time intervals to
the initial amount of drug encapsulated in the nanoparticles [12]. All experiments were performed in
triplicate and the mean value is presented.
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3. Results and Discussion
Weighting the residual solid of a certain known volume of silk solution after drying at 60 ◦C,
the concentration of the silk fibroin aqueous solution prepared was found to be approximately
4.6% (w/v).
3.1. XRD Characterization, Morphology, and FTIR Characterization of the Silk Fibroin Nanoparticles
XRD peaks of silk fibroin are associated with its crystalline structure; Figure 1 presents the
XRD results of the silk fibroin nanoparticles prepared in the current study. The 2θ diffraction peak
presented in the XRD pattern of the silk fibroin nanoparticles at 2θ = 19.2◦ could be attributed to the
silk II crystal structure of fibroin, indicating an increased crystallization degree of silk fibroin in the
nanoparticles [21,22].
Figure 1. XRD patterns of silk fibroin nanoparticles (SFNPs).
The morphology of silk fibroin nanoparticles was illustrated by SEM images and is presented in
Figure 2a. The nanoparticles observed presented a spherical and/or cylindrical shape with an average
mean diameter of about 290 nm. Silk fibroin nanoparticles previously prepared with the same method
by Shi et al. [18] presented an average diameter of about 686.5 nm as estimated by SEM image.
This difference in size could be attributed to the lower concentration (4%) of silk fibroin solution that
was used in this study to prepare the silk fibroin nanoparticles compared to the study by Shi et al. (6%).
According to Zhao et al., the increase of the starting silk fibroin solution concentration has an effect on
the particle size increase [23].
Figure 2. Cont.
61
Separations 2018, 5, 25
Figure 2. SEM images of SF nanoparticles (a); SF-propanolol NPs (b); SF-pramipexole NPs (c);
and SF-curcumin NPs (d).
In Figure 3, the FTIR spectrum of the prepared silk fibroin nanoparticles is presented.
The characteristic peak at 1632 cm−1 attributed to an amide I β-sheet and the peak at 1260 cm−1
attributed to amide III are due to random coil. So, when the nanoparticles of silk fibroin were formed
both the silk I crystal structure and the silk II crystal structure of silk fibroin were observed [24,25].
The assignments of the FTIR bands of silk fibroin nanoparticles are presented in detail in Table 2.
Figure 3. FTIR spectra of silk fibroin nanoparticles and drug-encapsulated silk fibroin nanoparticles.
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Table 2. Assignments of the FTIR bands of silk fibroin nanoparticles and drug-encapsulated silk
fibroin nanoparticles.









1465 CH3 bending 1469 CH3 bending 1465 CH3 bending 1488 curcumin
1401 CH3 bending 1422 CH3 bending 1399 CH3 bending
1354 CH2 bending (AG)n 1367 CH2 bending (AG)n
1311 OCO– stretching 1315 OCO– stretching 1319 OCO– stretching 1303 Amide III
β-turn


































(A)n, polyalanine; (AG)n, polyalanine glycine [26].
3.2. Encapsulation Efficiency
The encapsulation efficiency (EE) of the silk fibroin nanoparticles for the three model drugs was
studied at a range of concentrations from 10 to 500 ppm. For the curcumin-encapsulated silk fibroin
nanoparticles the highest EE was found to be 98 ± 2% and was achieved at 500 ppm, for propranolol
the highest EE was 69 ± 3% at 50 ppm and for pramipexole the highest EE was 68 ± 2% at 35 ppm
(data not shown).
3.3. Size, ζ-Potential, Morphology, and FTIR Characterization of Silk Fibroin Nanoparticles
and Drug-Encapsulated Silk Fibroin Nanoparticles
The size of silk fibroin nanoparticles measured by DLS is presented in Table 3. As seen in the Table,
the average diameter of the silk fibroin nanoparticles was found to be 301 ± 11 nm, which is consistent
with the size estimated by SEM; the average size was found to increase after the encapsulation
of the model drugs (curcumin, pramipexole, and propranolol) in the silk fibroin nanoparticles.
The polydispersity index, ranging from 0.10 to 0.25, revealed a uniform particle distribution.
Table 3. Diameter of silk fibroin nanoparticles measured by dynamic light scattering.
Diameter ± SD (nm) (n = 5) Polydispersity Index
SFNPs 301 ± 11 0.24
SF-curcumin NPs 354 ± 13 0.25
SF-pramipexole NPs 469 ± 14 0.10
SF-propranolol NPs 501 ± 7 0.20
The surface charge of the silk fibroin solution, of the drug solutions, of the silk fibroin
nanoparticles, and of the silk fibroin nanoparticles encapsulated with the model drugs was
determined by ζ-potential and the results are presented in Table 4. For all samples, the ζ-potential
was negative; it was observed that the ζ-potential of propranolol-encapsulated silk fibroin
nanoparticles (SF-propranolol NPs) was higher than that of curcumin (SF-curcumin NPs) and
pramipexole-encapsulated silk fibroin nanoparticles (SF-pramipexole NPs), leading to the conclusion
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that propranolol was encapsulated in the center of the silk fibroin nanoparticles while curcumin and
pramipexol were adsorbed on the surface of the nanoparticles.
Table 4. ζ-potential of model drug solutions, silk fibroin nanoparticles, and drug-encapsulated silk
fibroin nanoparticles.
Sample ζ-Potential ± SD (mV) (n = 3)
Fibroin solution 4.1% −4.3 ± 0.1
Curcumin solution 500 ppm −7 ± 2
Pramipexole solution 35 ppm −0.06 ± 0.02
Propranolol solution 50 ppm −2.1 ± 0.3
Silk fibroin nanoparticles −16.40 ± 0.02
SF-curcumin NPs −5.5 ± 0.2
SF-pramipexole NPs −6 ± 2
SF-propranolol NPs −14.9 ± 0.3
The morphology of drug-encapsulated silk nanoparticles, and that of the silk nanoparticles
for the sake of comparison, was illustrated by SEM images (Figure 2). The nanoparticles observed
presented a spherical and/or cylindrical shape with an average mean diameter of 290 nm. As expected,
the size of silk fibroin nanoparticles increased after drug encapsulation. The mean diameter of
the drug-encapsulated silk fibroin nanoparticles, as estimated from the SEM images, was 490, 392,
and 294 nm for propranolol-, pramipexole-, and curcumin-encapsulated silk fibroin nanoparticles,
respectively. It is worth noting that these results for nanoparticle sizes are relatively smaller than
those measured with DLS; this can be attributed to the dry state of the nanoparticles when measured
with SEM.
In Figure 3, the FTIR spectra of silk fibroin nanoparticles and of drug-encapsulated silk fibroin
nanoparticles are presented. In the spectra of the curcumin-encapsulated silk fibroin nanoparticles,
it was observed that certain characteristic peaks of the original curcumin were either not evident or
exhibited a slight shift or alteration, which demonstrated that certain structural changes and chemical
reactions may have occurred between the curcumin and the silk fibroin [12,27]. Curcumin showed
its characteristic group absorption peaks in sharp absorption bands at 1605 cm−1, 1502 cm−1 (–C=O
and –C–C vibrations), 1435 cm−1 (an olefinic –C–H bending vibration), 1285 cm−1 (an aromatic –C–O
stretching vibration), and 833 cm−1 (a C–H bond of alkene group) [12,27]. In addition, propranolol
exhibited characteristic peaks in sharp absorption bands at 1680–1620 cm−1 (C=C stretching) and
1260–1000 cm−1 (C–O stretching) [28]. On the contrary, the FTIR spectrum of pramipexole-encapsulated
fibroin nanoparticles presented no difference compared to pure fibroin nanoparticles; the characteristic
peaks of pramipexol were not evident, leading to the conclusion that after encapsulation with
pramipexole the chemical bonding remained unchanged [29]. The assignments of the FTIR bands
of silk fibroin nanoparticles as well as those of the drug-encapsulated silk fibroin nanoparticles are
presented in detail in Table 4.
3.4. In Vitro Drug Release
The drug release profile, presented in Figure 4, indicated that the encapsulated curcumin and
pramipexole silk fibroin nanoparticles had a short and low-level release percentage, about 1.2% and
0.25%, respectively (presented also in the insets of the Figure 4) while the propranolol-encapsulated
silk fibroin nanoparticles exhibited a release of about 65% within 6 days. This could be due to the
lack of interactions of propranolol with the silk fibroin as well as to the hydrophilic properties of
propranolol. Curcumin, as a hydrophobic drug, was possibly attached to silk fibroin via hydrophobic
interactions and π-π stacking, and presented a reduced release rate compared with that of the
hydrophilic drug propranolol [4,12,30]. Pramipexole was expected to be attached to silk fibroin
through strong electrostatic interactions attributed to the –NH2 groups, which could have resulted in
the decreased release rate.
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Figure 4. Drug release rate of model drugs from nanoparticles of silk fibroin.
3.5. Modification of SF with Bovine Serum Albumin and Magnetic Nanoparticles
In order to enhance the properties of silk fibroin nanoparticles, SFm-NPs and silk fibroin–bovine
serum albumin nanoparticles (SF-BSA-NPs) were prepared via the introduction of magnetic
nanoparticles (Fe3O4) and BSA during the silk fibroin nanoparticle formulation, and the drug
encapsulation and release efficiency of these silk fibroin nanoparticles were examined in detail.
Since propranolol presented the highest encapsulation and release performance, it was used as the
model drug for the performance of the two modified types of silk fibroin nanoparticles.
3.5.1. Characterization of Modified Nanoparticles
DLS measurements for silk fibroin-bovine serum albumin nanoparticles and magnetic silk fibroin
nanoparticles are presented in Table 5. Both samples indicated a small polydispersity index of 0.30 and
0.36, respectively, indicating a uniform diameter distribution of nanoparticles.
Table 5. Diameter of magnetic and fibroin-albumin nanoparticles measured by Dynamic Light Scattering.
Sample Diameter ± SD (nm) (n = 5) Polydispersity Index
SFNPs 301 ± 11 0.24
SFm-NPs 337 ± 14 0.30
SF-BSA-NPs 268 ± 4 0.36
SFm-NPs = magnetic silk fibroin nanoparticles; SF-BSA-NPs = silk fibroin-bovine serum albumin nanoparticles.
The encapsulation efficiency of magnetic silk fibroin and silk fibroin–bovine serum albumin
nanoparticles is presented in Table 6. From the Table, it can be seen that the modification of silk fibroin
with magnetic nanoparticles and bovine serum albumin increased the drug encapsulation compared to
the pure silk fibroin nanoparticles. Propranolol is a hydrophilic drug and the presence of bovine serum
albumin makes the silk fibroin–bovine serum albumin nanoparticles more hydrophilic; for this reason
the encapsulation efficiency was increased. Also, the increased encapsulation efficiency of magnetic
silk fibroin loaded with propranolol may be attributed to the adsorption of propranolol on Fe3O4.
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Table 6. Encapsulation Efficiency (EE) of magnetic silk fibroin and silk fibroin-bovine serum albumin
nanoparticles encapsulated with propranolol.
C (ppm)
EE ± SD (%)
Propranolol SFNPs
(n = 3)
EE ± SD (%)
Propranolol SFm-NPs
(n = 3)
EE ± SD (%)
Propranolol SF-BSA-NPs
(n = 3)
50 70 ± 2 96 ± 4 97 ± 3
The surface morphology of magnetic silk fibroin particles and the silk fibroin-bovine serum
albumin nanoparticles as well as their encapsulated-with-propranolol counterparts, illustrated by
SEM images, is presented in Figure 5. The magnetic silk fibroin (SFm) and silk fibroin-bovine serum
albumin nanoparticles (SF-BSA) exhibited a spherical shape with a diameter of about 288 nm, while the
propranolol-encapsulated silk fibroin-bovine serum albumin nanoparticles (SF-BSA + propranolol) and
propranolol-encapsulated magnetic silk fibroin nanoparticles (SFm + propranolol) exhibited a particle
size of about 384 nm and 490 nm, respectively (Figure 5).
Figure 5. SEM images of SFm nanoparticles (a); SFm + propranolol NPs (b); SF-BSA-NPs (c);
and SF-BSA + propranolol NPs (d).
The 2θ diffraction peak presented in the XRD pattern of the magnetic silk fibroin nanoparticles
(Figure 6a), that appeared at 2θ = 19.2◦, could be attributed to silk I, a random coil of silk fibroin,
while for the encapsulated-with-propranolol magnetic silk fibroin nanoparticles, the characteristic
peak at 2θ = 20.7◦ could be attributed to silk II, a β-sheet of fibroin. In addition, diffraction peaks
corresponding to the (3 1 1), (4 0 0), and (4 4 0) planes of the cubic crystal structure (fcc) of Fe3O4,
show the formation of magnetic silk fibroin nanoparticles [19]. The aforementioned XRD results are in
agreement with the FTIR results.
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Prior to the measurements, the instrument was calibrated against a NIST-certified Ni standard.
Each sample had approximately the same dimensions and an additional calibration procedure was
performed in order to minimize shape effects. All measurements were performed in a controlled room
temperature of 22 ◦C and consisted of a gradual increase of the applied external magnetic field up
to about +1.9 T (μ0H) then down to −1.9 T and again up to +1.9 T while measuring the magnetic
moment of the sample. The magnetic properties are attributed to the Fe3O4 particles and the overall
appearance of the loop is typical for nanoparticles of that composition and size. All measurements
have exactly the same appearance, i.e., initial slope, curvature, and saturation plateau, indicating
that there are no significant differences in the Fe3O4 particles between the samples and that the
procedure for the preparation of the magnetic silk fibroin nanoparticles (SFm-NPs) does not affect
significantly the magnetic properties of the Fe3O4 particles. Remanence, Mr, the Mass Magnetization
which corresponds to a zero field after the first application of the maximum external field equals to
5–7% of the saturation magnetization and coercivity, μ0Hc, the reverse external field which zeroes the
magnetic moment of the sample is about 0.01 T. Both the remanence and the coercivity are very low in
all cases as expected for a soft ferromagnetic material. Saturation magnetization, the maximum Mass
Magnetization which could be observed, was obtained for the sample via extrapolation from data of
Figure 6b,c and was found to be σs = 27.0 (8b) and 27.9 (8c) emu/g. These results correspond to about
50% wt. Fe3O4 content, since the saturation magnetization depends on the Fe3O4 content which is
diluted in the silk fibroin, confirmed that Fe3O4 particles are successfully incorporated into the silk
fibroin and that their magnetic properties are preserved after drug encapsulation.
Figure 6. (a) XRD patterns of the magnetic silk fibroin nanoparticles and the propranolol-encapsulated
magnetic silk fibroin nanoparticles; (b) hysteresis loop of the magnetic silk fibroin nanoparticles; and
(c) hysteresis loop of the propranolol-encapsulated magnetic silk fibroin nanoparticles.
FTIR results of silk fibroin-bovine serum albumin nanoparticles and propranolol-encapsulated
silk fibroin-bovine serum albumin nanoparticles are presented in Figure 7a,b, respectively, and the
characteristic peaks are presented in Table 7. The bands at 1645 cm−1 and 1491 cm−1 are due to the
BSA modification and can be attributed to amide I (C=O stretching) and amide II (C–N stretching and
N–H bending) vibrations of BSA, respectively (Table 7). The bands of BSA at 1392 cm−1 (–CH2 bending)
and ~1260 cm−1 (amide III, C–N stretching, and N–H bending) may be overlapped by the bands
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attributed to silk fibroin [7]. A slight shift in the spectra for the propranolol-loaded nanoparticles could
be due to drug binding.
Figure 7. FTIR spectra of: (a) silk fibroin-bovine serum albumin nanoparticles; (b) propranolol-encapsulated
silk fibroin-bovine serum albumin nanoparticles; (c) magnetic silk nanoparticles; and
(d) propranolol-encapsulated magnetic silk fibroin nanoparticles.
In Figure 7c,d, the FTIR results of fibroin magnetic nanoparticles (SFm) and
propranolol-encapsulated fibroin magnetic nanoparticles (SFm + propranolol) are presented,
while the characteristic peaks are also presented in detail in Table 7. The spectra presented
characteristic bands at 471 and 588 cm−1 and 506 and 595 cm−1, respectively, attributed to Fe–O
bonds [4], which confirmed the successful preparation of magnetic silk fibroin nanoparticles (Figure 7c).
From the spectra, the existence of both β-sheets and a-helices for magnetic fibroin nanoparticles could
be observed, while for the propranolol-encapsulated silk fibroin magnetic nanoparticles β-sheets
could be also observed.
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Table 7. Assignment of the main bands present in SF-BSA NPs, SF-BSA + propranolol NPs, and SFm
and SFm + propranolol NPs.
cm−1 SF-BSA NPs cm−1 SF-BSA + Propranolol NPs cm−1 SFm-NPs cm−1 SFm + Propranolol
NPs
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595 Fe–O (magnetite) 595 Fe–O (magnetite)
(A)n, polyalanine; (AG)n, polyalanine glycine [28].
3.5.2. In Vitro Drug Release
In Figure 8, the in vitro drug release profiles for the BSA- and magnetic-nanoparticles-modified
silk fibroin nanoparticles are presented compared to the initial silk fibroin nanoparticles. Due to
their higher encapsulation efficiency, the propranolol-encapsulated SF-BSA nanoparticles showed
a higher drug release rate as compared to the propranolol-encapsulated silk fibroin nanoparticles [13].
In contrast, propranolol-encapsulated magnetic silk fibroin nanoparticles showed less release, which
may be attributed to the strong electrostatic interactions of magnetite with the model drug. Another
reason for the lower release could be the higher content of β-sheets in the propranolol-loaded silk
fibroin magnetic nanoparticles causing a slow degradation of the silk fibroin and finally reducing the
drug release rate [26].
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Figure 8. Drug release rate of fibroin nanoparticles, magnetic fibroin nanoparticles, and fibroin–bovine
serum albumin nanoparticles encapsulated with propranolol.
4. Conclusions
Silk fibroin nanoparticles were prepared by an easy and safe-to-manipulate method that is
amenable to a wide range of drugs and thus useful for silk-based drug delivery systems. Silk fibroin
nanoparticles facilitated the entrapment of model drugs (curcumin, pramipexole, and propranolol)
with different molecular weights and hydrophobicities and made drug release controllable. Silk fibroin
particles loaded with propranolol exhibited a higher release percentage than those loaded with
curcumin or pramipexole. Moreover, modified silk fibroin nanoparticles with magnetic nanoparticles
as well as with bovine serum albumin were examined for the enhancement of the propranolol
encapsulation and release from these nanoparticles. Magnetic silk fibroin nanoparticles increased the
propranolol encapsulation efficiency. The silk fibroin-bovine serum albumin particles increased the
encapsulation efficiency as well as the release rate of propranolol and were found to be a promising
drug carrier.
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Abstract: Simultaneous determination of phosphorus and boron in fertilizers was performed by
Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP-AES). Three different samples were
analyzed, of which two were inorganic and one was of organic composition. Analysis of the samples
was performed after heated acidic digestion to completely dissolve them, using two different acid
mixtures. A solution of HCl + HNO3 was used to digest the inorganic fertilizers, and a solution
of H2SO4 + HNO3 for the organic fertilizer. The spectral emission lines used were 213.617 nm and
214.917 nm for P and 249.772 nm, 249.677 nm and 208.957 nm for B. The detection and quantification
limits for P were between 10–20 mg/kg and 40–80 mg/kg respectively, while for B they ranged
between 10–30 mg/kg and 40–100 mg/kg respectively. The repeatability of the technique was found
to be within the range 0.9–17.0% for P and 1.7–23.4% for B, expressed as relative standard deviation
(RSD). The concentrations found by the proposed method are in good agreement with those reported
on their package labels.
Keywords: phosphorus; boron; inductively coupled plasma; atomic emission spectrometry;
fertilizers; acid dissolution; wet digestion
1. Introduction
Fertilizers contain many elements which act as nutrients for plants, but also elements which
may be toxic, and which are therefore responsible for contamination of soils. This results in the
accumulation of chemicals in food [1,2]. As the development of agricultural productivity is directly
related to the use of fertilizers, it is necessary to analyze them with sensitive, multi-elemental
technical analyzers to monitor their quality [3]. Common fertilizers are either of inorganic or organic
composition, natural or synthetic. Chemical analysis and quality control of fertilizers result in improved
agricultural production [4], and methods have been developed. In this context, the determination
of minerals in fertilizers becomes necessary, and for this purpose, several techniques have been
reported in the literature [1,2,5]. Some techniques for the determination of heavy metals are based on
Graphite Furnace atomic absorption spectroscopy (GF-AAS), Continuous Source Flame Absorption
Spectroscopy (HR-CS-FAAS) [1,6–9], or Cold Vapor Atomic Absorption Spectroscopy (CV-AAS) for
Hg [5]. In addition, methods have been developed to determine nutrients in fertilizers by LIBS [10,11],
or by total X-ray fluorescence (TXRF) techniques [12]. Inductively coupled plasma atomic emission
spectroscopy (ICP-AES) allows rapid analysis and simultaneous determination of primary and
secondary nutrients as trace elements in fertilizers [2,13,14]. ICP-AES is a well-known analytical
technique suitable for simultaneous determination of almost 70 chemical elements, as it provides
high sensitivity and satisfactory detectability, has a wide range of applications, and does not suffer
from important spectral interferences [15–17], except in case of solutions with high TDS. The great
advantage of simultaneous determination of various elements in fertilizers, like P and K, has already
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been highlighted by other researchers [18]; this becomes more attractive considering the capability
of measuring also semi-metals, like boron [19], or non-metals, like phosphorus and sulfur. However,
in many cases for total element fraction, it requires complete digestion of solid samples before
quantitative analysis, which means a sample treatment step, which can potentially affect accuracy and
overall analytical performance of the method. In the present study, a method for the simultaneous
determination of total phosphorus and boron by ICP-AES in fertilizers was developed, after digestion
of the samples with two different acidic solutions. The examined acid mixtures were selected according
to the nature of the fertilizer samples. For determination of the total fraction of an element, inorganic
fertilizers usually do not require strong oxidative media, while organic fertilizers may need strong
oxidative acids and heating or incineration followed by acidic dissolution for complete decomposition
or other pretreatment techniques [19,20].
2. Experimental
2.1. Instrumentation
An inductively coupled plasma atomic emission spectrophotometer, model OPTIMA 3100 XL
(Perkin Elmer, San Francisco, CA, USA), was employed; the operating conditions are listed in Table 1.
The instrument was equipped with a liquid sample introduction system, including a peristaltic
pump to aspirate solutions into the nebulizer at variable flow rates. Tygon-type pump tubes
were used for sample delivery, and the nebulization system consisted of a cross-flow nebulizer
and a Scott double-pass spraying chamber. A quartz torch is mounted horizontally on the same
axis to the spectrophotometer window (axial viewing of emission). The torch inner injector tube
was composed of alumina, which is sufficiently resistant to highly acidic solutions. The radio
frequency generator (RF) that maintains the plasma is 40.68 MHz; this was adjusted to an incident
power of 1350 watts for this method. The spectrophotometer was equipped with a polychromator
in which an echelle-type diffraction grating was installed, and the detector was a segmented
charged-coupled device. The ICP-AES instrument was supplied by analytical grade argon as a plasma
gas. Three phosphorous and three boron atomic spectral lines were examined, as given in Table 2.
The phosphorous line at 178.221 nm was finally rejected for reasons described below.
Table 1. Operating conditions and settings of the ICP-AES.
Parameter Value
RF generator 40.68 MHz, free-running
RF incident power 1350 W
Torch type Fassel-type
Injector, id Alumina 2.0 mm
Viewing mode Axial
Auxiliary argon flow rate 0.50 L min−1
Nebulizer argon flow rate 0.80 L min−1
Plasma gas flow rate 15 L min−1
Spray chamber type Scott
Sample uptake flow rate 2 mL min−1
Detector Segment-array charge-coupled (SCD)
Table 2. Spectral lines employed for ICP-AES measurements.
Element Spectral Lines (nm)
P 178.221 213.616 214.914
B 208.977 249.677 249.772
74
Separations 2018, 5, 36
2.2. Reagents and Solutions
For the preparation of the working standard solutions, KH2PO4 (99.5%) and H3BO3 (99.5%) were
obtained from Merck (Darmstadt, Germany). For acid digestion of fertilizer samples, concentrated
HNO3 (65%), HCl (37%), and H2SO4 (95–97%) of analytical grade were obtained from Merck
(Darmstadt, Germany). All dilutions and solutions were carried out using ultrapure water of Milli-Q
quality (18.2 MΩ, Millipore, Bedford, MA, USA).
2.3. Fertilizer Samples
Inorganic and organic commercially available fertilizers from local companies in Greece were
analyzed in the present study to develop a fast analytical method. The inorganic samples were
crystalline, water-soluble, general-purpose fertilizers, while the organic one was a composite fertilizer
for vegetables. Their indicative nutritional content, as given on their packaging, is provided in Table 3.
Phosphorus and boron contents of the samples were calculated, and are presented in Table 4.





























(inorganic) 20 20 20 0.09 400 150 1 150 400 150 5
2nd sample
(inorganic) 5 10 42 4 500 100 100 100 100 500 -
3rd sample
* (organic) 4 30 -
* In 3rd sample (organic) organic matter is 15% w/w.
Table 4. Concentration of P and B in the samples.
Element
Mass Concentration g/kg
1st Sample (Inorganic) 2nd Sample (Inorganic) 3rd Sample (Organic)
P 87 43 131
B 0.15 0.10 -
2.4. Preparation of Working Standard Solutions
A mixed standard aqueous solution containing 50 mg/L each of phosphorus and boron was
prepared from standard solutions of 100 mg/L P (KH2PO4, 439.4 mg/L) and 100 mg/L B (H3BO3,
571.97 mg/L). Finally, five working standard solutions containing 0.00, 1.00, 2.50, 10.0, 25.0 mg/L of
phosphorus and boron, respectively, were prepared by proper dilutions of the above stock standard
solution (50 mg/L).
2.5. Acid Digestion of Samples
For the selection of the appropriate acid mixtures, dissolution tests were performed by acid
digestion of all samples. The most efficient mixtures were selected for the liquid digestion process
based on the solubilization effect. Thus, for the 1st and the 2nd sample (inorganic), the acid digestion
procedure was performed with the addition of 5 mL of 37% HCl + 1.5 mL of 65% HNO3, and then
heating for 2 min on a hot plate in high fume hood (ca 80 fpm face velocity) for nitrogen oxides fumes.
For the 3rd sample (organic), the acid digestion procedure was performed by adding 5 mL H2SO4
95–97% + 1 mL HNO3 65%, followed by heating for 3 min on a hot plate in a fume hood (ca 80 fpm).
For the acid digestion procedure, accurately weighed amounts of the samples were placed in 100 mL
open conical flasks and heated to 130 ◦C. When digestion was complete, the mixture was allowed
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to cool to room temperature. The mixtures were then transferred to 100 mL volumetric flasks and
diluted with Milli-Q water. The obtained diluted solution was further diluted at a ratio of 1:10 and
1:100 successively. The acid digestion process was repeated three times for each sample. Preparation of
acidic blank mixtures was performed three times.
Standard addition samples were also prepared by the addition of standard solutions of P and B to
0.500 g of the first sample. This process was carried out to study the recovery of the analytical method.
To this sample, 228 g/kg P (435 mg/L) of KH2PO4 and 174 g/kg B (0.75 mg/L) of H3BO3 were added.
The sample was then subjected to acidic digestion with 5 mL HCl + 1.5 mL HNO3 and warmed up.
The sample after acid digestion was diluted to 100 mL, followed by successive dilutions of 1:10 and
1:100. The whole procedure was performed three times.
3. Results and Discussion
3.1. Regression Analysis
The settings for the spectral lines and the operating conditions of ICP-AES were defined in the
computer software. For quantitative analyses of the samples, the required calibration curves were
constructed using the series of mixed working standard solutions.
The results of the regression analysis for each element at each tested wavelength are given in
Table 5. The emission spectra of P and B obtained from the mixed working standard solutions are
given in Figures 1 and 2 respectively. As shown in Table 5, at the examined spectral lines, both P and B
showed good correlation coefficients. The correlation coefficient R is greater than 0.999 for all elements,
except at the third spectral line of P (178.221 nm), where the correlation was much lower because of
baseline instability. Apparently, no sensitivity is observed also, and for this reason, this spectral line P
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Figure 1. Phosphorus emission spectra at 213.617 nm and 214.914 nm, respectively. Superimposed
traces refer to working standard solutions of increasing concentration, as described in Section 2.4.
Table 5. Results of regression analysis using the mixed standard aqueous solutions of boron
and phosphorus.




213.616 621 ± 19 61 0.9999
214.914 777 ± 38 123 0.9999
178.221 −0.5 ± 2 5 0.7171
B
249.772 53,417 ±1644 5390 0.9999
249.677 19,771 ± 496 1627 0.9999
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Figure 2. Boron emission spectra at 249.772 nm and 249.677 nm respectively. Superimposed traces refer
to standard solutions of increasing concentration, as described in Section 2.4.
3.2. Repeatability, Detectability and Recovery of Method
Acceptable repeatability of a method is expressed by low values of the relative standard deviation,
RSD%. Repeatability testing was done by measuring the working standard three times on the same day.
The solutions used were aqueous mixed solutions of P and B on all spectral lines. The concentrations
used to control the repeatability were 1.00 mg/L, 2.50 mg/L, 10.0 mg/L, and 25.0 mg/L. The results are
listed in Table 6. Based on these results, good repeatability is observed at concentrations of 10.0 mg/L
and 25.0 mg/L, but less good at 1.00 mg/L concentration. The repeatability for P in the examined
atomic lines ranged between 0.9–17%, and for B between 1.7–23.4%, respectively.
Limit of detection (LOD) and limit of quantification (LOQ) are defined as the minimum
concentration or quantity of the analyte that can be detected or quantified respectively with reasonable
certainty, according to IUPAC recommendations [21]. The detection and quantification limits of
the developed method were calculated using the 3s criterion (i.e., at a 99.6% confidence level).
The calculated detection limits for the examined spectral lines of phosphorus were found to be between
10–20 mg/kg, and those for B between 10–30 mg/kg. This variation is due to variability of the baseline
signal values in different spectral lines and with the different acid mixtures. The corresponding limits
of quantification were found to be between 40–80 mg/kg for P, and between 40–100 mg/ kg for B.
The results are presented in Tables 7 and 8. In these tables, the results are given as typical instrumental
LODs and LOQs (expressed in mg/L), and also as method equivalent LODs and LOQs (expressed in
mg/kg), considering a typical sample mass of 0.500 g for the analysis and initial dilution to 100 mL,
as described in paragraph 2.5.
Because no reference material was available, the recovery for P and B was calculated after adding
an amount of the standard solution to the first sample of fertilizer. Table 9 gives the calculated recoveries
for P and B in each spectral line, which are satisfactory regarding the spectral lines 213.616 nm for P
and 249.772 nm for B, correspondingly. The added amount of the standard was 228 g/kg (or 435 mg/L)
for P (as KH2PO4), and 176 g/kg (or 0.75 mg/L) for B (as H3BO3).
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Table 6. Method repeatability.
Element Spectral Line (nm)
RSD %
c = 1.00 mg/L c = 2.50 mg/L c = 10.0 mg/L c = 25.0 mg/L
P
213.616 14.8 4.9 0.9 2.3
214.914 17.0 6.2 1.3 2.9
B
249.772 23.4 7.9 1.7 2.0
249.677 19.4 7.3 1.9 1.8
208.977 18.6 6.5 1.9 2.2
Table 7. Detection and quantification limits using a constitutive blank of 3 mL HCl + 1 mL HNO3.
LODs and LOQs were calculated as described in Section 3.2.
Element Spectral Line (nm) LOD (mg/L) LOD (mg/kg) LOQ (mg/L) LOQ (mg/kg)
P
213.616 0.07 14 0.30 60
214.914 0.06 12 0.20 40
B
249.772 0.10 20 0.50 100
249.677 0.10 20 0.40 80
208.977 0.15 30 0.50 100
Table 8. Detection and quantification limits using a constitutive blank of 5 mL H2SO4 + 1 mL HNO3.
LODs and LOQs were calculated as described in Section 3.2.
Element Spectral Line (nm) LOD (mg/L) LOD (mg/kg) LOQ (mg/L) LOQ (mg/kg)
P
213.616 0.10 20 0.40 80
214.914 0.05 10 0.20 40
B
249.772 0.10 20 0.40 80
249.677 0.06 12 0.20 40
208.977 0.05 10 0.20 40
Table 9. Recovery results.
Element Spectral Line (nm)
Recovery R%
Adds: 228 g/kg P + 174 g/kg B








4. Application of the Method to Fertilizers Samples
The results of the analysis of elements P and B in three samples of inorganic and organic fertilizer
samples are presented in Table 10, while the corresponding label compositions are given in Tables 3
and 4. Acid digestion was performed three times for each sample under the same conditions and
with the same amounts of samples and solvents. Then, each of the three sets of samples was diluted
three times, i.e., initial dilution to 100 mL, which was used for boron determination, and subsequent
dilutions 1:10 and 1:100, which were used for phosphorus determination.
Regarding the 1st inorganic fertilizer, the indicated content for P in the form P2O5 is 20% w/w.
Thus, the concentration expressed in elemental P is 87 g/kg. The concentration using either of the
two spectral lines after the analysis is in good accordance with that on the label. On the other hand,
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the concentration of B as given on the label is 0.015% w/w, which means 0.15 g/kg. The concentration
as found after analysis i of the second and third spectral lines agrees with the indicated value.
Regarding the 2nd inorganic fertilizer, the indicated content for P given in the form of P2O5 is
10% w/w, so the concentration of elemental P is 43 g/kg. This concentration is also in agreement with
the concentration resulting from sample analysis using the first spectral line of P. The B content given
on the label is 100 ppm, which means 0.10 g/kg. The concentrations found from the first spectral line
of boron are consistent with the reported content.
Finally, the reported content of the 3rd organic fertilizer sample is 30% w/w P2O5; therefore,
the elemental P concentration is expected to be 131 g/kg, which is in accordance with the concentrations
resulting from ICP-AES analysis. For B, its content is not indicated on the package. The concentration
from the ICP-AES analysis was found to be at 0.12 ± 0.03 g/kg using the first emission line.
Table 10. Concentration of P and B in fertilizer samples found by ICP-AES analysis after digestion.









213.616 100 ± 40 34 ± 7 129 ± 9
214.914 65 ± 11 23 ± 5 101 ± 18
B
249.772 0.10 ± 0.01 0.13 ± 0.03 0.12 ± 0.03
249.677 0.17 ± 0.01 0.21 ± 0.04 0.27 ± 0.02
208.977 0.13 ± 0.01 0.16 ± 0.04 0.15 ± 0.02
5. Conclusions
In this study, the ICP-AES technique was applied to the development of a multi-elemental
fertilizer analytical method. The sample solution after heated acid wet digestion was introduced into
the inductively coupled plasma atomizer. From the conducted research, the following conclusions
regarding the performance of the developed method were drawn. The spectral line of P (178.221 nm)
showed low correlation coefficient and poor sensitivity. The spectral lines P (213.16 nm) and P
(214.914 nm) showed very good correlation, R > 0.999, with spectral line 214.914 nm being preferable in
terms of sensitivity. The three spectral lines of B showed similar correlation coefficients, with a spectral
line at 249.677 nm being preferable to the others in terms of sensitivity. The repeatability at high
concentration levels of the working curve is better compared to the lower concentrations, and the
calculated recoveries were satisfactory. Wet acid digestion of samples was completed in short
pretreatment time using mixtures of HCl, HNO3, and H2SO4 acids. The developed method was applied
to three different fertilizers of inorganic and organic natures. The P and B results are in accordance
with those reported on the product packages. According to the results, it has been concluded that the
developed method is a reliable, simple, and fast method for the simultaneous determination of P and
B in fertilizers. The method can be applied to rapid examination during fertilizers production, as well
as in the analysis of commercial products.
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Abstract: Non-steroidal anti-inflammatory drugs (NSAIDs) are being widely consumed without
medical prescription and are often the cause of intoxication, usually in young children. For this,
there is a special need in their determination in routine toxicology analysis. As screening methods
mainly focus on drugs of abuse (DOA) that are alkaline compounds in their majority, they are not
optimized for acidic drugs, such as NSAIDs. Thus, more specific methods are needed for the detection
and quantification of this class of drugs. In this study, the efficient extraction of NSAIDs from blood
serum and their accurate determination is studied. Optimum pH extraction conditions were studied
and thereafter different derivatization procedures for their detection. From the derivatization reagents
used, N,O-Bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% Trimethylchlorosilane (TMCS) was
found to be the optimum choice for the majority of the examined NSAIDs; pH of 3.7 was selected
as the most efficient for the extraction step. Herein the formation of the lactam of diclofenac was
also thoroughly investigated. The developed Gas Chromatography-Mass Spectrometry (GC-MS)
method had a run time of 15 min with the mass spectrometer operating in Electron Impact (EI)
within the mass range of 40 to 500 amu. The method was linear with R2 above 0.991 and limits
of quantitation (LOQ) ranging from 6 to 414 ng/mL. The intra-day accuracy and precision were
found between 1.03%–9.79% and 88%–110%, respectively, and the inter-day accuracy and precision
were between 1.87%–10.79% and 91%–113%. The optimum protocol was successfully applied to real
clinical samples, where intoxication of NSAIDs was suspected.
Keywords: NSAIDs; derivatization; GC-MS; serum
1. Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) are acidic compounds with anti-inflammatory
properties at high concentrations and several other properties at low concentrations (i.e., salicylic acid
is used as anticoagulant drug) [1]. These drugs exhibit toxicity in the upper concentration levels or
after a long time of intake [2,3]. Some of the toxic side effects are related with gastrointestinal disorders,
intestinal ulceration, aplastic anemia, myocardial infarction, cerebrovascular events, inhibition of
platelet aggregation, and renal dysfunction [4]. Especially, acetaminophen and nimesulide exhibit
significant hepatotoxicity [2,5–7]. In addition, there are several cases of suicide attempts or crime
commissions which are related with NSAIDs [8].
There is a number of analytical methods which report NSAIDs’ determination in biological fluids,
most of them related to pharmacokinetic studies or to the support of animal studies for the estimation
of exposure and the investigation of potential risk after consumption [4,9].
There are reports of determinations of these analytes by immunoassays, Gas Chromatography-
Flame Ionization Detection (GC-FID), High Performance Liquid Chromatography-UltraViolet/Diode
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Array Detection (HPLC-UV/DAD)/fluorimetric detector, spectrofluorimetry, thin layer
chromatography-UV/fluorimetric detector, GC-MS, GC-MS/MS, capillary electrophoresis, LC-MS,
and LC-MS/MS [10–14]. Immunoassays suffer from low selectivity due to cross-reactions, while all
other methods except LC-MS/MS include time-consuming sample pretreatment. There is a good
number of published multi-analyte LC-MS/MS methods for measuring NSAIDs and their metabolites
that provide sensitive and reliable concentration data from biological matrices [5]. In particular,
those methods are the most suitable for low concentrated salicylates originating from nutrition.
However, GC-MS still represents an integral tool of a clinical and/or toxicological laboratory due to
the fact that mass spectra databases are available aiding in the identification of unknowns, At the
same time, latest instruments and materials hold the promise for better chromatographic separations
and sensitivity, critically important for complex biological samples. Thus, GC-MS analysis provides
advantages clearly important in such applications.
For thedetection of NSAID by GC-MS, various sample pretreatment protocols have been applied.
Acidic liquid-liquid extraction is often used, however some researchers have also developed simple SPE
protocols instead [3,11]. Furthermore, it has been shown that the selection of a suitable derivatization
agent is a key factor for the sensitivity of their detection. Apart from this, there are several issues
which are related with the stability of these compounds in the GC-MS conditions.
In this paper, a multi-analyte GC-MS method was developed for the simultaneous quantification
of eight NSAIDs, based on a specific pro-analysis procedure. The optimum conditions were selected
based on experiments focusing on the sample treatment, to obtain a method able to address the needs
of a toxicological analysis for these challenging acidic analytes. The method provides a valuable tool
for the determination of eight different NSAIDS by GC-MS, with the pros that the GC-MS technique
offers, as stressed above, the additional potential of identification of metabolites, degradation products,
or others.
2. Materials and Methods
2.1. Chemicals and Reagents
All solvents were of analytical or LC-MS grade. Acetonitrile (ACN) LC-MS was purchased
from Chem Lab NV, (Zedelgem, Belgium). Nordiazepam-d5 solution 1 mg/mL in methanol
reference, material reference standards (>99%) of acetaminophen (APAP), acetyl salicylic acid
(ASA), salicylic acid (SA), ibuprofen (IBP), diclofenac (DCF), nimesulide (NI), niflumic acid (NFA),
mefenamic acid (MFA), and naproxen (NAP) were purchased from Sigma-Aldrich (Saint Louis,
MO, USA). Ethyl acetate (99%) was supplied from Penta (Livingston, NJ, USA). All derivatization
reagents; N,O-Bis(trimethylsilyl)trifluoroacetamide with 1% trimethylchlorosilane (BSTFA & 1%
TMCS), N-tert-Butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA), Pentafluoropropionic
anhydride (PFPA), 2,2,3,3,3-Pentafluoro-1-propanol (PFPOH), Trifluoroacetic anhydride (TFAA),
Heptafluorobutyric anhydride (HFBA), were for GC derivatization ≥ 99% grade and were purchased
from Sigma-Aldrich (Saint Louis, MO, USA). Serum samples were obtained from 4 cases that arrived
in AHEPA University General Hospital and were suspected for intoxication. Drug-free human serum
was obtained from healthy donors and before its use it was screened by GC/MS for the presence of
the NSAIDs.
2.2. Preparation of the Standard Solutions
Stock solutions of all compounds were prepared in ACN at 10,000 μg/mL. From these, a mix
solution containing all nine drugs was prepared and diluted to the following concentrations:
1000 μg/mL, 200 μg/mL, 100 μg/mL, 40 μg/mL, 20 μg/mL, 4 μg/mL, and 2 μg/mL.
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2.3. Sample Preparation
For the selection of the optimum pH conditions, 200 μL of spiked human serum at 200 μg/mL
was adjusted at pH of 3.7, 4.7, and 5.7 with the addition of 100 μL of HCOOH/HCOONa buffer
solutions prepared at these pH values (by mixing appropriate values of 0.2 M solutions of HCOOH
and HCOONa). Then 1 mL of ethyl acetate was added and the mixture was shaken for 10 min.
After centrifugation for 5 min at 6300× g the organic phase was collected and dried under gentle
nitrogen stream at room temperature. The obtained residue was redissolved either in 50 μL of ethyl
acetate or in 50 μL of derivatization reagents, as described in Section 2.5. In any case, 1 μL of the extract
was injected in the GC-MS system.
2.4. Derivatization Procedure
For the selection of the optimum derivatization procedure, five different reagents were used:
(a) BSTFA with 1% TMCS, (b) MTBSTFA, (c) HFBA, (d) PFPA with PFPOH, and (e)TFAA. The procedure
followed for silylation was as follows; addition of 50 μL BSTFA, 1% TMCS, or 50 μL MTBSTFA in the
dry residue and after vortexing the mixture was heated for 20 min at 70 ◦C, finally 1 μL was injected
in the system. Acetylation was performed with the addition of either 50 μL of HFBA, or of 30 μL
PFPA with 20 μL PFPOH, or of 50 μL of TFAA. The mixture was heated for 20 min at 70 ◦C and then
after cooling down was evaporated and the residue was dissolved in 50 μL of ethyl acetate. From this
extract, 1 μL was injected to GC-MS.
2.5. GC/MS Analysis
GC-MS analysis was performed on an Agilent Technologies 7890A GC, equipped with a
CTC autosampler and combined with a 5975C inert XL EI/CI MSD with Triple-Axis Detector
(Agilent Technologies, Santa Clara, CA, USA). GC separations were performed on a 30 m Agilent J&W
HP-5ms UI capillary column, with a film thickness of 0.25 μm and an i.d. of 0.25 μm. Back-flash was
performed with a 1.5 m deactivated Agilent column with a film thickness of 0.18 mm. The method
had a duration of 15 min with the following temperature program: Initial oven temperature at 120 ◦C,
hold for 1 min, and then increase to 300 ◦C with a 15 ◦C/min rate. A back-flash step followed, at 300 ◦C
for 10 min. Injection of 1 μL of sample was made on a PTV injector operating from 200 ◦C to 320 ◦C.
The mass spectrometer (MS) was operated at electron impact ionization mode (EI, 70 eV) and the mass
scan range was from 40 to 500 amu.
3. Results
The majority of the studied drugs are categorized in the acidic class of compounds as they contain
carboxyl moieties, except from APAP and NI. Their chemical structures, together with their pKa values,
can be seen in Table 1. These are expected to be extracted more efficiently by the organic solvent
under acidic conditions, where the ionization of their carboxyl group is suppressed. However, as their
physicochemical properties are varying due to their structure and the presence of different substitution
groups, the optimum pH for their extraction is needed to be examined.
Table 1. Chemical structures and pKa values of the studied non-steroidal anti-inflammatory
drugs (NSAIDs).
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Table 1. Cont.






















Under three different pH conditions, extraction of the eight NSAIDs from a serum sample spiked
at 200 μg/mL was performed, and the extracts were thereafter analyzed without any derivatization.
As expected, detection sensitivity of the underivatized drugs is low, however it was acceptable
for comparative purposes. Apart from the eight drugs, two more peaks were considered: (1) The
peak which corresponds to salicylic acid, a product occurring from ASA in the sample, and (2) the
diclofenac-lactam peak, which is obtained by DCF partial conversion during GC analysis. Table 2
provided the peak areas of the studied drugs at three different pHs tested for their extraction. As can
be seen, more acidic pH conditions favor the extraction of the majority of the drugs resulting in
higher detected peak areas. NI, however, provides higher signal under pH 4.7. For the case of
diclofenac, its lactam is detected in higher proportion under all three pH conditions. Apart from that,
the methylester of dichlofenac (DCF-ME) is also detected with relatively high signal. Salicylic acid is
detected with higher amount under the more acidic pHs compared to acetyl salicylic acid.
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Table 2. Absolute area of each NSAID at different pH extraction conditions.
Compound
Absolute Area (106)
pH = 3.7 pH = 4.7 pH = 5.7
APAP 282.2 261.5 139.0
DCF-lactam/DCF-ME/DCF 78.3/52/24 56.1/27/35 10.8/3.9/-
NAP 28.2 6.2 0.8
NFA 12.0 3.4 0.5
ASA 4.1 1 0.2
SA 10.1 1.1 0.2
IBP 267.6 158.6 20.4
MFA 77.7 74.6 4.4
NI 123.7 185.6 23.6
3.2. Analysis Without Derivatization
When the extracted NSAIDs were analyzed directly without prior derivatization, the detection
sensitivity was not satisfactory for the majority of the eight drugs. The chromatographic peaks were
broad with excessive tailing, which was attributed to intramolecular interactions and the interaction of
polar carboxylic groups of drugs with the column’s supporting material. Detection of such compounds
can be challenging as several transformation products of the drugs were also detected. During GC/MS
analysis, NFA, MFA, and NAP were not found stable without derivatization, as their decarboxylated
compounds (-CO2) were also detected. This has also been reported in previous studies [15]. As an
example, together with NAP detected at 9.86 min, its NAP-CO2 degradation product is also detected at
7.04 min with characteristic ions at m/z 184 and 141. Another issue is that ASA is converted to SA over
time in both aqueous and organic solutions, thus it can also be detected due to that reason. This can
mislead its determination, due to the fact that SA is always detected in serum after administration as it
is the active metabolite of ASA. Because of that, freshly prepared solutions of ASA should always be
used, and SA should also be determined when ASA is present in serum.
In addition, for the cases of ASA, SA, MFA, NFA, IBP, NAP, and DCF, their methyl ester products
were also detected in the spiked extract.
As it concerns DCF, it was observed that when the analysis was performed directly in the serum
extract without prior derivatization, only a small amount of DCF could be detected, whereas the
highest amount was detected as diclofenac lactam. This was firstly reported by El Haj et al. in 1999,
who studied the methanolic solutions of DCF [15]. The authors attributed the formation of lactam to
the high temperatures applied in the inlet during the GC-MS analysis. Here, in order to investigate
this phenomenon, various analyses were conducted and the findings are discussed below.
3.3. Derivatization Study
In order to enhance the chromatographic peak characteristics of the compounds and the detection
sensitivity, the derivatization procedure was performed with different reagents. The aim was to
select the optimum procedure and facilitate the simultaneous determination of the eight NSAIDs.
In spiked serum samples at 200 μg/mL the derivatization procedures were conducted as described
in Section 2.4, and the obtained chromatographic traces with the five reagents are summarized in
Table 3. The chromatographic peaks were assigned based on the GC-MS libraries used [NIST v11 and
Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants, and Their Metabolites, 3th Edition
(PMW_Tox3.l)]. All the obtained peaks could be identified, apart from the acetyl derivatives, the spectra
of which didn’t exist in any of the used MS libraries, web-based libraries, or in the literature. In Table 3,
the retention time and the characteristic ions of each drug or drug derivative are juxtaposed for the
five derivatization procedures and that without any derivatization. As can be seen, AS and ASA, could
not be detected at all with HFBA, TFA, or PFPA-PFPOH derivatization. In some cases, more than one
derivative was detected, for example for APAP with MTBSTFA, while for others the underivatized drug
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was also detected, such as for NI with silylation reagents. In the case of PFPA-PFPOH, derivatization
of NFA gives two peaks which cannot be assigned based on their spectra, as acetyl-derivatives are not
registered in the MS spectral libraries used. The major peak is that at 6.9 min, which was attributed
to NFA-pfp, while the other peak at 8 min can be another derivative of NFA. Ideally, the optimum
procedure should lead to a sole derivative, whereas when the underivatized compound or more than
one derivative is detected, the complexity of the detection is increased and the reproducibility of the
obtained results is hindered. Based on the obtained results, HFBA, TFA, and PFPA-PFPOH are not
considered to be the most appropriate for the simultaneous detection and determination of the eight
NSAIDs for the above mentioned reasons.
As it concerns the detection sensitivity of the tested derivatization protocols, silylation provided
better results in comparison to the other reagents for all NSAIDs except from IBP. The latter formed
a derivative with PFPA/PFPOH which exhibited higher peak area when compared to the BSTFA
and MTBSTFA derivatives. Between the two silylation reagents, BSTFA was selected as the best one.
In Figure 1, a characteristic total ion chromatogram of serum sample spiked with the studied NSAIDs
is presented. The selection was based on the fact that the majority of the peaks had higher peak areas
and that MTBSTFA, in the case of APAP, forms two derivatives at the same peak height. Only NI
derivatization with BSTFA seems to have low yield, as it gives a small peak of the derivative and
the largest peak as NI. However, this is observed for the other silylation reagent as well, whereas NI
does not derivatized at all with HFBA, PFPA/PFPOH, and TFA. This means that NI will finally be
determined by considering the peak of the underivatized drug. In Table 4, the obtained peak areas are
given for the eight drugs, where the higher peak areas can be seen for the silyl-derivatives. In the cases
where the peak of the underivatized drug is detected this is noted by an asterisk.
 
Figure 1. TIC of a serum sample spiked with the studied non-steroidal anti-inflammatory drugs
(NSAIDs) at 5 μg/mL, derivatized with BSTFA & 1% TMCS.
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Table 4. Peak areas of the obtained derivatives with the five derivatization protocols applied in the
eight NSAIDs.
Compound Peak Area 106
BSTFA MTBSTFA HFBA PFPA-PFPOH TFAA
APAP 330 194/190 190 171 90
IBP 362 266 137 * 455 20.7/219 *
MFA 443 350 188 244 153
NFA 381 350 97.5 310/12 * 22.4
NAP 196 190 8 */4 185 8 */3
ASA 425 420 - - -
SA 350 345 - - -
NI 115 */2.5 107 */3 130 * 140 * 100 *
DCF-lactam 440 402 306 * 280 * 322 *
* Underivatized compound.
3.4. Application of the Method
With the aim to apply the method to real clinical human samples, recovery of the optimum
procedure was examined and linearity and limits of detection and quantification of the method was
assessed. Recovery (R%) was experimentally calculated and expressed as the percentage ratio of the
peak areas of the serum spiked before extraction at 10 μg/mL to the peak areas of the serum extract
spiked after extraction. The R% ranged from 51.50% for ASA to 85.81% for NAP. The R% for all the
studied drugs are presented in Table 5.
Table 5. Recovery % of the studied NSAIDs.










Linearity of the method was evaluated by analyzing human serum samples spiked with a mixture
of NSAIDs at concentrations of 0.5, 1, 5, 10, 25, and 50 μg/mL using as internal standard 20 μL
nordiazepm-D5 (C = 5 μg/mL). BSTFA derivatization was applied with 1% TMCS as described in
Sections 2.3 and 2.4, and the peak areas ratios were considered for quantitation. For the case of NI,
the peak of underivatized drug was considered, as in low concentrations the derivative is not detected
at all. The limits of quantitation (LOQ) were experimentally calculated as signal to noise ratio 10:1 and
the limits of detection, and limits of detection (LOD) as signal to noise 3:1. The equations of calibration
curves based on linear regression, LOQs, and LODs for all drugs are given in Table 6.
Selectivity was determined on the drug-free blood serum samples obtained from six different
healthy volunteers from the laboratory staff. No traces of the studied NSAIDs or other interferences
could be detected.
Here it should be noted that freshly prepared ASA solutions in ACN were used for the
determination of ASA, as it was observed that ASA transforms to SA. This has been observed to
proceed faster in methanol than in ACN [16]. As SA is also present in real samples, its co-determination
is required for both reasons.
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Table 6. Linearity features of the method such as R2, limits of detection and quantitation, and the linear
equation for all drugs.
Compounds Linear Equation R2 LOD (ng/mL) LOQ (ng/mL)
ASA-tms y = 0.578x + 0.407 0.994 10 30
SA-2tms y = 0.456x + 0.965 0.998 5 15
APAP-2tms y = 0.8222x + 0.8157 0.997 2 6
DCF-lactam-tms y = 0.3448x + 0.7265 0.991 3 10
MFA-tms y = 0.4625x + 0.9759 0.993 12 40
NFA-tms y = 0.516x + 1.0058 0.992 13 43
IBP-tms y = 0.567x + 1.7578 0.993 2 6
NAP-tms y = 0.3187x + 1.1305 0.996 10 34
NI * y = 0.7793x − 1.4552 0.999 124 414
* Nimesulide was determined underivatized.
The accuracy and precision of the method was evaluated within a day (n = 4) and over a period of
a week (n = 3) at low, medium, and high concentration levels (1, 10, 50 μg/mL). The intra-day accuracy
and precision were found to be between 1.03%–9.79% and 88%–110%, respectively, while the inter-day
accuracy and precision were between 1.87%–10.79% and 91%–113%. In Table 7, the data from accuracy
and precision assays are presented.
Table 7. Intra- and inter-assay data of the method.






SD CV % Accuracy %
Overall Mean
Found (μg/mL)
SD CV % Accuracy %
ASA
1 1.09 0.02 1.83 109.00 1.07 0.02 1.87 107.00
10 11.00 0.60 5.45 110.00 11.30 0.61 5.40 113.00
50 48.00 1.81 3.77 96.00 49.10 2.10 4.28 98.20
SA
1 0.98 0.05 5.10 98.00 0.99 0.06 6.06 99.00
10 9.85 0.51 5.18 98.50 9.87 0.54 5.47 98.70
50 51.10 1.20 2.35 102.20 50.80 1.30 2.56 101.60
APAP
1 0.97 0.01 1.03 97.00 1.00 0.03 3.00 100.00
10 10.70 0.30 2.80 107.00 10.40 0.32 3.08 104.00
50 49.80 0.90 1.81 99.60 50.20 1.20 2.39 100.40
DCF
1 0.88 0.04 4.55 88.00 0.91 0.06 6.59 91.00
10 10.62 0.24 2.26 106.20 10.42 0.35 3.36 104.20
50 49.20 1.50 3.05 98.40 49.30 1.90 3.85 98.60
MFA
1 1.12 0.05 4.46 112.00 1.05 0.06 5.71 105.00
10 9.30 0.60 6.45 93.00 9.70 0.63 6.49 97.00
50 51.30 2.40 4.68 102.60 50.90 3.10 6.09 101.80
NFA
1 0.98 0.03 3.06 98.00 1.01 0.05 4.95 101.00
10 10.20 0.46 4.51 102.00 10.30 0.64 6.21 103.00
50 51.60 3.20 6.20 103.20 51.60 3.50 6.78 103.20
IBP
1 0.94 0.07 7.45 94.00 0.96 0.08 8.33 96.00
10 9.76 0.75 7.68 97.60 9.83 0.89 9.05 98.30
50 49.80 2.60 5.22 99.60 50.30 3.20 6.36 100.60
NAP
1 1.02 0.05 4.90 102.00 1.06 0.08 7.55 106.00
10 9.79 0.46 4.70 97.90 9.86 0.53 5.38 98.60
50 50.50 4.60 9.11 101.00 50.81 2.26 4.45 101.62
NI
1 0.95 0.06 6.32 95.00 0.98 0.07 7.14 98.00
10 9.86 0.42 4.26 98.60 9.88 0.56 5.67 98.80
50 52.10 5.10 9.79 104.20 51.90 5.60 10.79 103.80
The method was then applied to four clinical cases where exposure to NSAIDs was suspected.
The findings are presented in Table 8. S1 and S2 correspond to serum samples which were taken 12 h
after APAP ingestion, and they were found below toxic levels (below 50 μg/mL, Rumack-Matthew
nomogram). S3 corresponds to a case of a 13 year old girl claiming a suicide attempt with DCF,
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however the concentration after 3 h at 2.31 μg/mL was at the therapeutic levels. S4 corresponds to a
patient treated with ASA (the sample was taken 40 min after ingestion) and the concentration was
found to be below the therapeutic levels. The extracted ion chromatograms of S2 and S3 are presented
in Figure 2a,b.
Table 8. Concentrations found with the applied method in the serum cases positive to NSAIDs.
Sample/Compound Found Concentration Found (μg/mL) ± SD
S1/APAP 18.2 ± 0.3
S2/APAP 7.50 ± 0.02
S3/DCF 2.31 ± 0.05
S4/ASA 2.0 ± 0.2





Figure 2. Extracted ion chromatograms of real serum sample (a) S3 at 349 m/z found positive for
diclofenac determined at 2.31 μg/mL and (b) S2 at 206 m/z found positive for APAP determined at
7.5 μg/mL.
4. Discussion
According to our findings, more efficient extraction of the studied drugs was performed under an
acidic pH of 3.7. NI showed also high extraction recovery in higher pH as well.
For most of the studied drugs, derivatization was required for their sensitive detection,
however NI provided high, sharp peak in the initial extract and can be best determined without
any derivatization.
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Some of our findings lead us to the conclusion that determination of these drugs needs cautious
sample treatment and data interpretation. We have observed, like previous findings [16], that ASA
is not stable in solution and it is hydrolysed into SA, and finally over time both compounds are in
equilibrium in the solution. Degradation of ASA has been studied thoroughly [16–18], however there
are recent studies where the authors overlook this parameter [1,19]. In order to overcome this
transformation, freshly prepared solution should be used for ASA.
Without derivatization, the majority of the NSAIDs seem to be unstable under the high
temperature conditions in GC-MS, and a variety of different derivatives are also detected.
The decarboxylated products of NAP, MFA, and NFA are detected to elute some minutes earlier
than the parent compound peaks. The formation of these compounds have been reported by others [15]
and most probably is due to the fact that the underivatized compounds are labile compared to their
derivatives under the same high temperature conditions in GC-MS.
In addition, for almost all the studied drugs, their methylesters were also detected.
The esterification process seems to take place at the high temperature conditions in GC-MS, especially
in methanolic solutions, whereas this doesn’t seem to happen for the derivatives. For this, ACN was
used as a solvent.
What is most interesting is that DCF transformed to its dehydrated product, the lactam.
To investigate this, a series of experiments was conducted. First, a solution of DCF was analyzed
directly with GC-MS, and it was observed that almost all of the diclofenac was transformed to its
lactam form. When the same solution was analyzed after derivatization with BSTFA + 1% TMCS only
diclofenac-tms was determined, indicating stability of the molecule with derivatization. Then a real
human serum sample positive to DCF and a human serum sample spiked with DCF were analyzed
after derivatization with BSTFA + 1% TMCS. In both cases, and in contrast to the previous finding,
DCF-lactam-tms was mainly detected. Contrastingly, in an aqueous solution of DCF, which was
analyzed after extraction and derivatization, similarly to a real sample, only DCF-tms could be
detected. This could mean that diclofenac-tms is more stable than the underivatized drug, which is
dehydrated under high temperatures in the GC-MS. However, it seems that the serum matrix under
acidic conditions enhances the full conversion of DCF to lactam, as DCF-lactam-tms is the sole peak
detected in this case, whereas in the absence of serum matrix DCF-tms is detected. The transformation
of DCF to DCF-lactam in water samples, pharmaceutical dosage forms, and urine was reported
previously but it hasn’t been thoroughly studied [11,16]. In a study, DCF-lactam was falsely reported
as DCF [20], and in another study DCF-lactam-tms wasn’t detected at all [21].
5. Conclusions
Based on our findings, the most efficient sample preparation protocol for the accurate
determination of the studied commonly prescribed NSAIDs is derivatization, more specifically with
BSTFA, except from NI where no derivatization step is needed, after acidic extraction.
For some of these drugs, cautious handling is needed, as ASA hydrolyses quickly in solution and
DCF is converted to its lactam form in the serum matrix under acidic pH. This conversion is enhanced
at high temperatures when its carboxyl group is not protected.
The method needs only 200 μL of blood serum and can determine even trace amounts of the
studied compounds.
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Abstract: The crucial role of mobile phase pH for optimizing the separation of a mixture of ionized
and non-ionized compounds on a Phenomenex extended pH-range reversed-phase column (Kinetex
5 μm EVO C18) was examined. A previously developed Excel-spreadsheet-based software was used
for the whole separation optimization procedure of the sample of interest under isocratic conditions as
well as under single linear organic modifier-gradients in different eluent pHs. The importance and the
advantages of performing a computer-aided separation optimization compared with a trial-and-error
optimization method were realized. Additionally, this study showed that the optimized separation
conditions for a given stationary phase may be used to achieve successful separations on new columns
of the same type and size. In general, the results of this work could give chromatographers a feel
of confidence to establish desired separations of a mixture of ionizable and neutral compounds in
reversed-phase columns.
Keywords: reversed-phase liquid chromatography; ionizable and non-ionizable analytes; isocratic
and gradient elution in different eluent pHs; computer-assisted separation optimization; visualization
of predicted chromatograms
1. Introduction
Reversed-phase liquid chromatography (RPLC) is one of the most widely used chromatographic
techniques. It is a consequence of its universality, relatively low costs, and general simplicity of
analytical procedures. Still, the development of any method with the desired RPLC separation
might be long due to the large number of chromatographic settings that might be adjusted (mobile
phase composition, pH, temperature, etc.). The most popular trial-and-error approach has several
disadvantages since it is often time-consuming, usually requires a large number of preliminary
experiments, and might not be fully efficient. Model-based techniques (fully or semi-automated
software programs) can be used in the process of searching for desired RPLC separations [1–5].
These methods usually provide very successful separations based on a series of preliminary
experiments. We believe that the number of experimental data may be reduced by utilizing the
optimal separation conditions predicted for a specific column by an optimization software to other
new columns of the same type and size.
In the present contribution, we report on the optimization of reversed-phase separations of mixture
of ionized and non-ionized solutes under isocratic conditions as well as under single linear organic
modifier-gradients in different eluent pHs using the Excel-spreadsheet-based software previously
developed for simulating and optimizing liquid chromatographic separations [6]. Furthermore,
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the importance and the advantages of performing a computer-aided separation optimization compared
with a trial-and-error optimization method will be confirmed as well as the crucial role of mobile phase
pH for optimizing the separation of ionizable compounds [7,8]. This study also provides an example
that the optimized separation conditions predicted for a certain column by an optimization software
result in almost baseline separation of the test analytes in different columns of the same type and size.
2. Materials and Methods
2.1. Materials and Reagents
All chemicals were used as received from commercial sources. The solutes tested are: four monoprotic
acids, 2-bromo-4-nitrophenol (2B-4NP), 4-bromo-2-nitrophenol (4B-2NP), 3-bromophenol (3-BP),
and 2,4-dibromophenol (2,4-DBP); two monoprotic bases, p-chloro aniline (p-CA) and p-bromoaniline
(p-BA); and two non-ionized compounds, benzene (B) and toluene (T). The orthophosphate system
(85% H3PO4, KH2PO4, Na2HPO4) was employed for the preparation of buffer solutions in HPLC studies.
Acetonitrile (ACN) or methanol (MeOH) of HPLC grade was used as organic modifiers.
2.2. Buffers and Standard Sample Solutions
Aqueous phosphate buffers with a total ionic strength of 0.2 M were used for preparing the
mobile phases with different pH values. The composition of the different buffers employed was found
in [9]. The working solutions with single solute or solute mixtures were prepared at a concentration of
360 μg mL−1 for benzenes, 240 μg mL−1 for 3-BP and 2,4-DBP, 24 μg mL−1 for 2B-4NP and 4B-2NP
and 8 μg mL−1 for anilines.
2.3. HPLC System and Conditions
The liquid chromatography system consisted of a Shimadzu LC-20AD pump, a Shimadzu
DGU-20A3 degasser, a model 7125 syringe loading sample injector fitted with a 5 μL loop and
a Shimadzu UV–visible spectrophotometric detector (Model SPD-10A, Kyoto, Japan) operating at
254 nm. The column was thermostatted at 25 ◦C by a CTO-10AS Shimadzu column oven.
Four different Phenomenex reversed phase columns of the same size (150 × 4.6 mm) were used.
Three of them (Kinetex 5 μm EVO C18, Kinetex 5 μm XB-C18 and Kinetex 2.6 μm XB-C18) were of
core–shell technology i.e., with core–shell silica of different particle sizes. The Kinetex 5 μm EVO
C18 column exhibits high pH stability from 1–12 similar with that of fully porous organo-silica column
(Gemini 5 μm NX-C18), which was also used in this study.
The systematic chromatographic behavior of solutes was investigated on the Kinetex 5 μm EVO
C18 column and in mobile phases consisting of diluted aqueous phosphate buffers with a total ionic
strength of 0.02 M and a fixed pH value at 2, 3, 5, 7, or 9 modified with ACN. The mobile phase pHs
were measured in aqueous buffers before the addition of the organic solvent. Three isocratic runs
were performed in different eluent pHs with different ACN volume fraction, (φ = 0.3, 0.4, and 0.5) and
three φ-gradient runs were performed by linearly increasing the ACN content in the mobile phase
from an initial value of volume fraction φ0 = 0.3 to a final one φf = 0.5. In all gradients, a linear elution
program was applied with the same starting time (tin = 0 min) but with different gradient duration, tG.
Moreover, the effect brought on retention of test solutes the use of MeOH as organic modifier instead
of ACN was investigated at a fixed eluent pH = 3 performing three isocratic runs with φMeOH = 0.4,
0.5 and 0.6 as well as three simple linear φMeOH-gradient runs from φ0 = 0.4 to φf = 0.6 with different
gradient duration. The retention data obtained under the above chromatographic conditions, as well as
under optimal conditions determined by the optimization procedure adopted in this study, are given
in Table S1 in the Supporting Information.
The hold-up time of the Kinetex 5 μm EVO C18 column was estimated to be t0 = 0.983 min,
whereas the dwell time tD = 0.73 min, at the flow rate set at 1.0 mL min−1.
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2.4. Excel-Spreadsheet-Based Optimization Software
The separation optimization procedure under isocratic and simple gradient conditions in different
eluent pHs modified with ACN or MeOH was performed using the Excel-spreadsheet-based program
developed for simulating and optimizing liquid chromatographic separations [6]. The Excel-spreadsheet
-based software ‘Isocr&GradSeparationOptimization’, with detailed instructions, available on the ACS
Publications website at doi:10.1021/acs.jchemed.7b00108 was modified in order to be used for the
separation optimization of the mixture of solutes under consideration. An Excel file with the name
“Optimization in eluent pH 3 modified with ACN” is provided in the Supporting Information as an
example for the whole computer-aided separation optimization procedure adopted in this study.
3. Results
3.1. Effect of the Eluent pH on the Retention of Ionizable Solutes
The effect of eluent pH on the retention factor, k, of a monoprotic acid ( HA ↔ H+ + A− ) or base





where k0 and k1 are the retention factors of the neutral and fully ionized species of these ionogenic
analytes, j is an indicator parameter, which is equal to 1 for acids and −1 for bases and pK = −logK,
K being the equilibrium constant of the appropriate acid/base equilibrium in the eluent, given by
K = [
H+][A−]
[HA] for a monoprotic acid and by K =
[H+][B]
[BH+] for a monoprotic base. Note that the values
of k0, k1, and pK depends on the organic content of mobile phase and can be determined by fitting
to Equation (1) either isocratic data obtained in different eluent pHs modified with the same organic
content or by fitting gradient data of a fixed change of organic content with a fixed gradient duration
in different eluent pHs [13].
The influence of eluent pH on the retention of each of the examined solutes is shown in Figure 1
created by fitting to Equation (1) the experimental retention data obtained under isocratic conditions
in different eluent pHs with φACN = 0.3, which are given in Table S1. From this figure it is clear the
influence of pH on the different types of ionogenic analytes, as well as the superiority of eluent pH 3
in the separation of the test mixture of ionized and non-ionized solutes tested.
 
Figure 1. Variation of tR as a function of mobile phase pH for each of the examined solutes. Points
are experimental data taken from Table S1 for isocratic runs performed in different eluent pHs with
φACN = 0.3. Lines are obtained by fitting experimental data of ionized solutes to Equation (1).
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3.2. Computer-Aided Separation Optimization in Different Eluent pHs
A computer-assisted separation optimization of a mixture of solutes comprising a visualization of
predicted chromatograms involves the following steps [6]:
1. An initial experimental study of the chromatographic behavior of solutes obtained by the least
number of chromatographic runs adequately selected.
2. The fitting of the experimental retention data of each solute to a retention model in order to
determine its adjustable parameters.
3. The modeling of the peak shape of analytes in the form of a preferred function.
4. The determination of the optimal separation conditions—i.e., the conditions that lead to the best
separation of solutes under consideration—based on the above determined retention and peak
shape parameters of solutes.
5. The comparison of the simulated chromatogram plotted under the optimal predicted conditions
with the corresponding experimental chromatogram recorded under the same conditions in order
to test the accuracy of the optimization process.
The whole separation optimization procedure of the test analytes under isocratic conditions as
well as under single linear φ-gradients in different eluent pHs was implemented on different MS Excel
spreadsheets. The optimization procedure followed for separation optimization in eluent pH 3 is given
as an example.
The isocratic retention data of solutes, tR(exp), given in Table S1 and obtained on the Kinetex
5 μm EVO C18 column with different ACN volume fraction (φ = 0.3, 0.4, and 0.5) in eluent pH 3 were
fitted to the quadratic retention model lnk = c0 + c1ϕ+ c2ϕ2 [14] (where k is the solute retention factor,
k = (tR − t0)/t0, and φ is the volume fraction of ACN in the mobile phase) using the spreadsheet
‘retention fit’ of the file “Optimization in eluent pH 3 modified with ACN” provided in the Supporting
Information. Note that, although the spreadsheet ‘retention fit’ is designed for fitting isocratic retention
data to the quadratic retention model, the linear retention model, lnk = c0 + c1ϕ, could be used instead,
if the chromatographic behavior of solutes was studied in a very narrow range of φ.
After correction of the baseline of the experimental chromatograms recorded in eluents with
φACN = 0.3 and 0.4 by pressing Ctrl+q on the spreadsheet with the name ‘BLcor.’, available in
“Optimization in eluent pH 3 modified with ACN” file, modeling of the peak shapes is straightforward.








the spreadsheet ‘peak shape fit’ is used. This spreadsheet is designed to estimate the peak shape
parameters (h0, h1, h2, D0, D1, and D2) of a quadratic dependence of both peak height, h, and peak
width, D, on tR, given by h(tR) = h0 + h1tR + h2t2R and D(tR) = D0 + D1tR + D2t
2
R. It should be
noted that the data for two experimental chromatograms are enough for the above procedure since the
peaks experimentally recorded in this study permit a linear dependence of both the peak height and
peak width on tR instead of the quadratic one initially assumed.
After the retention times and peak shape parameters for all of the solutes studied under isocratic
conditions have been estimated, the values of these parameters (i.e., c0, c1, c2, h0, h1, h2, D0, D1, and D2)
are transferred into the spreadsheet ‘isocr.optim.’ in “Optimization in eluent pH 3 modified with ACN”
file. A screenshot of this spreadsheet is displayed in Figure 2. The isocratic separation optimization of
the sample mixture is easily automated by pressing Ctrl+w. Then, the minimum resolution, Rs, and the
maximum of tR values, tR(max), of all solutes separated under isocratic conditions in eluent pH 3 are
recorded as a function of the organic content φ on columns A, B, and C, where φ is altered between two
values (φ(min) = 0.3 and φ(max) = 0.5, preset in cells B15 and B16) with a selected interval δφ = 0.005
placed in cell B17. Simultaneously, the values of Rs and tR(max) vs. φ are plotted in a graph, see the inset
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Graph A of the layout of this worksheet, and simulated chromatograms are generated for each mobile
phase strength φ in the inset Graph B of the worksheet. The execution of the macro is accomplished
by finding the optimal eluent, φACN = 0.365, which leads to the best separation of the sample—i.e.,
the separation with a desirable value of resolution—Rs = 1.5 (preset in cell D11), in the shortest
separation time, which in this case is only 10.36 min. The inset Graph B of Figure 2 depicts a perfect
similarity between the simulated chromatogram created for the optimal eluent with φACN = 0.365
(plotted as the red solid line) and the original experimental one (plotted as the blue dashed line).
 
Figure 2. Screenshot of the MS Excel supplementary spreadsheet ‘isocr. optim.’ used for isocratic
separation optimization of solutes in eluent pH 3 modified with ACN. See the text for details.
A procedure similar with that described above for isocratic separation optimization and simulation
is also followed for optimizing single linear gradient conditions and simulating chromatograms
obtained under selected different gradient profiles. A screenshot of the spreadsheet ‘grad. optim.’ is
depicted in Figure 3.
The values of φ0 and φf—i.e., φ0 = 0.3 and φf = 0.5 for the data set analyzed—are placed in cells
G2 and G3, respectively, the features of chromatographic system—i.e., the values of tD = 0.73 min
and t0 = 0.983 min in cells B9 and B10—whereas the estimated retention and peak shape parameters
of all solutes are transferred in cells I2:Q10. Note that, in this procedure the retention adjustable
parameters, c0, c1, and c2, were determined in the worksheet ‘retention fit’ from initial isocratic
conditions. In contrast, the peak shape parameters, h0, h1, h2, D0, D1, and D2, were obtained from
gradient runs between φ0 = 0.3 to φf = 0.5 with different gradient durations, tG = 5 and 20 min,
in the worksheet ‘peak shape fit’, since the peak widths in gradient elution are normally compressed
compared to those obtained under isocratic conditions. By pressing Ctrl+e, the minimum resolution,
Rs, and the maximum of tR values, tR(max), of all solutes separated under gradient conditions with
different gradient durations, tG, are calculated in columns A, B, and C, where tG, varied between two
values, tG(min) = 5 min and tG(max) = 20 min, defined in cells B15 and B16 with a selected interval
δtG = 0.5 min (placed in cell B17). Moreover, a plot is simultaneously created with these values of
Rs and tR(max) vs. tG, as well as a graph is generated for simulated chromatograms obtained under
different gradient profiles. Again, the execution of the macro is accomplished by finding the optimal
gradient duration, tG = 6.5 min, which leads to the best separation of the sample—i.e., the separation
with a satisfactory resolution, i.e., Rs = 1.5 (preset in cell D10)—in the shortest separation time, which in
this case is only 8.15 min. The inset Graph B of Figure 3 depicts a perfect similarity between the
predicted/simulated chromatogram in the optimal gradient elution with a duration tG = 6.5 min
(plotted as the red solid line) and the original experimental one (plotted as the blue dashed line).
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Figure 3. Screenshot of the MS Excel supplementary spreadsheet ‘grad. optim.’ used for separation
optimization under single linear gradient conditions of solutes in eluent pH 3 modified with ACN.
See the text for details.
The same optimization approach is applied to chromatographic data obtained under isocratic
conditions as well as under single linear φ-gradients in other examined eluent pHs—i.e., at pH = 2,
5 and 7, respectively—depicted in Table S1. The retention data recorded in eluent pH = 9 were not
analyzed by means of the above spreadsheet optimization program since peak shape distortions
appeared for some solutes at that mobile phase pH. The optimal conditions found for the separation of
test mixture of solutes on the Kinetex 5 μm EVO C18 column in different eluent pHs are summarized in
Table 1. The chromatograms recorded under the optimal gradient conditions found by the optimization
algorithm are depicted in Figure 4. In the same Figure, the influence of mobile phase pH on the elution
order as well as on the peak shape of ionizable compounds is also illustrated.




in an Eluent Modified with ACN
Optimum Gradient Conditions for the Linear
Variation of φACN from φ0 = 0.3 to φf = 0.5
φACN Rs tR(max), min tG, min Rs tR(max), min
2 0.370 1.41 9.87 6.5 1.47 8.10
3 0.365 1.45 10.96 6.5 1.48 8.15
5 0.365 1.38 10.40 5.0 1.43 7.46
7 0.370 1.42 10.07 6.0 1.42 7.93
 
Figure 4. UV detected chromatograms of the mixture of 8 ionized and non-ionized solutes obtained
on Kinetex 5 μm EVO column under optimal gradient conditions in different eluent pHs. The elution
order of solutes is shown in the Figure. See Table 1 for details of optimal gradient conditions.
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3.3. Utility of Computer-Aided Separation Optimization
Once the optimal separation conditions of the sample of interest were found for the Kinetex 5 μm
EVO C18 column by the proposed Excel-spreadsheet-based software, the effectiveness of the same
optimal conditions into separation of solutes in different reversed-phase-type columns of the same
size was tested. Indeed, a perfect resolution of the sample of interest is achieved in the chromatograms
recorded in different columns under the optimal conditions determined for the Kinetex 5 μm EVO C18
column; see, as an example, Figure 5 for the application of optimal gradient conditions determined at
eluent pH 3. Consequently, the optimal conditions derived for the separation of a sample on a certain
column by the optimization algorithm could be successfully applied to other columns of the same type
and size. Moreover, in Figure 5, the superiority of the core–shell technology columns and especially of
the Kinetex EVO column is illustrated, since it is clear that a complete separation of test compounds
was achieved within the minimum run time.
 
Figure 5. UV detected chromatograms of the mixture of 8 ionized and non-ionized solutes obtained
on different columns under optimal gradient conditions found for eluent pH = 3 and Kinetex 5 μm
EVO column. The elution order of solutes is shown in the Figure. See Table 1 for details of optimal
gradient conditions.
The importance and the advantages of performing a computer-aided separation optimization
are clearly shown in Figures 6 and 7. Figure 6 is a screenshot of the MS Excel spreadsheet ‘isocr.
optim.’ used for isocratic separation optimization of test solutes in eluent pH 3 modified with MeOH.
The retention data recorded in this eluent, depicted in Table S1, were analyzed by means of the
Excel-spreadsheet optimization program following a procedure similar to that described above for
separation optimization in eluent pH 3 modified with ACN. The optimal eluent, φMeOH= 0.575 was
automatically found by pressing Ctrl+w. However, the selection of the optimal separation conditions
is also possible from a good appreciation of the inset Graph A of Figure 6, which is also automatically
created as described above. As shown in this figure, tR(max), decreases with increasing organic
content φ in the mobile phase (purple circle markers), as is expected for a reversed-phase-type elution.
However, the dependence of Rs (the resolution of the least resolved pair of adjacent solutes) on φ
(depicted by the green diamond markers) is rather peculiar. For example, the resolution in mobile
phases with either φMeOH = 0.46 or φMeOH = 0.52 is almost zero, which means that at least two
solutes co-elute under the above isocratic conditions even though the run times, i.e., the values of
tR(max) correspond to these eluent concentrations are longer than that in the optimal eluent with
φMeOH = 0.575. Consequently, the foreknowledge of the precise dependence of Rs and tR(max) upon φ,
provided by Excel-spreadsheet-based software adopted in this study and not by a trial-and-error
method gives chromatographers a feel of confidence for the selection of the optimal conditions for a
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desired separation. Indeed, Figure 7 depicts a perfect resolution of the test solutes in the chromatogram
recorded on the Kinetex 5 μm EVO C18 column and in the optimal eluent with φMeOH = 0.575.
In contrast, the resolution of the same sample in a mobile phase with φMeOH = 0.5 is worse than that in
an eluent φMeOH = 0.575 even though the separation time is longer, see also Figure 7.
 
Figure 6. Screenshot of the MS Excel spreadsheet ‘isocr. optim.’ used for isocratic separation
optimization of solutes in eluent pH 3 modified with MeOH. See the text for details.
 
Figure 7. UV detected chromatograms of the mixture of eight ionized and non-ionized solutes obtained
on Kinetex 5 μm EVO column under different isocratic conditions in eluent pH = 3 modified with
MeOH. The elution order of solutes is shown in the Figure.
4. Conclusions
In this study, the whole separation optimization procedure of the test analytes under isocratic
conditions as well as under single linear φ-gradients in different eluent pHs was successfully
implemented by using an Excel-spreadsheet-based software, a user-friendly and widespread software
platform, based on a few initial experiments for each eluent pH: three isocratic runs and two single
linear φ-gradient runs performed in the studied range of mobile phase strength, φ. In the adopted
optimization process, for computational simplicity, the solute retention parameters were obtained from
the analysis of isocratic data, whereas a Gaussian function was used to fit peak shapes. The importance
and the advantages of performing a computer-aided separation optimization compared with a
trial-and-error optimization method were realized. The optimal separation conditions derived by
the optimization algorithm for the separation of the sample of interest on a certain reversed-phase
column were successfully applied to other same-type columns of the same size. The superiority of the
core–shell technology columns and especially of the Kinetex EVO column was illustrated. In general,
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we consider that the results of this study could give chromatographers a feel of confidence for the
selection of the optimal separation conditions for a sample of ionizable and neutral compounds in
reversed-phase columns.
Supplementary Materials: The following are available online at www.mdpi.com/2297-8739/5/1/19/s1, Table S1:
Experimental retention data, tR(exp) in min, of test solutes obtained on the Kinetex 5 μm EVO C18 column and
under isocratic and linear gradient conditions in different eluent pHs modified with ACN or MeOH (PDF),
Excel-spreadsheet-based software: “Optimization in eluent pH 3 modified with ACN” (ZIP).
Author Contributions: The experimental design was constructed and supervised by A.P.-L. The experiments
were performed by A.M.M. and E.B. The data were analyzed by C.Z. The manuscript was drafted and written by
A.P.-L. and C.Z.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Jupille, T.; Snyder, L.; Molnar, I. Optimizing multi-linear gradients in HPLC. LC-GC Eur. 2002, 15, 596–601.
2. Concha-Herrara, V.; Vivó-Truyols, G.; Torres-Lapasio, J.R.; García-Alvarez-Coque, M.C. Limits of multi-linear
gradient optimization in reversed-phase liquid chromatography. J. Chromatogr. A 2005, 1063, 79–88.
[CrossRef]
3. Fasoula, S.; Zisi, C.; Gika, H.; Pappa-Louisi, A.; Nikitas, P. Retention prediction and separation optimization
under multilinear gradient elution in liquid chromatography with Microsoft Excel macros. J. Chromatogr. A
2015, 1395, 109–115. [CrossRef] [PubMed]
4. Debrus, B.; Lebrun, P.; Rozet, E.; Schofield, T.; Mbinze, J.K.; Marini, R.D.; Rudaz, S.; Boulanger, B.; Hubert, P.
A new method for quality by design robust method optimization in liquid chromatography. LC-GC Eur.
2013, 26, 370–375.
5. Tyteca, E.; Liekens, A.; Clicq, D.; Fanigliulo, A.; Debrus, B.; Rudaz, S.; Guillarme, D.; Desmet, G. Predictive
elution window shifting and stretching as a generic search strategy for automated method development for
liquid chromatography. Anal. Chem. 2012, 84, 7823–7830. [CrossRef] [PubMed]
6. Fasoula, S.; Nikitas, P.; Pappa-Louisi, A. Teaching simulation and computer-aided separation optimization
in liquid chromatography by means of illustrative Microsoft Excel spreadsheets. J. Chem. Educ. 2017, 94,
1167–1173. [CrossRef]
7. Canals, I.; Valkó, K.; Bosch, E.; Hill, A.P.; Rosés, M. Retention of ionisable compounds on HPLC. 8. Influence
of mobile-phase pH change on the chromatographic retention of acids and bases during gradient elution.
Anal. Chem. 2001, 73, 4937–4945. [CrossRef] [PubMed]
8. Andrés, A.; Rosés, M.; Bosch, E. Gradient retention prediction of acid–base analytes in reversed phase liquid
chromatography: A simplified approach for acetonitrile–water mobile phases. J. Chromatogr. A 2014, 1370,
129–134. [CrossRef] [PubMed]
9. Christian, G.D.; Purdy, W.C. The residual current in orthophosphate medium. J. Electroanal. Chem. 1962, 3,
363–367. [CrossRef]
10. Horvath, C.; Melander, W.; Molnar, I. Liquid chromatography of ionogenic substances with nonpolar
stationary Phases. Anal. Chem. 1977, 49, 142–154. [CrossRef]
11. Wiczling, P.; Kaliszan, R. pH gradient as a tool for the separation of ionizable analytes in reversed-phase
high-performance chromatography. Anal. Chem. 2010, 82, 3692–3698. [CrossRef] [PubMed]
12. Nikitas, P.; Pappa-Louisi, A.; Zisi, C. pH-gradient reversed-phase liquid Chromatography of ionogenic
analytes revisited. Anal. Chem. 2012, 84, 6611–6618. [CrossRef] [PubMed]
13. Fasoula, S.; Zisi, C.; Nikitas, P.; Pappa-Louisi, A. Retention prediction and separation optimization of
ionizable analytes in reversed-phase liquid chromatography by organic modifier gradients in different eluent
pHs. J. Chromatogr. A 2013, 1305, 131–138. [CrossRef] [PubMed]
14. Schoenmakers, P.J.; Billiet, H.A.H.; de Galan, L. Description of solute retention over the full range of mobile
phase compositions in reversed-phase liquid chromatography. J. Chromatogr. A 1983, 282, 107–121. [CrossRef]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution







Tel. +41 61 683 77 34






St. Alban-Anlage 66 
4052 Basel 
Switzerland
Tel: +41 61 683 77 34 
Fax: +41 61 302 89 18
www.mdpi.com ISBN 978-3-03936-931-7 
